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ABSTRACT 
 
Cytochrome P450s represent a promising class of biocatalysts which has emerged as an 
alternative and eco-friendly synthesis route for fine chemicals and pharmaceuticals in the 
past decade. Protein engineering of cytochrome P450s offer opportunity to generate tailor-
made biocatalysts that match industrial demands. The work described in this thesis tackles 
two major hurdles while employing P450s in cell free reaction systems – multi-component 
nature of P450s and the necessity of NAD(P)H, an expensive co-factor for the conversion of 
substrate to product. The work described in this thesis has been performed using 
cytochrome P450cin. 
Cytochrome P450cin is a multi-component bacterial monooxygenase consisting of three 
domains namely CinA (heme), CinB (cindoxin reductase, FAD) and CinC (cindoxin, FMN). It 
stereo specifically converts 1,8-cineole to 2-β-hydroxy-1,8-cineole using NADPH as the 
reduction equivalent. CinB is usually replaced in activity measurements by the E. coli 
NADPH-ferredoxin (flavodoxin) reductase (Fpr) since CinB is not expressible in an active 
form. 
The first part of the thesis describes a novel, technically simple and enzyme free method (P- 
LinK-Protein fusion with variable linker insertion) for generation of fusion proteins with 
variable linker length. Using P-Link CinC was fused to the C terminal end of CinA through 
sixteen different linker lengths in a single experiment employing three PCRs. Enzymatic 
activity screening of the linker library revealed that a linker length between 8 and 12 amino 
acids is optimal in terms of 1,8-cineole hydroxylation activity. The highest activity was 
observed for fusion protein with a linker length of 10 amino acids.  
The second part of the thesis describes characterization of the CinA-CinC fusion protein 
with a linker length of 10 amino acids. Investigation using computational and experimental 
approach indicates that the electron transfer pathway in the P450cin fusion protein is 
predominantly intermolecular and that the length of the linker separating the fused 
domains is crucial in determining the activity of the fusion protein.  
In the third part of the thesis, the CinA-linker-10 aa-CinC fusion protein was engineered 
using random and rational protein engineering for improvement in 1,8-cineole 
hydroxylation activity using alternative co-factor system. The main goal of the protein 
engineering campaign was to replace NADPH in cell free reactions with alternative co-factor 
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system. Two different alternative co-factor systems have been investigated 
(Zn/Co(III)sepulchrate and the second was a bioelectrocatalytic approach employing 
platinum electrodes and Co(III)sepulchrate). For the approach using Zn/Co(III)sepulchrate 
a mutant KB8 carrying four mutations (Q385H/V386S/T77N/L88R) showed a 3.8 times 
improved catalytic efficiency (kcat /Km) (keff = 27.77 µM min-1 mM-1) compared to the 
starting wild type variant (CinA-linker10aa-CinC) (keff = 7.4 µM min-1 mM-1). kcat value for 
mutant KB8 (2.5 µM min-1) improved by about 4-fold as compared to the wild type (0.67 µM 
min-1) with no significant change in the Km value (90 µM). Total turnover numbers for the 
mutant KB8 were determined to be 1170 and 480 using 5 mM and 1 mM 1,8-cineole 
concentration respectively. A rational protein engineering approach was performed and 
amino acid residues 79, 80, and 81 were selected based on docking studies of 
Co(III)sepulchrate in the active site of the P450cin fusion protein with 10 amino acid linker 
length. The sites 79, 80, and 81 completed a putative path of electron transfer from the 
Co(III)sepulchrate to the active site of the enzyme. A mutant KB9 
(Q385H/V386S/P79G/R80D/Y81S) with 1.5 fold improvement in activity was identified 
after screening of simultaneous site saturation library at the selected positions (amino acid 
residues 79, 80, and 81). 
Preliminary investigation using electrobiocatalytic reactions employing platinum and 
Co(III)sepulchrate displayed highest product formation (61 µM µM-1 P450) in a reaction 
time of 6 h for the mutant KB8 which is approximately 3 times higher than that obtained for 
WT variant (CinA-linker10aa-CinC) (23 µM µM-1 P450). 
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ALA    5-Aminolevulinic Acid Hydrochloride 
Co(III)sepulchrate  Cobalt (III) sepulchrate 
CYP    Cytochrome P450 Monooxygenase 
dATP    Deoxyadenosine triphosphate 
dGTP    Deoxyguanosine triphosphate 
ddH2O    Double distilled water 
DEAe    Diethylethanolamine 
DMSO    Dimethyl sulfoxide 
DNA    Deoxyribonucleic acid 
dNTP    deoxynucleotide triphosphate 
E. coli    Escherichia coli 
e.g.    exempli gratia (for example) 
FAD    Flavin Adenine Dinucleotide 
FID    Flame ionization detector 
FMN    Flavin Mononucleotide  
GC    Gas Chromatography 
h    Hour(s) 
IPTG    Isopropyl-β-D-thiogalactopyranoside 
Kan    Kanamycin 
kb    Kilobase(s) 
kDa    Kilo Dalton  
LB     Luria-Bertani Medium 
min    Minutes 
MTP    Microtiter Plate 
NADPH   Nicotinamide adenine dinucleotide phosphate 
n.d.    Not determined 
OD600    Optical density of viable bacteria at 600 nm 
PCR    Polymerase Chain Reaction 
rpm    Revolutions per minute 
SDM    Site Directed Mutagenesis  
SDS-PAGE   Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SeSaM    Sequence Saturation Mutagenesis 
SOC    Super optimal broth with catabolic repressor  
TB    Terrific Broth Medium 
TLC    Thin layer chromatography 
UV    Ultra Violet 
WT    Wild type 
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1. INTRODUCTION 
1.1 Enzymes: Towards “Green Chemistry”  
 
Enzymes are highly specialized proteins, present in every living organism and catalyze 
innumerable different chemical reactions necessary to sustain life. In the field of chemistry, 
enzymes are capable of performing chemical reactions with high regio and stereo selectivity 
in comparison to chemical catalysts, act under mild conditions of temperature and pressure 
as opposed to chemical catalysts and generate practically no toxic waste products (Cooper, 
2000). Thus they provide an environmentally friendly “green chemistry” approach to 
perform preparative chemical synthetic reactions. United States Environmental Protection 
Agency defines green chemistry as the design of chemical products and processes that 
reduce or eliminate the use or generation of hazardous substances. It applies to the use or 
generation of a chemical product including its design, manufacture, use and disposal. The 
impressive repertoire of these biocatalysts can be utilized as an alternative to chemical 
synthesis (Koeller and Wong, 2001). 
However, enzymes are extremely well suited for supporting life but are usually not very 
suitable for applications in industry and technology. There has been a tremendous progress 
in tailoring enzymes by protein engineering and design to develop “new and improved 
biocatalysts” (Bornscheuer et al., 2012; Schmid et al., 2001; Woodley, 2008). Various 
reports on improvement of biocatalysts include evolution of cellulases for applications in 
paper and textile industry (Datta et al., 2010; Kuhad et al., 2011; Lehmann et al., 2012), 
proteases for applications in detergent and laundry industry (Gupta et al., 2002; Martinez et 
al., 2013; Maurer, 2004), cytochrome P450s for applications in production of fine chemicals 
and pharmaceutical intermediates (Dennig et al., 2012; Urlacher and Girhard, 2012). 
 
1.2 Cytochrome P450 Monooxygenases 
 
Cytochrome P450 monooxygenase (CYP450s or CPYs) is one of the largest superfamily of 
heme-thiolate proteins. Present nearly in all genomes of the biological kingdom (De 
Montellano, 2005; Denisov et al., 2005), they catalyze oxidation of diverse range of 
endogenous and exogenous compounds in human, bacteria and plants (Bernhardt, 2006). 
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The terminology P450 describes the spectral properties of this enzyme class. Cytochrome 
P450s are named after their unusual spectral properties displaying absorption maxima at 
450 nm of the reduced carbon monoxide bound complex (Omura and Sato, 1964). This 
spectral feature of P450s is induced by a cysteine thiolate group forming the fifth ligand of 
the heme iron and classifies cytochrome P450 enzymes as heme-thiolate proteins (Ichikawa 
and Yamano, 1967; Murakami and Mason, 1967). Cytochrome P450s usually act as terminal 
monooxygenases. The classification of P450s in the enzyme group is as shown in Figure 1.1. 
 
Figure 1.1. Assignment of Cytochrome P450 to enzyme group. P450 are highlighted with 
dark grey colored subgroups. Figure taken from (Hannemann et al., 2007). 
 
Cytochrome P450 primarily catalyzes oxidation reaction by insertion of one atom of 
molecular oxygen into an organic substrate. Oxidation reactions are manifested as 
hydroxylation, oxygenation, epoxidation, dealkylation and are usually highly regioselective 
and stereoselective (Jung et al., 2011) (Figure 1.2). Selective C-H oxyfunctionalization at 
unactivated carbons, one of the most challenging reactions in synthetic chemistry is 
performed by P450s especially in water, at room temperature and under atmospheric 
pressure (Cryle et al., 2003; Whitehouse et al., 2012). 
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Figure 1.2. Reactions catalyzed by Cytochrome P450 monooxygenases (Cryle et al., 2003; 
Whitehouse et al., 2012; Fasan 2013). 
 
1.2.1 Catalytic Mechanism of P450s 
 
P450s catalyze the incorporation of one atom of molecular oxygen into various substrates. 
For this reaction P450s obtain their electrons from NADPH or NADP and shuttle it to the 
catalytic heme center via one or more electron transfer proteins (Jung et al., 2011; Urlacher 
and Girhard, 2012). 
 
     R-H + NAD(P)H + H+      P450 monooxygenase     ROH + NAD(P)+ + H2O 
  O2  
Scheme 1. A typical reaction catalyzed by P450 monooxygenases during hydroxylation of 
substrates. The reaction is characterized by insertion of one oxygen atom from molecular 
oxygen to the substrate (R-H) to form the product (R-OH) with parallel reduction of the 
other oxygen atom to water. 
 
The catalytic cycle of P450s has been a topic of extensive research since 1950s in an 
attempt to decipher the mechanism of oxygen activation and its subsequent transfer to non-
activated carbon atoms by P450 monooxygenases. The general scheme of reaction 
mechanism considered universal for all P450s is shown in Figure 1.3. 
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The substrate binds to the ferric form of protein in close proximity to the heme (Figure 1.3, 
step I). This results in a dramatic increase in redox potential of the heme iron, enabling it to 
accept an electron from the electron transfer protein. Transfer of electron is coordinated by 
electron transport proteins. The main function of these electron transfer proteins is 
uncoupling two electrons from the reducing equivalents (NADH or NADPH) and funneling 
them singly to the catalytic heme domain. The transfer of this electron results in the 
formation of ferrous state of the enzyme (Figure 1.3, step II). This reduced form of the 
enzyme can now bind to molecular oxygen forming ferrous dioxy complex (Figure 1.3, 
step III) which in turn is further reduced to ferric peroxy anion (Figure 1.3, step IV). 
Protonation of the ferric peroxy anion produces a highly unstable hydroperoxo-iron species 
(Fe(III)-OOH) (Figure 1.3, step V). Hydroperoxo-iron species upon further protonation 
forms iron-oxo Fe(V)=O complex (compound I) with simultaneous release of a water 
molecule (Figure 1.3, step V). Interaction of the substrate with compound I through radical 
rebound mechanism leads to the formation of a hydroxylated product (Figure 1.3, step VI) 
(De Montellano, 2005; Denisov et al., 2005; Makris et al., 2005; Meunier et al., 2004). 
 
 
 
Figure 1.3. Catalytic cycle of P450 monooxygenases. Figure adapted from Cryle et al., 2003. 
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1.2.2 Classification of Electron Transport Systems for Cytochrome P450s  
 
Cytochrome P450s belong to external monooxygenases (Figure 1.1), implicating the need 
for an external electron donor necessary for oxygen activation and subsequent substrate 
hydroxylation. Genomic, biochemical and biophysical characterization of cytochrome P450 
monooxygenases revealed a great diversity in the molecular organization of the P450s and 
their redox partners (McLean et al., 2005; McLean et al., 2007; Urlacher and Girhard, 2012). 
Initially cytochrome P450s were grouped in two main classes. First, the adrenal 
mitochondrial P450 systems in which electrons were shuttled from NADPH via 
adrenodoxin and adrenodoxin reductase. Second, the liver microsomal P450s in which 
electrons from NADPH are transferred via a FAD-FMN containing reductase to the P450 
monooxygenase. The first bacterial cytochrome P450 system discovered was a camphor 
monooxygenase and it was organized analogously to the mitochondrial one. Electrons were 
transferred via an iron –sulfur cluster [2Fe-2S] to P450cam. Later, CYP102 (P450 BM3) was 
discovered showing an unusual property, a fusion of the P450 and the reductase 
components into one polypeptide chain. Since then, several unusual electron transfer 
partner complexes for different P450s have been described (Figure 1.3, Table 1.1). Figure 
1.4 and table 1.1 shows ten different classes of cytochrome P450s with their electron 
transfer chain components (Hannemann et al., 2007). 
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Figure 1.4. Organization of different cytochrome P450 systems. Adapted from (Hannemann 
et al., 2007). 
(I) Class I, bacterial system; (II) Class II, mitochondrial system; (III) class II microsomal 
system; (IV) class III, bacterial system e.g. P450cin; (V) class IV, bacterial thermophilic 
system; (VI) class V, bacterial [Fdx]- [P450] fusion system; (VII) class VI, bacterial [Fldx]- 
[P450] fusion system; (VIII) class VII, bacterial [PFOR]- [P450] fusion system; (IX) class VIII, 
bacterial [CPR]- [P450] fusion system; (X) class IX, soluble eukaryotic P450nor. 
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Table 1.1. Classes of P450 systems classified depending on the topology of the protein 
components involved in the electron transfer to the P450 enzyme. Table has been taken 
from Hanemann et al., 2006. 
 
Class/Source Electron Transport Chain Location/Remarks 
Class I 
Bacterial 
Mitochondrial  
 
NAD(P)H      [Fdr]      [FdX]     [P450] 
NADPH     [Fdr]      [FdX]      P450 
Cytosolic, soluble, P450cam from 
Pseudomonas putida 
Class II 
Bacterial 
Microsomal A 
Microsomal B 
Microsomal C 
 
NADH      [CPR]      [P450]  
NADPH     [CPR]      [P450] 
NADPH     [CPR]     [cytb5]     [P450] 
NADH     [cytb5Red]    [cytb5]    [P450]  
Cytosolic, soluble; Streptomyces 
carbophilus 
Membrane anchored, ER 
Membrane anchored, ER 
Membrane anchored, ER 
Class III 
Bacterial  
NAD(P)H      [Fdr]     [FldX]    [P450] Cytosolic, soluble, P450cin from 
Citrobacter braakii 
Class IV 
Bacterial 
Pyruvate     [OFOR]    [FdX]     [P450]   Cytosolic, soluble, Sulfolobus 
tokadaii 
Class V 
Bacterial 
NADH     [Fdr]      [FdX-P450] Cytosolic, soluble, Methylococcus 
capsulatus 
Class VI 
Bacterial 
NAD(P)H      [ FdR]     [Fldx-P450] Cytosolic, soluble, Rhodococcus 
rhodochrous strain 11Y 
Class VII 
Bacterial 
NADH      [PFOR-P450] Cytosolic, soluble, Rhodococcus sp 
strain,   
Class VIII 
Bacterial, Fungal 
NADPH     [CPR-P450] Cytosolic, soluble, Bacillus 
megaterium, Fusarium oxysporum 
Class IX 
Only NADH 
dependent, Fungal 
[NADPH]        [P450] Cytosolic, soluble, Fusarium 
oxysporum 
Class X 
Independent in 
plants /mammals 
P450 Membrane bound, ER 
 
 
1.2.3 Artificial Cytochrome P450 Fusion Proteins 
 
Various classes of cytochrome P450s classified on the basis of proteins involved in electron 
transfer to heme center are described above (Table 1.1 and Figure 1.3). Most prokaryotic 
P450s are three component systems and eukaryotic P450s are membrane bound requiring 
another membrane associated redox protein for their function. A variety of polycistronic 
expression systems have been described for construction of catalytically active 
multicomponent systems systems (Kim and de Montellano, 2009; van Beilen et al., 2006).  
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However the application of multicomponent P450s as oxidation catalyst still remains 
challenging. After the discovery of natural fusion of heme and reductase domains (P450 BM 
3), efforts were made to generate artificial fusion proteins or search for new self-sufficient 
cytochrome P450s. The first self-sufficient bacterial P450 system was constructed by fusing 
P450cam and its natural redox partners, putidaredoxin reductase (PdR) and putidaredoxin 
(Pdx); P450cam-Pdx-PdR catalyzed the conversion of camphor to 5-exo-hydroxy-camphor 
(Sibbesen et al., 1996). However, the activity of the fusion protein reached only 30% as 
compared to the activity obtained after using an equimolar mixture of its individual 
components. A recent study reports the construction of fusion protein fusion for P450cam 
by employing enzymatic cross linking of lysine tagged PdX with a peptide fragment 
between PdX and P450cam containing a reactive glutamyl residue prone to attack by 
transglutaminase. This type of fusion showed a 10-fold higher catalytic activity compared to 
the P450cam-Pdx-PdR fusion described by Sibbesen et al (Hirakawa et al., 2007). In another 
report, Hirakawa et al., used PCNA (proliferating cell nuclear antigen), a trimeric DNA 
binding protein complex, to make a heterotrimeric P450. The three components of 
P450cam monooxygenase system were fused to PCNA1, PCNA2, and PCNA3 to generate 
PCNA1-PdR, PCNA2-Pdx, and PCNA3-P450cam, respectively. Although the specific activity 
of the fusion protein was decreased, the designed complex exhibited a 50-fold higher 
NADPH and oxygen consumption rates compared to the reconstituted system (Hirakawa 
and Nagamune, 2010). 
Recently isolated native fusion of heme domain and its redox partner is P450RhF isolated 
from Rhodococcus sp. NCIMPB 9784. Sabbadin et al. described a general LICRED method for 
rapid generation of libraries of various heme domains fused to the reductase domain of 
P450RhF (RhFRED) as a general redox partner (Sabbadin et al., 2010). The LICRED method 
was demonstrated on heme domains from P450cam and P450 XpIA, and the resulting 
enzymes were shown to be active on their original substrates, d-camphor and hexahydro-
1,3,5-trinitro-1,3,5-triazine (RDX) (Sabbadin et al., 2010). 
One important parameter that governs the activity of fusion proteins is the orientation of 
the fused protein domains and the length of the linker separating these domains. In case of 
P450 BM 3, naturally fused cytochrome P450, the C terminal of heme domain is fused to the 
N terminal of the reductase domain via short stretch of amino acid residues. The role of the  
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linker region is not clear however, it is commonly postulated that the linker region acts as a 
flexible hinge allowing recognition and interaction between the two domains (Hannemann 
et al., 2007; Sevrioukova et al., 1999). Furthermore, Munro et al. reported that the linker 
region might also be responsible for stabilization of the active dimeric form of P450 BM3. 
Previous reports demonstrate that the length of the linker is decisive for activity of fusion 
proteins rather than the amino acid composition of the linker. In two individual studies 
Govindraj and Poulos reported that changing Arg-Lys-Lys stretch in the middle of the linker 
sequence in P450 BM3 to Ala-Ala-Ala does not alter the functional properties of either of 
the two domains. However, deleting three or six amino acids leads to drastic effect of the 
hydroxylation activity of enzyme. The three amino acid deletion mutant exhibited 10% of 
the hydroxylation activity while the six amino acid deletion mutant showed nearly 
undetectable levels of fatty acid hydroxylase activity (Govindaraj and Poulos, 1995, 1996). 
 
1.2.4 Applications of P450s  
 
P450s have received a great attention from industry with an aim to exploit their reaction 
chemistry for production of fine chemicals. P450s also have potential application in 
bioremediation. 
A well-established commercial application of P450s in 11β-hydroxylation is of Reichstein S 
to hydrocortisone with Curvularis sp. at a scale of ~ 100 tons/year: a process which allows 
regio and stereoselective hydroxylation by incorporation of oxygen in Reichstein S 
(www.schering.de; (Petzoldt K, 1982). Furthermore, it has also been used for the 
conversion of progesterone to cortisone by Rhizopus sp. (www.pfizer.com); (Peterson 1952; 
Hogg 1992). 
Development of new and cheap resources for large scale usage of P450s will further aid in 
use of P450s for production of pharmaceuticals and fine chemicals. Streptomyces sp. strain 
Y-110 has been reported to produce Pravastatin, a cholesterol lowering drug (1 g/l) (Lin et 
al., 2011). Another example is Saccharopolyspora erythraea which catalyzes a hydroxylation 
step in the production of macrolide antibiotic erythromycin. The production of anticancer 
drug perrillyl alcohol from limonene has been reported using cytochrome P450 alkane 
hydroxylase isolated from Mycobacterium sp. 
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In addition to this, P450s have also been reported to be used for bioremediation purposes. 
Numerous reports discuss the biodegradation of environmentally harmful pesticides; 
insecticides are other agrochemicals (Guengerich, 1995; Kellner et al., 1997). Several P450 
BM 3 mutants constructed using site directed mutagenesis are reported for degradation of 
polycyclic aromatic hydrocarbons such as phenanthrene, fluoranthrene and pyrene 
(Carmichael and Wong, 2001). 
 
1.3 Cytochrome P450cin 
 
Cytochrome P450cin (CYP176A1) is a bacterial monoxygenase isolated from Citrobacter 
braakii which can grow on 1,8-cineole as its sole source of carbon (Hawkes et al., 2002). 
P450cin catalyzes the stereoselective hydroxylation of 1,8-cineole to (2S)-2β-hydroxy 1,8-
cineole or (S)-6β-hydroxycineole (Scheme 2) (Hawkes et al., 2002; Meharenna et al., 2004). 
 
 
 
 
 
 
Scheme 2. Hydroxylation of 1,8-cineole to 2β-hydroxy 1,8-cineole with multicomponent 
Cytochrome P450cin. 
 
1,8-cineole, a cyclic monoterpene ether, also known as eucalyptol, is the major component 
of the essential oils derived from Eucalyptus polybractea. It imparts the pleasant and unique 
odor associated with the eucalyptus derived essential oils (Miyazawa et al., 2001). In 
industry, it is widely used in cosmetic and pharmaceutical preparations for external 
applications in nasal sprays, disinfectants, as analgesic and food flavoring (Rodrí guez et al., 
2006). The hydroxylated products of 1,8-cineole are chiral intermediates for organic 
chemistry applications. In addition, 2-endo-hydroxy-1,8-cineole and its esters have 
antimicrobial and bactericidal activities and are also used as valuable aroma components 
(Miyazawa and Hashimoto, 2002; Miyazawa et al., 2001). 
 
 
 
 
 
 
 
O 
 
 
 
 
 
 
 
O 
OH 
CinA +CinB + 
CinC 
1,8-cineole 2β-hydroxy 1,8-cineole 
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The three component electron transfer system of P450 consists of a heme-containing active 
center (P450cin/CinA), a flavin adenine dinucleotide (FAD)-containing cindoxin reductase 
(CinB), and a flavin mononucleotide (FMN)-containing cindoxin (CinC), encoded by the cinA, 
cinB and cinC genes respectively. The CIN operon consists of four open reading frames and 
are shown in figure 1.5 (Hawkes et al., 2002). 
 
 
Figure 1.5. Map of the CIN operon that contains the four open reading frames, cinA, cinB, 
cinC and cinD. 
 
The first ORF (cinA) encodes for a 405 amino acid protein with a molecular weight of 
45 kDa. Homology modelling indicated that it belonged to P450 family being similar to a 
number of bacterial P450s. The second ORF (cinB) encodes a 49 kDa, 452 amino acid 
protein which is a NADPH dependent ferrodoxin reductase on the basis of sequence 
homology. cinC encodes a protein (16 kDa, 155 amino acids) that was most similar to the 
FMN containing domain of cytochrome P450 reductase based on homology modelling. A 
fourth ORF (cinD) encodes the protein (1R) - 6β-hydroxycineole dehydrogenase which 
displays a significant homology to a number of short chain alcohol dehydrogenases. The 
cinD gene is divergently transcribed with respect to cinA, cinB and cinC (Figure 1.5) 
(Hawkes et al., 2002; Slessor et al., 2010). cinD exhibits (1R)-6β-hydroxycineole 
dehydrogenase activity, the second step in the degradation of 1,8-cineole. (1R)-6β-
hydroxycineole dehydrogenase displays a strict requirement for NADH, with no reaction 
observed in the presence of NADPH. The enzyme also catalyzes the reverse reaction, 
reducing (1R)-6-ketocineole to (1R)-6β-hydroxycineole (Figure 1.6) (Slessor et al., 2010). 
P450cin shares many properties with P450cam (27 % identity and 46 % similarity) and 
other bacterial P450s however has two unique features. First, the highly conserved, 
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catalytically important threonine residue in the distal I-helix in all P450s involved in 
dioxygen activation is replaced by the Asn242 in P450cin. Site directed mutagenesis and 
crystallographic studies have suggested that Asn242 does not appear to be critical for O2 
activation but instead is essential in regio-selective hydroxylation of the substrate. The 
second difference is unlike P450cam, the active site is not surrounded by non-polar 
residues but instead an intricate lattice of water bridged hydrogen bonds. This water 
network involves residues Tyr81, Asn242 and Asp241. 
 
  
 
 
Figure 1.6. Proposed pathway for 1,8-cineole degradation. The first step is the 
hydroxylation of 1,8-cineole to (1R)-6β-hydroxycineole, which is further oxidized to (1R)-6-
ketocineole by cinD. 
 
Another unique feature of cytochrome P450cin electron transfer system is the presence of 
multicomponent reductase system comprising of FAD (cindoxin reductase, CinB) and FMN 
(cindoxin, CinC) containing electron transfer proteins (Slessor et al., 2010). CinB has strong 
similarity with the FAD containing ferredoxin reductase found in class I adrenal 
mitochondrial system whereas CinC has a strong similarity with class II reductase. 
 
1.4 Electron Transfer in Redox Proteins  
 
Redox (reduction-oxidation) reactions include all chemical reactions in which atom(s) have 
their oxidation state changed and are characterized by transfer of electrons between 
different species. The transfer of electrons between and within proteins is an essential 
feature for many physiological processes including biological energy transfer, metabolism 
CinA +CinB 
     + CinC 
CinD 
1,8-cineole (1R)-6β-hydroxycineole (1R)-6-ketocineole  
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and enzymatic catalysis (Cordes and Giese, 2009; Gray and Winkler, 2009, 2010). The 
electron transfer process in redox protein is complex, versatile and tightly regulated in 
order to minimize energy loses and production of toxic metabolites like hydrogen peroxide 
and superoxide anions (Saab-Rincón and Valderrama, 2009; Wong and Schwaneberg, 
2003). 
Specific and efficient electron transfer in redox proteins depends on the interaction of two 
factors (i) the amino acid residues of the redox enzyme and (ii) the distribution of charged 
and uncharged amino acid residues. The primary sequence of amino acids determines the 
conformation for the co-factor binding pocket which in turn might determine the 
interaction of co-factor and amino acid residues necessary for electron transfer. Secondly, 
the native fold pattern of a protein displays a unique distribution of charged and uncharged 
amino acid side chains that determine the electrostatic potential surrounding the molecule 
(Saab-Rincón and Valderrama, 2009). 
Redox enzymes generally contain metal ions like iron, copper, manganese and are arranged 
in order to assists electron flow and charge separation. The redox centers are placed in 
order of their redox potential, so that the direction of electron flow is established 
thermodynamically (Bizzarri and Cannistraro, 2005). The process of electron transfer in 
redox proteins can be well explained by Marcus theory. In Marcus theory, three factors 
govern the electron transfer within proteins: reorganization energies (quantitatively 
reflecting the structural rigidity in the oxidized and reduced form); potential differences 
and orientations of involved redox active sites; and the distance between the redox active 
site and intervening media (Marcus and Sutin, 1985). 
Direct electrical communication between redox active center and electron donors is usually 
prohibited. Redox enzymes and electrode can be regarded as an electron donor-acceptor 
pair. Electron transfer theory defines the rate of electron transfer between a donor acceptor 
pair by equation 1,  
ket∝ e-β(d-d0)]e 
-(∆G0+λ)2
4RTλ
                                                  Equation 1 
 
Where ΔGo is the change in free energy associated with electron transfer and the generation 
of the redox products; λ is the reorganization energy; d0 is the van-der-Waals distance; d 
the distance separating the donor and acceptor; and β is the electronic coupling co-efficient. 
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The mechanism of electron transfer in cytochrome P450s usually involves protein-protein 
interaction where electrons are transferred from redox proteins to the P450s in a complex 
electron transfer chain (Saab-Rincón and Valderrama, 2009). The redox centers are often 
buried in the protein core, with the protein serving as an insulator and a tight regulation 
over the electron transfer mechanism to avoid wastage of energy resources (Wong and 
Schwaneberg, 2003). One way of improving the activity of redox proteins is by protein 
engineering techniques particularly using rational design. The strategies to engineer a 
redox protein include trimming the protein, protein surface modification, active site 
mutation, domain shuffling or using alternative cofactor systems to substitute or replace 
NADPH in biocatalytic conversions. 
 
1.5 Alternative Co-factor Systems for Cytochrome P450s 
 
The use of isolated cytochrome P450 monooxygenase in catalysis is restricted due to the 
continuous requirement of NADPH in equimolar concentration during technical 
applications. NADPH is extremely expensive to use in cell free reaction systems, 
decomposes over time and is difficult to recover once oxidized (Udit and Gray, 2005). 
Therefore several approaches to substitute or recycle NADPH during biocatalytic 
conversions have been explored. These include co-factor regeneration using enzymatic or 
electrochemical approaches or co-factor substitution systems like mediated electron 
transfer, light induced systems, peroxide shunt pathway, electrochemically driven 
reactions. A useful co-factor regeneration/substitution method should fulfil several 
requirements. First, the enzymes, reagents, electrodes, immobilization matrices, should be 
readily available, inexpensive, easy to manipulate and stable under operational conditions. 
Second reagents used or byproducts of regeneration/substitution step should not 
negatively affect product stability and isolation (Holtmann and Schrader, 2007). 
1.5.1 Co-factor Regeneration 
 
Co-factor regeneration is one of the most commonly used strategy for whole cell 
biocatalysis using cytochrome P450s. Enzymatic co-factor regeneration is most commonly 
reported using enzymes formate dehydrogenase (FDH), glucose dehydrogenase (GDH), 
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glucose-6-phosphate dehydrogenase (G6PDH), and alcohol dehydrogenase (ADH) (Kubo et 
al., 2006; Maurer et al., 2005; Maurer et al., 2003; Michizoe et al., 2005; Müller et al., 2013; 
Wandrey, 2004). But, enzymatic co-factor regeneration approaches generally suffer from 
low enzyme stabilities and complexity of product isolations (Wichmann and Vasic-Racki, 
2005). The most common system is using a dehydrogenase along with a substrate which 
can be oxidized with simultaneous regeneration of NAD(P)H from NADP+ (for instance 
oxidation of formic acid to C02 using formate dehydrogenase)(Tishkov et al., 1999). 
Limitation of this system is the presence of two enzymes in the reaction system and most 
dehydrogenases use NAD+ contrary to NAD(P)H like most P450s. To tackle this, P450 
monooxygenases have been engineered to use NADH as cofactor instead of NADPH (Müller 
et al., 2013). NADH has the advantage to be less expensive and more stable than NADPH. 
Nevertheless, in vivo recycling systems suffer from drawbacks such as limited substrate 
uptake, toxicity of the substrate or product, product degradation and difficult downstream 
processing (Hollmann et al., 2006) as a result various co-factor substitutions systems have 
been reported as described below. 
 
1.5.2 Co-factor Substitution 
 
Strategies to substitute NAD(P)H include use of light induced systems (Shumyantseva et al., 
2002), use of peroxide shunt pathway (Cirino and Arnold, 2003; Joo et al., 1999b), using 
mediators (Nazor et al., 2008; Nazor and Schwaneberg, 2006; Prasad et al., 2005; 
Schwaneberg et al., 2000; Shumyantseva et al., 2000). 
In case of light induced systems, the catalytic enzyme complex is directly reduced by light. 
Shumyantseva et al., reported the covalent attachment of riboflavin to the mammalian 
cytochrome CYP2B4, yielding an artificial flavocytochrome for photo-induced 
intermolecular electron transfer between the isoalloxazine ring cycle of flavins and the 
ferric heme group of cytochrome CYP2B4 (Shumyantseva et al., 2002). Electrochemical 
regeneration of NADPH was described by Reipa et al., through its natural redox partner 
(putidaredoxin) using antimony doped tin oxide working electrode. The oxygen required 
for thr reaction was produced at a Pt counter electrode by water electrolysis. A continuous 
catalytic cycle continued for more than 5 h with approximately 2,600 enzyme turnovers. 
The maximum product formation rate was 36 nmol of 5-exo hydroxycamphor/nmol of 
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CYP101 per min (Reipa et al., 1997). The use of peroxide shunt pathway for P450 catalyzed 
reactions is an interesting approach, however, the enzyme rapidly inactivates at peroxide 
concentration required for catalysis (Cirino and Arnold, 2003; Joo et al., 1999b). Alternative 
approaches include the direct electron transfer (Nazor and Schwaneberg, 2006; 
Schwaneberg et al., 2000) and mediated electron transfer (Nazor et al., 2008) as described 
below. 
 
1.5.2.1 Direct Electron Transfer Systems 
 
Direct electron transfer involves the direct electron transfer to the active site of the enzyme 
from an electron donor. Direct electron transfer was reported for P450 BM 3 in which 
electrons were directly transferred from a conducting polymer Baytron into the active site 
of P450 BM 3 (Nazor, 2007). However the electron transfer is not yet understood on a 
molecular level. 
Direct electron transfer using electrochemical approach has been reported using a variety 
of metal and non-metal electrodes but often without any proof of electrochemically driven 
substrate conversion. One major disadvantage of using direct electrochemically mediated 
catalysis is the instability of enzymes upon interaction with the electrode surface 
(Holtmann and Schrader, 2007). 
Protein engineering and protein surface modification have been reported to tackle this 
problem. Ferapontova and Gorton reported a six-histidine tag at the C terminus of 
horseradish peroxidase, which was adsorbed on a pre-oxidized gold electrode and 
generated more than 30-fold increase in electron transfer rate (Tosstorff et al., 2014). 
Another example was addition of a polylysine chain at the C terminus of glucose oxidase. 
The polylysine chain was added to anchor the electron transfer mediator 
ferrocenecarboxylic acid, for improving sensitivity and stability of glucose biosensors. The 
modiﬁed glucose oxidase showed comparable kinetic parameters to those of the wild-type 
however, the polylysine tagged enzyme retained 90% of its activity whereas the wild type 
retained only 20% (Ferapontova et al., 2002). Another strategy which was reported for 
improving the direct electron transfer include trimming or removing of amino acids 
residues around the active site which are not essential for maintaining protein structure 
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and function. This strategy was successfully employed for improving the electron transfer 
rates of microperoxidase and laccases (Petzoldt K, 1982; You and Arnold, 1996). Davidson 
reported the introduction of active site mutations in methylamine dehydrogenase which led 
to a fourfold improvement in the sensitivity of a histamine sensor owing to a lowered Km 
value (Bao et al., 2002; Davidson, 2003). 
An alternative to direct electron transfer approach is the mediated electron transfer 
systems. Mediated electron transfer systems make use of a mediator (a redox compound) 
which acts as a shuttle between the electron source and enzyme active site. It overcomes 
the limitations of direct electron transfer like dependency of the protein orientation on 
electrode surface or enzyme inactivation. 
 
1.5.2.2 Mediated Electron Transfer Systems 
 
Electroactive heme center is deeply buried inside the protein core and the transfer of 
electrons depends on the orientation of protein and the proximity of protein with the 
electron source. In such a case a mediator can be used to increase the electron transfer 
rates between the electron source and active site of the enzyme. In such a reaction set up, 
mediator must be able to be reduced, e.g. at an electrode at an appropriate potential, and 
the reduced form must be able to transfer the enzyme active site. Faulkner et al., first 
described Cobalt(III)sepulchrate as a mediator for P450 catalyzed hydroxylation reactions 
using platinum electrodes. They replaced NADPH for hydroxylation reaction using mediator 
Co(III)sepulchrate for the electro-catalytically driven -hydroxylation of lauric acid with 
P450 BM 3. However, the turnover rates were nearly 9 folds lower while using 
Co(III)sepulchrate as compared to those obtained for NAD(P)H (Faulkner et al., 1995). 
Cobalt sepulchrate has found a broad application as mediator in P450 catalyzed reactions. It 
acts as an one electron shuttle between the electron source and enzyme, where the cobalt 
atom switches between Co(II) and Co(III) oxidation states (Nazor and Schwaneberg, 2006). 
One promising approach for expensive cofactor regeneration or substitution is the use of 
electrochemical methods. Application of electrochemical methods with P450s has also 
attained a growing attention due to the possibility of developing applications such as 
biosensors and bioreactors (Holtmann and Schrader, 2007; Shumyantseva et al., 2005). 
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Schwaneberg et al., reported the use of Cobalt(III)sepulchrate as mediator for cytochrome 
P450 BM 3 in solution in combination with zinc dust as a cheap source of electrons. Using 
the Zn/Co(III)sepulchrate system a turnover rates of 125 nmol substrate consumed nmol-1 
P450 was obtained which was considerably lower as compared to turnover rates of 574 
nmol substrate consumed nmol-1 P450  using NADPH as a reduction equivalent for a mutant 
of P450 BM3 (Schwaneberg et al., 2000). 
Although, the direct and mediated electron transfer systems provide a promising approach 
for substitution of NAD(P)H in cell free catalysis, they suffer from various drawbacks like 
enzyme inactivation, low enzyme stability, low turnover numbers and low turnover 
frequencies. These drawbacks can be tackled by developing biocatalysts using protein 
engineering techniques to make up for these inadequate properties to obtain a variant for 
electrobiocatalytic applications. 
 
1.6 Protein Engineering 
 
The application of enzymes is constantly increasing for synthesis of pharmaceutical 
intermediates and fine chemicals. The development of genetic engineering methods 
enabled an expansion on the use of enzymes in industry using protein engineering tools. 
Naturally occurring enzymes (wild type) are optimized for physiological conditions; 
however they are not suitable for industrial applications (Arnold, 2001). Limitations 
include low stability (towards temperature, pH and oxidative agents), narrow operating 
conditions (pH, temperature), poor activity in non-aqueous solvents, and low catalytic 
activity for non-natural substrates. The aim of protein engineering approach is to tailor and 
redesign the biocatalysts to make them suitable for industrial applications (Farinas et al., 
2001). 
It also generates valuable information to understand structure- function relationship of an 
enzyme class (Wong et al., 2007). It basically mimics the process of Darwinian evolution in 
a test tube. It however differs from the Darwinian evolution, firstly, it does not create new 
enzymes but improves the properties of existing one (microevolution) and secondly, the 
time scale is reduced from millions of years (natural evolution) to a few months or years 
(protein engineering) (Stemmer and Holland, 2003). Besides improving a native property of 
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an enzyme, protein engineering can also be used to impart and improve non-native 
properties in an enzyme. The most widely used approaches for protein engineering are 
rational design and directed evolution (Arnold, 2001; Wong et al., 2007). A comparison of 
different enzyme engineering approaches is given in Table 1.2. 
 
Table 1.2. Comparison of different enzyme engineering approaches (Chica et al., 2005). 
 Rational 
Design 
Random 
Mutagenesis 
Semi-Rational design 
High throughput 
screening 
Not essential Essential Advantageous 
Structure and/or 
functional information  
Both essential Neither essential Either sufficient 
Probability of obtaining 
synergistic mutants 
Moderate Low High 
Sequence space 
exploration 
Low Moderate Computational: vast  
Experimental:moderate 
 
1.6.1 Directed Evolution of Enzymes 
 
Directed protein evolution is an approach which was introduced in 1967 (Yamane et al 
2004). Starting a directed evolution experiment does not require any knowledge of the 
target protein. It can be applied to enzymes for which no crystal structure is available 
and/or key amino acid positions are unknown. Major steps involved in a directed evolution 
experiment are presented in Figure 1.6. It comprises of I) generation of diversity, II) 
screening of generated mutant library in a screening condition comparable to the final 
application, III) isolation of gene encoding for the improved protein variant. This process is 
repeated in an iterative cycle until a protein variant having desired property is obtained 
(Wong et al., 2007). 
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Figure 1.7. Scheme of a directed evolution experiment in an iterative cycle. Step I- 
generation of mutant library, step II- screening of the generated mutant library to obtain an 
improved variant, step III- isolation of gene encoding for the improved protein variant. 
Figure taken from (Güven et al., 2010). 
 
The two main challenges in a directed evolution campaign are unbiased diversity 
generation and developing a screening/selection system that mimics the desired final 
working condition (Schmidt-Dannert and Arnold, 1999). A variety of chemical and 
molecular biology methods are available for generation of random mutagenesis libraries in 
the gene of interest. A perfect diversity generation method should fulfill seven criteria: I) 
unbiased mutational spectrum II) controllable mutation frequency, III) consecutive 
nucleotide substitution or codon-based substitution, IV) enable subset mutagenesis, V) 
independence of gene length, VI) technically simple and reproducible and VII) economical 
(Wong et al., 2007). 
Methods to introduce random mutations include PCR based random mutagenesis methods 
(Cadwell and Joyce, 1994), using mutator strains, using chemical mutagens (Mohan and 
Banerjee, 2008), UV radiation (Cox and Parry, 1968) or recombination methods like DNA 
shuffling (Stemmer, 1994), Staggered Extension Process (StEP) (Zhao et al., 1998). The 
most commonly used are PCR based method under low fidelity conditions. PCR based 
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methods are based on the use of error prone polymerase or biased nucleotide or Mn+2 
concentrations. PCR based methods for generation of random libraries are transition 
biased, which fail to generate consecutive mutations and as a result fail to cover the entire 
sequence space. A recently developed method which overcomes the limitations of PCR 
based methods is Sequence Saturation Mutagenesis (SeSaM) (Wong et al., 2004). SeSaM 
enables introduction of mutations by randomizing each amino acid position in the protein 
sequence. It also overcomes the limitation of polymerase bias (transitions over 
transversions) and can introduce subsequent mutations. Thus SeSaM generates a higher 
theoretical diversity that potentially increases the likelihood of finding improved variants. 
The method used for generation of a random library depends on the property of the enzyme 
which is to be improved and also the screening capabilities. For instance, engineering an 
enzyme for thermostability requires high mutational load and substitution with chemically 
different amino acids making SeSaM the method of choice for diversity generation. While, 
engineering an enzyme for enantioselectivity often requires substitution with similar kind 
of amino acids making epPCR, the method of choice (Arnold, 2001; Reetz and Jaeger, 2000). 
However, only the generation of a high quality mutagenic library does not suffice the need 
of a directed evolution experiment but a reliable and high throughput screening system is 
necessary to screen the generated mutant library in order to obtain improved variant(s). 
The screening system should as close as possible be able to replicate the conditions for final 
application (Aharoni et al., 2005). The most common screening methods are based on solid 
phase screening assays and microtiter plate assays. Solid phase screening can be performed 
directly on an agar plate, on a filter paper or on a membrane. These types of screening 
systems have a high throughput (104 to 106) and are based on visual signals like color 
development or formation of halos. However, they usually have low accuracy and are 
generally used as pre-screens for differentiation between active and inactive clones (Lin 
and Cornish, 2002) 
Screening systems centered on microtiter plates (96-, 384- or 1536 well) are usually based 
on colorimetric or fluorometric reactions and are currently the most widely used screening 
technique with a throughput of 103 to 105. They can be performed using cell lysates or 
supernatants and enzyme activity is measured using a spectrophotometer or a fluorometer 
(Aharoni et al., 2005). The introduction of flow cytometry based screening systems in 
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directed evolution enable the screening of mutant libraries with more than 107 clones per 
hour (Farinas, 2006). This system is based on detection of fluorescent product generated by 
enzymatic reaction in which the enzyme is linked to the cell surface or entrapped in a 
double emulsion (Miller et al., 2006). The use of FACS (fluorescence activated cell sorter) 
and microfluidic devices greatly accelerates the screening system, however currently it 
offers only the qualitative differentiation of positive and negative variants. In addition, dye 
diffusion and limited number of fluorescent based assays for enzymes which are necessary 
for flow cytometric screening are still the prevailing challenges. Table 1.3 summarizes the 
comparison of currently available screening formats for screening of mutant libraries in a 
directed evolution experiment. A typical random library usually consists of 106-108 clones 
required to cover a considerable portion of protein sequence space. Thus a high 
throughput, reliable screening system is required to screen such a large amount of clones in 
order to select improved variant(s). 
 
Table 1.3. Comparison of currently used screening techniques in directed evolution. Table 
reproduced from (Leemhuis et al., 2009). 
Strategy Library 
Size 
Advantge Disadvantage 
Selection ~109 Yields desirable variants 
only  
Only possible if 
property confers an 
advantage 
Agar plate screening  ~105 Simple to operate Limited dynamic range 
Microtiter plate 
screening 
~104 Most analytical methods 
possible. 
Excellent dynamic range 
Relative low screening 
capacity 
Cell in droplet method ~109 Large libraries Fluorescence detection 
and DNA modifying 
enzymes 
Cell as microreactor ~109 Large libraries Fluorescence detection 
Cell surface display ~109 Large libraries Fluorescence detection 
In vitro 
compartmentalization  
~109 No cloning steps. Large 
libraries  
Fluorescence detection 
 
1.6.2 Rational Evolution of Enzymes 
 
Rational evolution of enzymes target one or more preselected amino acid residue(s) in the 
target gene. The selection of the amino acids residue(s) is based on previous structural and 
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functional knowledge of the enzyme or crystal structure of the enzyme to identify 
promising residues (Chica et al., 2005). The selected amino acid is exchanged to a specific 
amino acid e.g. by site directed mutagenesis (SDM) or saturated using site saturation 
mutagenesis. Prediction of the ‘best’ amino acid at a particular position is difficult and often 
a site saturation mutagenesis method is applied. SSM allows the identification of the best 
amino acid on a specific position by applying a NNN (64 codons) or NNK degeneracy (32 
codons), covering all 20 canonical amino acids (Reetz et al., 2008). Screening of focused 
library can be generally achieved using a medium throughput assay in a MTP. Rational 
design not only requires the knowledge of the crystal structure of enzyme but also of the 
property which should be improved. Many properties are well understood for instance 
thermostability of an enzyme can be improved by introduction of disulfide bridges or salt 
bridges which increase the rigidity of the protein scaffold (Korkegian et al., 2005). The 
experiments based on rational evolution are significantly less time consuming and 
accelerates the generation of new biocatalysts by generation of small and high quality 
mutant libraries (Reetz et al., 2008; Wong et al., 2007). 
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2. MATERIALS 
 
Instruments, kits and devices were used according to supplier’s recommendation. 
2.1 Chemicals 
 
Chemicals used were of analytical grade or higher quality and purchased from Sigma 
Aldrich Chemie (Taufkrichen, Germany), AppliChem (Darmstadt, Germany) or Carl Roth 
(Karlsruhe, Germany). Chemicals purchased from other suppliers or synthesized in-house 
are mentioned below: 
Cobalt (III) sepulchrate                                   Synthesized as previously reported (Gahan, 1989) 
Sodium hydrosulfite                                                                         ABCR GmbH, Karlsruhe, Germany 
Yeast Extract                                                                                      Merck KGaA, Darmstadt, Germany 
 
2.2 Instruments and Devices 
 
Äktaprime plus with UV detector   GE Healthcare, München, Germany 
Autolab Potentiostat/Galvanostat   Metrohm, Riverview, USA. 
Bench top shaker Certomat II           Sartorius, Göttingen, Germany 
BioPhotometer Plus                                                         Eppendorf, Hamburg, Germany 
Centrifuge 5424, 5810R                                                 Eppendorf, Hamburg, Germany 
CO-lecture bottle station                                                Sigma Aldrich, Steinheim, Germany 
Deep well plates (96 well-round bottom)  Brand GmbH, Wertheim, Germany 
Deep well plates (96 well-V bottom)  Eppendorf, Hamburg, Germany  
Evaporator IKA RV 10 basic    IKA-Werke, Staufen, Germany 
GC-FID 2010 Plus     Shimadzu GmbH, Duisburg, Germany 
Gel documentation U: Genius   Syngene, Cambridge, UK 
Glass columns TAC15/125PE5- AB-2  YMC Europe GmbH, Dinslaken, Germany 
Heat Gun      Steinel HL, Aachen, Germany 
High Pressure Homogenizer   Avestin, Ottawa ON, Canada 
Lyophilizer Alpha 1-2 LD plus   Christ, Osterode am Harz, Germany 
Luggin capillary     Seele-Glas, Swisttal-Strassfeld, Germany 
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Polypropylene Microtiter plates (96 well)  Eppendorf, Hamburg, Germany 
Microtiter plate shaker Microtron   INFORS, Heinsbach, Germany 
Microtiter plate reader Tecan Sunrise  Tecan Group AG, Männendorf, Switzerland 
Mini-Protean Tetra Cell system   Bio-Rad, München, Germany 
Multipoint magnet stirrer Variomag 15  Thermo Fischer Scientific,Wilmington USA 
NanoDrop Spectrophotometer 1000  Thermo Fischer Scientific,Wilmington USA  
PCR thermocycler Mastercycler pro S  Eppendorf, Hamburg, Germany 
Platinum                  Allgemeine, Pforzheim, Germany 
Pre-coated Silica gel 60 F254 plates  Merck KGaA, Darmstadt, Germany 
Resin dispenser 48 position    Mettler- Toledo, Columbus OH, USA 
Silver-Silver Chloride electrode               SensortechnikGmbH,Kaufbeuren, Germany  
Sonicator Vibra-Cell VCX130   Sonics & Materials, Newton, USA 
Spectrophotometer Varian Cary 50 UV  AgilentTechnologies, Darmstadt, Germany 
Thermomixer Comfort    Eppendorf, Hamburg, Germany 
Thin layer chromatography Unit*   CAMAG, Muttenz, Switzerland 
Vortex Genie 2     Scientific Industries Inc., New York, USA 
 
2.3 Cultivation and Expression Media 
 
All media were sterilized by autoclaving (20 psi pressure, 121 °C, 20 min) and were stored 
at room temperature or frozen as 1 mL aliquots  at -20 °C (SOC media) until further use. 
Lysogenic Broth  (LB medium) contained 10 g L-1 peptone, 5 g L-1 yeast extract, 10 g L-1 
NaCl; pH 7.5 adjusted with 1 M HCl or NaOH. For preparation of agar plates the medium 
additionally contained 20 g L-1 agar-agar. 
Terrific Broth (TB medium) contained 12 g L-1 peptone, 24 g L-1 yeast extract, 4 g L-1 
glycerol (solution A; 800 mL), 2.31 g L-1 KH2PO4 and 12.54 g L-1 K2HPO4 (solution B; 200 
mL). Solutions A and B were prepared separately and mixed together after autoclaving. 
                                                          
*
 Thin layer chromatography unit consists of Automatic TLC sampler 4 (ATS 4), Automatic developing chamber (ADC 
2) and TLC scanner 3 
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Super Optimal Broth with catabolite repression (SOC medium) contained 20 g L-1 
tryptone, 2 g L-1 NaCl, 5 g L-1 yeast extract and 2.5 g L-1 KCl. Sterile solutions of 10 mM 
MgCl2, 10 mM MgSO4 and 20 mM glucose were added after autoclaving. 
 
2.4 Media Additives 
 
All media additives were prepared as 1000X stock by dissolving individual components in 
MilliQ water and sterilized by filtration (0.2 µM polyvinylidene difluoride (PVDF) filter). 
Media additives were used in 1:1000 ratio in all media. Trace element solution was stored 
at 4 °C, magnesium chloride and sodium sulphate at room temperature until use. All other 
solutions were aliquoted (1 mL) and stored at -20°C until use. 
Kanamycin sulphate solution contained kanamycin sulphate (100 mg mL-1) dissolved in 
MilliQ water. 
Trace element solution contained Calcium chloride dihydrate (0.45 mM), Zinc sulphate 
heptahydrate (0.65 mM), Manganese sulphate monohydrate (0.6 mM), Disodium EDTA (54 
mM), Ferric chloride hexahydrate (62 mM), Copper sulphate pentahydrate (0.6 mM) and 
Cobalt chloride (0.75 mM) dissolved in MilliQ water. 
Aminolevullinic acid solution (ALA) solution contained 5-Aminolevullinic acid (0.5 M) 
dissolved in MilliQ water. 
Isopropyl-β-D-thiogalactopyranoside (IPTG) solution contained Isopropyl-β-D-
thiogalactopyranoside (1 M) dissolved in MilliQ water. 
Thiamine hydrochloride solution contained thiamine hydrochloride (0.5 M) dissolved in 
MilliQ water. 
Sodium chloride solution contained sodium chloride (1 M) dissolved in MilliQ water. 
Magnesium chloride solution contained Magnesium chloride (1 M) dissolved in MilliQ 
water. 
 
2.5 Other Reagents, Solutions and Buffers 
 
Iodine cleavage solution was prepared by mixing 5 µL of cleavage buffer (500 mM Tris, 
pH 9.0), 2 µL of iodine (100 mM in 99 % ethanol) in 2 µL MilliQ water (final volume of 10 
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µL). The iodine cleavage solution was prepared fresh and wrapped in aluminum foil and 
refrigerated (4 °C) until use. 
Piranha solution contained conc. H2SO4: 30% H2O2 solution (3:1). The solution was 
prepared on ice under a fume hood cabinet by drop-wise addition of 30% H2O2 solution in 
conc. H2SO4 with gentle swirling. 
Phosphate buffer was prepared by mixing equimolar (50 mM) solutions of dipotassium 
phosphate and monopotassium phosphate until the desired pH value (7.4 or 7.8) was 
achieved. 
Tris/HCl buffer was used for purification of P450cin fusion protein. It contained 500 mM 
Tris/HCl, pH 7.8 (6.05 g L-1 Tris, pH adjusted by titration with 37% (v/v) HCl). Tris/HCl 
elution buffer contained additionally 1 M NaCl. The buffers were freshly prepared and 
filtered using a glass filter. 
 
2.6 Strains, Vectors and Genes 
 
The strains used in this work (Table 2.1) are E. coli DH5α for sub-cloning and E. coli BL21-
Gold (DE3) lacIQ1 for recombinant protein expression. The vectors used in the study are 
listed in Table 2.2. 
 
Table 2.1. Genes employed in this work (see sequence in the appendix). 
 
Gene Origin Reference 
cinA       Citrobacter braakii               (Hawkes et al., 2002). 
cinC       Citrobacter braakii               (Hawkes et al., 2002). 
Fpr       Escherichia coli                     (Jenkins and Waterman, 1994) 
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Table 2.2. Strains used for genetic manipulation and recombinant protein expression. 
 
Strain Genotype Reference 
E. coli DH5α F- φ80lacZΔM15 Δ(lacZYA-argF)U169 recA1 
endA1 hsdR17(rk-, mk+) phoA supE44 thi-1 
gyrA96 relA1 λ- 
Agilent 
Technologies 
E. coli BL21-Gold 
(DE3) 
F– ompT gal dcm lon hsdSB(rB- mB-) λ(DE3 [lacI 
lacUV5-T7 gene 1 ind1 sam7 nin5])  
Agilent 
Technologies 
E. coli BL21-Gold 
(DE3) LacIQ1† 
Same as E. coli BL21Gold (DE3); additionally 
pGRG36-lacIQ was used for site-specific 
integration of lacI into the chromosome 
 
(Blanusa et 
al., 2010). 
 
 
Table 2.3. Vectors used for genetic manipulation and recombinant protein expression. 
 
Recombinant bacterial strains produced and used in this study are shown as vector maps in 
Figures 2.1 and 2.2. 
                                                          
† E. coli BL21 (DE3) lacIQ1 strain which contains the lacI repressor gene integrated into the genome of E. coli 
BL21 (DE3). 
‡ pALXtreme vector was always used in combination with the genetically engineered E. coli BL21 (DE3) lacIQ1 
strain which contains the lacI repressor gene integrated into the genome of E. coli BL21 (DE3). 
Vector Promoter Antibiotic 
resistance/ 
Concentration 
Replicon Reference 
pET28a(+) T7 Kanamycin 
(Kan)/ 100 µg mL-1 
ColE1 
(pBR32) 
Novagen (Merck)  
pALXtreme-1a‡ T7 Kanamycin 
(Kan)/ 100 µg mL-1 
ColE1 
(pBR32) 
Derived from 
pET28a(+), ΔlacIQ 
(Blanusa et al., 
2010). 
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Figure 2.1. Vector map of pALXtreme-1a, a derivative of pET-28a(+). pALXtreme-1a was 
kindly provided by Dr. Alexander Schenk, Jacobs University, Bremen (Germany). 
 
 
                               
 
Figure 2.2. Plasmid map of CinA-CinC fusion protein and CinA-Linker 10AA-CinC fusion 
protein cloned in pALXtreme-1a vector. (A) C-terminus of CinA was fused to the N-terminus 
of CinC using PLICing cloning technique. A library of linkers from one to sixteen amino acids 
between the CinA-CinC fusion proteins was generated. Figure 2.2 (B) shows an exemplary 
plasmid map of CinA-CinC fusion protein with 10 amino acid linker (marked by magenta 
colored arrow). 
A B 
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2.7 Enzymes and PCR Components 
 
Restriction enzymes, Phusion-DNA polymerase, ligase, terminal deoxynucleotidyl 
transferase (TdT) were purchased from New England Biolabs (Frankfurt, Germany) and 
were used according to supplier’s recommendation. PhuS DNA polymerase and Taq DNA 
polymerase were prepared in-house. Catalase from bovine liver and lysozyme from chicken 
egg white were purchased from Sigma Aldrich Chemie (Taufkrichen, Germany). 
2.8 Commercial Kits  
 
NucleoSpin Plasmid kit    Macherey-Nagel, Düren, Germany 
NucleoSpin Gel and PCR Clean-up kit  Macherey-Nagel, Düren, Germany 
QIAquick PCR purification kit   Qiagen, Hilden, Germany 
BCA Protein Assay kit     Thermo Fischer Scientific, Bonn, Germany 
PD- 10 Desalting columns    GE Healthcare, USA 
 
2.9 Oligonucleotides 
 
Unmodified oligonucleotides and phosphorothioated oligonucleotides were purchased from 
Eurofins MWG Operon (Ebersberg, Germany) in salt-free form and dissolved in Milli-Q 
water to a concentration of 100 µM from which a working stock of 5 µM was prepared. 
Concentration of oligonucleotides used in all PCRs was 20 µM unless otherwise specified. 
2.10 Software 
 
Clone Manager 9 Professional Edition Software (Scientific & Educational Software, Cary, 
NC, USA) for analysis of sequencing data. 
Nova 1.5 (Metrohm Autolab, USA) for electrochemical characterization of enzyme mutants. 
WinCATS (CAMAG, Muttenz, Switzerland) used for semi-quantification of 2-β-hydroxy-1,8-
cineole using thin layer chromatography unit. 
Yet Another Scientific Artificial Reality Application (YASARA) used for generation of 
homology models of CinA-linker(1-16)-CinC proteins and their variants. 
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3. METHODS 
 
Molecular Biology methods were performed as described in Molecular Cloning, A 
laboratory Manual (Sambrook, 2001). Directed evolution methods were performed with 
minor modification wherever necessary according to protocols reported in Directed 
Evolution Library Creation: Methods and Protocols; Methods in Molecular Biology (Arnold 
and Georgiou, 2003). 
3.1 Microbiological Methods 
3.1.1 Agarose Gel Electrophoresis 
 
DNA-fragments were separated on an agarose gel by electrophoresis in 1X TAE-buffer 
(TAE-buffer (50X): 2 M Tris, 1 M glacial acetic acid, 50 mM EDTA dissolved in Milli-Q H2O 
pH 8.0) for 30-60 min at 90-110V depending on fragment size and gel concentration (0.8-
2%). Samples from restriction endonuclease digestions, PCRs, plasmid isolation (containing 
approximately 25-100 ng DNA) were mixed with 1X loading dye (10 mM Tris-HCl, pH 7.6; 
0.03% bromophenol blue, 0.03% xylene cyanol; 60% glycerol; 60 mM EDTA) and 
subsequently loaded an agarose gel (6 µL /well) along with a DNA ladder (GeneRuler 1kbp 
DNA Ladder, Fermentas, St. Leon-Rot, Germany) as reference. Visualization of DNA on the 
gel was achieved using Roti-Safe GelStain from Carl Roth (Karlsruhe, Germany) which was 
pre-mixed with liquid agarose before casting of the gel. 
 
3.1.2 Polyacrylamide Gel Electrophoresis  
 
SDS-PAGE 
Protein samples were separated by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) as described previously (Sambrook et al., 1989)(Sambrook and 
Russell 2001). 12% SDS-PAGE were prepared composing of resolving gel (1.6 mL ddH2O, 
2 mL acrylamide mix (30%), 1.3 mL Tris (1.5 M, pH 8.8), 50 µL  SDS (10%), 50 µL 
ammonium persulphate (APS; 10%) and 2 µL TEMED and stacking gel (1 mL) 680 µL 
ddH2O, 170 µL acrylamide mix (30%), 130 µL 1.0 M Tris (pH 6.8), 10 µL 10% SDS, 10 µL 
10% APS and 1 µL TEMED. Sample were prepared by incubating 10 μL of protein sample 
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(cell lysate or purified protein) in 6 μL SDS-PAGE loading buffer in a Thermostat 
(Eppendorf, Hamburg, Germany) at 95 °C for 10 min. 5 μL of sample and a pre-stained 
reference protein ladder (10-170 kDa, Fermentas, Germany) were loaded on the SDS-PAGE 
gel. The protein fractions were separated in 1 X SDS-buffer (0.3% Tris, 1.5% glycine, 0.1% 
SDS in H2O) at 30 mA for 75 min using a Mini-Protean Tetra Cell system (Bio-Rad, München, 
Germany). For visualization of protein bands, the gels were stained in Coomassie Brilliant 
Blue solution (0.25% v/v coomasie, 45.5% v/v methanol, 9.2% v/v acetic acid) for 20 min 
followed by de-staining in 10% (v/v) acetic acid solution overnight. 
 
3.1.3 Preparation of Chemically Competent E. coli cells 
 
Chemically competent cells were prepared by inoculation of 5 mL overnight culture in LB 
media (37°C, 250 rpm for 16 h) with respective E. coli strain. Main culture of LB media 
(200 mL in 1 L flask) was inoculated with 1 mL preculture and incubated (37°C, 250 rpm) 
until an OD600nm of 0.4. The culture was cooled on ice and subsequently centrifuged (4°C, 
3000 rpm, 10 min; Eppendorf, Hamburg, Germany). All following steps were carried on ice 
and under sterile conditions. The cell pellet was resuspended in 15 mL filter sterilized ice 
cold TFB-1-solution (containing 30 mM potassium acetate, 50 mM manganese chloride, 
100 mM rubidium chloride, 10 mM calcium chloride, 15% glycerin in Milli-Q H2O) and 
incubated on ice for 10 min. The resuspended cells were centrifuged (4°C, 3000 rpm, 
10 min, Eppendorf, Hamburg, Germany) and cell pellet obtained was resuspended in 2 mL 
filter sterilized ice cold TFB-2 solution (containing 10 mM MOPS, 75 mM calcium chloride, 
10 mM rubidium chloride, 15% glycerin in Milli-Q H2O). Competent cells were divided in 
50 µL aliquots in sterile and pre-cooled Eppendorf tubes and stored at -80°C. 
Transformation efficiencies of up to 1 x 107 cfu µg-1 pUC19 were obtained. 
 
3.1.4 Transformation of Plasmid DNA in E. coli cells 
 
Transformation of DNA ligation/hybridization reaction (4 µL, around 200 ng) or plasmid 
DNA (20 to 30 ng) was performed using chemically competent E. coli cells on ice. DNA was 
added under sterile conditions to 50 µL frozen competent E. coli cells followed by 
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incubation on ice (10 min). DNA uptake by E. coli cells was achieved by heat-shock 
treatment (42°C for 40 s), followed by incubation on ice (2 min). Cell regeneration was 
achieved by addition of 900 µL SOC medium followed by incubation at 37°C for 45 min and 
250 rpm. The regenerated cells were plated on LB-agar plates containing appropriate 
antibiotic and incubated at 37°C overnight. 
 
3.1.5 Preparation of Cryocultures 
 
E. coli cells harboring the desired construct were grown overnight in 5 mL culture vials 
(37°C, 250 rpm, 16 h). Overnight grown culture and sterile glycerol (50 % w/w in H2O) 
were mixed (1:1) under sterile conditions in 2 mL Eppendorf tubes and stored at -80°C 
until further use. Cryocultures in microtiter plates were prepared by supplementing 
100 µL/well sterile glycerol (50% w/w in H2O) in 100 µL of overnight grown cultures 
(37°C, 900 rpm, 16 h, 70% humidity) and stored at -80°C until further use. 
 
3.2 Molecular Biological Methods 
 
3.2.1 Cloning 
 
Two different cloning techniques were used in this thesis for sub-cloning of genes and for 
cloning of randomly generated mutant libraries. 
 
Using Restriction Endonucleases 
Standard restriction cloning was performed using restriction endonucleases from New 
England Biolabs (Frankfurt, Germany) according to manufacturer’s instructions. Insert and 
vector DNA (1 µg each) were digested for 3 h with 1 U of corresponding restriction 
endonuclease in buffered reaction mixtures. The restriction endonucleases were 
inactivated at 55°C for 30 min. The linearized DNA fragments (gene and vector) were 
purified either directly using a DNA clean up kit or if necessary by gel extraction and 
subsequent clean up (NucleoSpin Gel and PCR Clean-up, Macherey-Nagel, Düren, Germany). 
In case of vector, additional incubation with 0.5 U of alkaline phosphatase was performed 
(37°C, 60 min) in order to reduce vector background by removal of 5’-phosphate groups. 
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Ligation of insert and vector (molar ratio 10:1) was performed using T4 DNA Ligase (0.5 U) 
in 1X T4 DNA ligase buffer (Fermentas, St. Leon-Rot Germany) at 16 °C for 16 h. The ligation 
reaction was subsequently transformed into chemically competent E. coli cells. 
 
PLICing 
PLICing (Phosphorothioate-based Ligase-Independent Gene Cloning) (Blanusa et al., 2010) 
was carried out as an alternative method to standard restriction endonuclease digestion in 
order to clone randomly generated mutant libraries. 
 
Step 1: Amplification of target gene and vector  
Vector backbone (pALXtreme-1a) and target gene (cinA-cinC fusion) were amplified in a 
PCR using oligonucleotides containing 12 complementary phosphorothioated nucleotides 
and a high-fidelity DNA polymerase. PCRs were performed in a final volume of 50 µL 
containing 1X PfuS DNA polymerase buffer, 0.2 mM dNTP mix, 20 µM each forward and 
reverse primer, 1 U PfuS DNA polymerase and 10 ng of template-plasmid. PCR protocol: 
98°C for 1 min (1 cycle); (98°C for 30 s; 65 °C for 30 s; and 72°C for 1 m 10 s (cinA-cinC 
fusion) or 90 s (pALXtreme-1a) (20 cycles); followed by a final extension at 72°C for 5 min. 
Subsequently, the PCR products were analyzed by agarose gel electrophoresis and purified 
using the PCR cleanup kit. Parental DNA was digested by incubation with DpnI 
endonuclease at 37°C for 16 h. 
 
Step 2: Chemical cleavage of phosphorothioated nucleotides 
Cleavage of the introduced phosphorothioated nucleotides was achieved by incubation of 
the amplified and purified gene and vector with an iodine cleavage solution. The cleavage 
reaction was performed in a PCR tube and contained 0.2 pmol insert DNA and 0.12 pmol 
vector DNA in 1 µL of iodine cleavage solution in a total reaction volume of 5 µL. The 
reaction mixture was subsequently incubated for 5 min at 70°C. 
 
Step 3: Hybridization of vector and insert 
Hybridization reaction of linearized vector and insert DNA was performed by mixing equal 
volumes of both cleavage reactions (typically 5 µL of vector and 5 µL of insert) and 
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subsequent incubation at room temperature for 5 min. Hybridization reaction (4 µL) was 
subsequently transformed into chemically competent E. coli cells (Chapter 3, Section 3.2.5). 
SeSaM libraries were cloned in pALXtreme-1a vector by PLICing using primers P5 - P8. The 
primer sequence is given in Appendix, Table 1. 
 
3.2.2 PCR 
 
PCRs were performed in 0.2 mL thin-walled PCR tubes from Sarstedt (Nümbrecht, 
Germany) employing a Mastercycler Gradient PCR-machine from Eppendorf (Hamburg, 
Germany). As negative control, a PCR reaction without template DNA was performed. 
Another PCR reaction was set without primers which served as control for DpnI 
endonuclease digestion. This reaction was treated with DpnI along with amplified products 
and was transformed in BL21-Gold (DE3) LacIQ1 to check the efficiency of DpnI 
endonuclease to digest the parental DNA strand. Colonies obtained on the agar plates plated 
with control reactions were considered as background. A standard PCR (50 µL) contained: 
5 U of Taq polymerase, 0.2 mM dNTPs, 1x Taq buffer, template (10-30 ng), primers (20 µM 
each) unless otherwise specified. 
 
3.2.3 Colony PCR 
Colony PCR was performed in order to verify cloning of target gene in vector backbone. It 
was performed by picking a single isolated colony from agar plate which was resuspended 
in 15 µL Milli-Q H2O and incubated (98°C for 15 min) in order to achieve cell lysis. The PCR 
contained 5 µL of plasmid DNA from single colony, 5 U of Taq polymerase, 0.2 mM dNTPs, 
1x Taq buffer and 5 µM each forward and reverse primer in reaction volume of 12.5 µL. 
Following temperature program was used: initial denaturation at 98°C (2 min), followed by 
25 cycles of denaturation at 98°C (30 s), annealing (at temperature optimum for primer 
annealing) for 30 s and elongation at 72°C for 1 min/kb followed by a final elongation at 
72°C for 5 min. The PCR products were verified by agarose gel electrophoreses. 
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3.2.4 SeSaM Library Generation 
 
SeSaM library of P450cin fusion protein was generated based on the protocol by Mundhada 
et al., 2011 (Mundhada et al., 2011). 
 
Preliminary step: Generation of ds DNA template for Step 1 and Step 3  
For step 1 and step 3 template-generation, a 50 µL PCR-mixture contained: 1x Phusion GC 
rich Buffer; (New England Biolabs); 0.2 mM of each dNTP; 0.5 µM of each primer (P1 and P2 
for Step 1 template-DNA, and P3 and P4 for Step 3 template-DNA, sequences for primer, 
Appendix; Table 1); 0.5 U Phusion High-Fidelity DNA polymerase (New England Biolabs, 
Frankfurt, Germany) and 50 ng template DNA. PCR protocol: 98°C for 30 s (1 cycle); 98°C 
for 10 s, 58°C for 30 s, 72°C for 50 s (15 cycles); 72°C for 5 min (1 cycle). The PCR products 
were digested with DpnI (20 U, 37°C, 3 h) and purified (Nucleospin Extract II kit from 
Macherey Nagel, Düren, Germany). 
 
Step 1: Generation of ssDNA fragment pool with random length distribution.  
 
The preliminary generated CinA-Linker10-CinC fusion Step 1 template-DNA was amplified 
by PCR in presence of dATPαS and dGTPαS to randomly incorporate chemically cleavable 
phosphorothioated bonds. PCR solutions (50 µL) contained: 1 x Taq Pol buffer, 0.5 µM of 
each primer (P1 and P4 sequences for primers, Appendix, Table 1), 5 U Taq DNA 
polymerase, 360 ng/kb of the SeSaM template-DNA (prepared in preliminary Step 1). 
According to the desired library the following nucleotide combinations were used for A and 
G libraries. A-libraries: 0.2 mM of each dATP, dGTP, dTTP and dCTP, and 0.06 mM dATPαS; 
G-libraries: 0.2 mM of each dATP, dGTP, dCTP, and dTTP and 0.05 mM dGTPαS. For both 
setups the same PCR protocol was performed: 94°C for 2 min (1 cycle); 94°C for 15 s, 65°C 
for 30 s, 72°C for 50 s (15 cycles); 72°C for 3 min (1 cycle). PCR products were purified 
(Nucleo Extract II kit) and eluted (80 µL NE-buffer). The cleavage of phosphorothiodiester 
bonds was performed in SeSaM-TaqTM buffer (1x), supplemented with iodine (10 µL, 20 mM 
in EtOH) and incubated (30 min, 70°C). Cleaved biotinylated DNA fragments were isolated 
by magnetic streptavidin beads (M-PVA SAV1, Chemagen, Baesweiler, Germany) and ssDNA 
was purified employing the NTC binding buffer (Nucleospin Extract II kit). 
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Step 2: Enzymatic addition of universal base to ssDNA fragment pool  
Single-stranded DNA fragments generated in Step 1 were elongated at the 3´-OH groups by 
TdT (deoxynucleotidyl transferase) catalyzed incorporation of dPTP (37°C, 15 min) and 
terminated by heat inactivation (30 min, 75°C). Reaction mixtures (25 µL) contained: 1x 
TdT buffer, 0.25 mM CoCl2, 1 pmol of ssDNA fragment (from Step 1b), 5 pmol dPTP and 10 
U TdT. The ssDNA was purified using NucleoSpin Gel and PCR Clean-up kit using NTC buffer 
(Macherey Nagel, Düren, Germany). 
 
Step 3: Full length gene synthesis 
Full-length cinA-linker10-cinC fusion genes were generated using dPTPαS elongated DNA 
fragments (from step 2) as primers and step 3 dsDNA as templates (generated during 
preliminary step). The PCRs (50 µL) contained: 80 ng of ssDNA from step 2, 80 ng of dsDNA 
step 3 DNA template, 1x 3D1 polymerase buffer, 0.2 mM of each dNTPs and 1 U 3D1 
polymerase. PCR protocol: 94°C for 2 min (1 cycle); 94°C for 30 sec, 52°C for 60 sec, 72°C 
for 2 min (30 cycles). PCR products were purified using NucleoSpin Gel and PCR Clean-up 
kit (Machery Nagel, Düren, Germany). 
 
Step 4: Degenerate base replacement 
Universal bases were replaced by standard nucleotides during PCR amplification. The PCR 
solutions (50 µL) contained: 0.5 U SeSaM Taq polymeraseTM, 0.5 µM of each primer (P2 and 
P3, Primer sequence in Appendix, Table 1), 50 ng full-length DNA from Step 3, 0.2 mM of 
each dNTP, 1x SeSaM TaqTM buffer. The following PCR protocol was employed: 94°C for 2 
min (1 cycle); 94°C for 15 s, 60°C for 30 s, 72°C for 1 min 20 s (15 cycles); 72°C for 10 min 
(1 cycle). The amplified PCR product was run on 0.8 % agarose gel and gel purified with 
QIAquick Gel Extraction kit (Qiagen,  Hilden,  Germany), if non-specific amplification was 
observed. The purified product representing final SeSaM library was cloned by PLICing in 
BL-21 Gold (DE3) LacIQ1. 
 
3.2.5 Site directed and Site Saturation Mutagenesis 
Site directed mutagenesis (SDM) of the target gene was achieved using a two-step, protocol 
based on the QuikChange Site-Directed Mutagenesis (SDM) System developed by Stratagene 
(La Jolla, CA). 
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In the first PCR-step, linear amplification of the target DNA with a single oligonucleotide 
primer is performed (forward or reverse) which avoids primer dimerization. In the second 
PCR-step, equal parts of amplified products from first step are mixed together followed by 
exponential DNA amplification. Design of primers was based on recommendations of 
QuikChange Site-Directed Mutagenesis manual (Agilent Technologies). Both primers were 
complementary to each other, with a length between 25 and 45 bases and the mutation site 
was flanked by at least 10 to 15 correct bases. 
Site-saturation Mutagenesis (SSM) was used in order to introduce a randomize codon at a 
specific amino acid position in the gene of interest. The procedure employed was 
comparable to SDM except for the use of wobble primers, which contain instead of a single 
point mutation a randomized (wobble) codon. Degenerated NNK-oligonucleotides were 
used, where N codes for G, A, T and C, and K codes for G and T, enabling the generation of all 
32 base triplets. The targeted amino acid is therefore randomized to all 20 canonical amino 
acids. The design of oligonucleotide primers and the mutagenic procedure were similar to 
site directed mutagenesis. The steps and program used for SDM and SSM are as follows: 
Step I: PCR (50 µL) contained: 1x PhuS DNA polymerase buffer, 1 U PhuS DNA polymerase, 
0.2 mM dNTPs, template DNA (10-30 ng) and 20 µM primers. PCR program: 98°C for 2 min 
(1 cycle), 98°C for 30 s, annealing at 60-65°C for 30 s min and elongation at 72°C for 1 min 
20 s (3 cycles). 
Step II: 25 µL of forward and 25 µL of reverse reaction were mixed together and 0.5 U of 
PhuS DNA polymerase was added. PCR program: 98°C for 2 min (1 cycle), 98°C for 30 s, 
annealing at 60-65°C for 30 s and elongation at 72°C for 1 min 20 s (15 cycles) followed by 
final elongation at 72°C for 5 min. 
The PCR products were analyzed by agarose gel electrophoresis and parental DNA was 
digested by addition of 10 U of DpnI endonuclease and incubation at 37°C for 16 h. It was 
subsequently purified using a PCR cleanup kit (Macherey Nagel, Düren, Germany) and 
transformed in chemically competent E. coli cells. The incorporation of the point mutation 
by SDM was verified by sequence analysis. 
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3.2.6 Cultivation of E. coli for Heterologous Protein Expression in Deep 
Well Plates 
 
Individual colonies were picked from a transformation agar plate after a mutagenic 
procedure (SSM or SeSaM) using sterile toothpicks and were transferred into individual 
well of a microtiter plate (MTP) prefilled with 100 µL LBkana. The MTP was cultivated in a 
MTP-shaker (Microtone INFORS, Heinsbach, Germany) at 37°C, 900 rpm and 70% humidity 
for 16 h. Overnight grown cultures were supplemented with 100 µL of 50% (w/w) glycerol 
and the plate was stored at -80°C as master plate. In each MTP, a negative and a positive 
control cultivated in triplicate served as references. Wild-type (WT) enzyme or the best 
enzyme variant obtained from a previous round of screening was used as the positive 
control. Whereas, empty vector without any cloned gene served as the negative control. 
During screening, the activity of mutants was analyzed and compared with respect to the 
activity observed in the clone containing wild-type enzyme and empty vector. Mutants 
showing higher activity compared to the wild-type enzyme were considered for re-
screening. 
 
3.2.7 Heterologous Expression in 96-Well Deep Well Plates 
 
Expression of CinA-CinC Linker Library and Mutant Libraries 
Master microtiter plates containing individual clones of CinA-linker(1-16)-CinC library or 
clones obtained from mutant libraries were duplicated using a 96-well pin replicator to 
preculture flat bottom microtiter plates (Grierner Bio-one, GmbH, Frickenhausen, Germany) 
containing 150 µL of LBkan per well. The latter were incubated in a microtiter plate shaker 
at 37°C for 16 h (900 rpm, 70% humidity; Multitron II, Infors GmbH, Einsbach, Germany). 
Expression cultures of CinA-linker(1-16)-CinC library or mutant libraries were inoculated 
from overnight grown pre-cultures (6 µL) and was performed in 2 mL deep well plates 
(Polypropylene plates, Brand GmbH, Wertheim, Germany) containing TB media (600 µl; 
supplemented with 17 µM kanamycin, 0.1 mM trace element solution, 0.1 mM thiamine and 
0.5 mM δ-aminolevulinic acid). Expression cultures were incubated at 37°C until an OD600nm 
of 0.6, induced with isopropyl-thio-β-galactopyranoside (0.1 mM) and incubated in a 
microtiter plate shaker at 27°C for 18 h (900 rpm, 70% humidity; Multitron II, Infors GmbH, 
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Einsbach, Germany). Expression cultures were harvested by centrifugation at 3200 g, 4 °C 
for 20 min and cell pellets obtained were frozen over night at -20°C. 
 
Expression of E. coli Flavodoxin Reductase (Fpr) 
Master microtiter plate containing individual clones of E. coli Flavodoxin Reductase (Fpr) 
was duplicated using a 96-well pin replicator to preculture flat bottom microtiter plates 
(Grierner Bio-one, GmbH, Frickenhausen, Germany) containing 150 µL of LBkan per well. 
The latter were incubated in a microtiter plate shaker at 37°C for 16 h (900 rpm, 70 % 
humidity; Multitron II, Infors GmbH, Einsbach, Germany). Expression culture of Fpr was 
inoculated from overnight grown pre-cultures (6 µL) and was performed in 2 mL deep well 
plates (Polypropylene plates, Brand GmbH, Wertheim, Germany) containing TB media (600 
µL; supplemented with 17 µM kanamycin, 0.1 mM trace element solution, 0.1 mM sodium 
chloride and 0.1 mM manganese chloride). Expression cultures were incubated at 37°C until 
an OD600nm of 0.6, induced with isopropyl-thio-β-galactopyranoside (0.1 mM) and incubated 
in a microtiter plate shaker at 33°C, for 4 h (900 rpm, 70% humidity; Multitron II, Infors 
GmbH, Einsbach, Germany). Cultures were harvested by centrifugation (3200 g, 4°C for 
20 min) and cell pellets were frozen overnight (-20 °C). 
3.2.8 Heterologous Protein Expression in Shake Flasks 
 
Protein expression of CinA, CinC and CinA-CinC Fusion Protein 
Preculture of CinA, CinC or CinA-CinC fusion protein was grown in sterile glass culture tube 
containing 4 mL of LBkana medium at 37°C, 250 rpm for 16 h. Expression was performed in 
TB media in sterile Erlenmeyer flasks (1000 mL) containing 100 mL media. The expression 
media was supplemented with 17 µM kanamycin, 0.1 mM trace element solution, 0.1 mM 
thiamine and 0.5 mM δ-aminolevulinic acid (except for CinC) was inoculated with 1% 
preculture and incubated first at 37°C , 250 rpm, 70% humidity (Infors HT, Minitron, 
Einsbach, Germany) until an OD600nm of 0.6 was reached. Expression was induced by 
addition of isopropyl-thio-β-galactopyranoside (0.1 mM) and incubated further for 18 h at 
27 °C, 250 rpm (70% humidity, Infors HT, Minitron, Einsbach, Germany). Expression 
cultures were harvested by centrifugation (3200 g, 4°C for 20 min) and cell pellets were 
frozen overnight (-20°C). 
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Expression of E. coli Flavodoxin Reductase (Fpr) 
Preculture of Fpr was grown in sterile glass culture tube containing 4 mL of LBkana medium 
at 37°C, 250 rpm for 16 h. Expression was performed in TB media in sterile Erlenmeyer 
flasks (1000 mL) containing 100 mL media. The expression media was supplemented with 
17 µM kanamycin, 0.1 mM trace element solution and inoculated with 1% preculture and 
incubated first at 37°C, 250 rpm, 70 % humidity (Infors HT, Minitron, Einsbach, Germany) 
until an OD600nm of 0.6 was reached. Expression was induced by addition of isopropyl-thio-
β-galactopyranoside (0.1 mM) and incubated further for 4 h at 33°C, 250 rpm (70% 
humidity, Infors HT, Minitron, Germany). Expression cultures were harvested by 
centrifugation (3200 g, 4°C for 20 min) and cell pellets were frozen overnight (-20°C). 
 
3.2.9 Preparation of Crude Cell Lysates 
 
For Screening of Mutant Libraries in Microtiter Plates 
Cell pellets obtained after expression (Chapter 3, section 3.2.6) in microtiter plates were 
thawed at room temperature and subsequently resuspended in 200 µL of phosphate buffer 
(50 mM KHxPO4, pH 7.4) for 10 min containing 1.5 mg/mL lysozyme (≥ 40,000 U/mg) from 
chicken egg white (Sigma Aldrich). Cell lysis was performed by incubation in a microtiter 
plate shaker at 37°C for 1 h (900 rpm, 70% humidity; Multitron II, Infors GmbH, Einsbach, 
Germany). Clear supernatants (crude cell lysates) were obtained by centrifugation at 
3200 g, 4°C for 20 min and subsequently used for activity assay. 
 
For Purification or Activity Assay of Selected CinA-CinC Fusion Variants 
 
Cell pellets obtained after expression (Chapter 3, section 3.2.6) in shake flasks were thawed 
at room temperature for 10 min and subsequently resuspended in 25 mL of appropriate 
buffer. Pre-lysis step was performed by sonication (40% amplitude, 30 sec x 4 cycles; 
SONICS Vibra cell VCX-130, Zinsser Analytics, Frankfurt, Germany) followed by cell lysis 
using high pressure homogenation (3 cycles; 1500 bar EmulsiFlux C3, Avestin Europe 
GmbH). Disrupted cells were centrifuged (3200 g, 4°C for 30 min) and the supernatant 
obtained was further filtered through a polyvinylidene difluoride filter (0.45 µm; Ministart 
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RC 25 disposable syringe filters; Sartorius, Hamburg, Germany). The cleared lysate was 
used for purification. 
 
3.3 Biochemical Methods  
3.3.1 Screening of P450cin Mutant Libraries in Microtiter Plates 
 
3.3.1.1 NADPH Consumption Assay 
 
During the development of screening system, NADPH consumption assay was performed 
using an equimolar mixture of CinA and CinC in a 96 well microtiter plate format using 
crude cell lysate (prepared as mentioned in section 3.2.8). E. coli Fpr was supplemented in 
all reaction mixtures and NADPH was used as the reduction equivalent. The final reaction 
mixture (50 mM KHxPO4, pH 7.4; 250 µL) contained 50 µL of cell lysate, 50 µl of E. coli Fpr 
lysate, 1,8-cineole (6 mM) and catalase (1500 U; Catalase from bovine liver). Immediately 
after supplementing NADPH, the absorption was recorded at 340 nm for 1 h at intervals of 
5 min in a spectrophotometer. 
3.3.1.2 Spectrophotometric Detection of Indigo Formation 
 
In vivo Detection of Indigo Formation 
Indole (final concentration: 1 mM; in DMSO 0.5% v/v) was added once 30 min after IPTG 
induction in E. coli cells harboring CinA gene carrying mutation at amino acid position 81. 
Following in vivo oxidation (24 h, 27°C, 900 rpm) cells were centrifuged (4°C, 3220 g, 
30 min; 5810R, Eppendorf) and the supernatant was discarded. DMSO (300 µl) was added 
to wells and plates were vigorously stirred (45 min, RT, 1000 rpm) until blue color 
formation was visible. After short centrifugation (5 min; 4°C; 3220 g,) supernatant was 
transferred into polypropylene microtiter plates (Greiner Bio-One GmbH) for 
spectrophotometric analysis (600 to 700 nm; Tecan; Männendorf, Switzerland). 
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In vitro Detection of Indigo Formation 
In vitro detection of indigo formation was performed in a 96- well microtiter plate format 
using crude cell lysate for E. coli cells harboring CinA with amino acid mutation at position 
Y81 (prepared as mentioned in section 3.2.8). E. coli Fpr was supplemented in all reaction 
mixtures and NADPH was used as reduction equivalent. The final reaction mixture (50 mM 
KHxPO4, pH 7.4; 250 µL) contained 50 µL of cell lysate, 50 µl of E. coli Fpr lysate, 1,8-cineole 
(6 mM) and catalase (1500 U; Catalase from bovine liver), 1 mM; in DMSO 0.5% v/v. 
Reaction was performed for 2 h at RT DMSO (300 µl) was added to wells and plates were 
vigorously stirred (45 min, RT, 1000 rpm) until blue color formation was visible. After short 
centrifugation (5 min; 4°C; 3220 g,) supernatant was transferred into polypropylene 
microtiter plates (Greiner Bio-One GmbH) for spectrophotometric analysis (600 to 700 nm; 
Tecan; Männendorf, Switzerland). 
 
3.3.1.3 Hydroxycineole dehydrogenase (CinD) Based Detection Assay 
 
Oxidation of 2-β-hydroxy-1,8-cineole to ketocineole was detected by measuring the rate of 
NADH formation. The assay was performed in a 96 well microtiter plate format using crude 
cell lysate (prepared as mentioned in section 3.2.8). The final reaction mixture (50 mM 
KHxPO4, pH 7.4; 250 µL) contained 30 µL of cell lysate of CinA , 30 µL of cell lysate of CinC, 
30 µl of E. coli Fpr lysate, 1,8-cineole (6 mM) and catalase (1500 U; Catalase from bovine 
liver). Reaction was performed for 2 h at RT for formation of 2-β-hydroxy-1,8-cineole 
followed by addition of cell lysate or purified CinD (50 µL) The subsequent reaction was 
initiated by the addition of NAD+ (6 mM; ε 340 = 6200 M-1 cm-1). The reaction (2 h; RT) was 
monitored by UV spectroscopy (340 nm) measuring the appearance of NADH. 
3.3.1.4 Thin Layer Chromatography 
 
Thin layer chromatography (CAMAG, Muttenz, Switzerland) was used for screening of CinA-
linker(1-16)-CinC libraries, SeSaM and site saturation libraries described in this thesis. TLC 
was employed for semi-quantification of 2-β-hydroxy-1,8-cineole formed. 
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3.3.1.4.1 Activity Assay Using NADPH as Reduction Equivalent 
 
Screening for improvement in hydroxylation activity towards 1,8-cineole for CinA-
linker(1 16)-CinC fusion proteins and mutant libraries (SeSaM round I) using thin layer 
chromatography was performed in 96-deep well plate (Eppendorf, Hamburg, Germany) 
format using crude cell lysate (prepared as mentioned in section 3.2.8 for semi-quantifying 
2-β-hydroxy-1,8-cineole production. E. coli Fpr was supplemented in all reaction mixtures 
and NADPH was used as reduction equivalent. The final reaction mixture (50 mM KHxPO4, 
pH 7.4; 250 µL) contained 50 µL of cell lysate, 50 µl of E. coli Fpr lysate, 1,8-cineole (6 mM) 
and catalase (1500 U; Catalase from bovine liver, Sigma Aldrich). Conversions were 
initiated by supplementing NADPH (20 µL, 0.4 mM final concentration) and performed for 
2 h at 30°C in a MTP shaker (900 rpm, Microtone INFORS, Heinsbach, Germany). Reaction 
products were extracted with 250 µL of ethyl acetate containing 800 µM thymol as an 
internal standard, dried over anhydrous NaSO4 and analyzed using automated TLC (Section 
3.4.4) and subsequently using Gas Chromatography (Section 3.4.3). 
 
3.3.1.4.2 Activity Assay Using Cobalt(III)Sepulchrate and Zinc dust as an Alternative 
Source of Reduction Equivalent 
 
Mediator (Cobalt(III)sepulchrate) and alaternative electron source (Zinc dust) driven 
activity screening and re-screening of mutant libraries using thin layer chromatography 
was performed in 96-deep well plate (Eppendorf, Hamburg, Germany). The reactions were 
performed using crude cell lysate (prepared as mentioned in section 3.2.8) and automated 
TLC for semi-quantifying 2-β-hydroxy-1,8-cineole production. The final reaction mixture 
(50 mM KHxPO4, pH 7.4; 250 µL) contained 5 mg zinc dust dispensed in each well of the 
deep well plate using a resin dispenser (Mettler- Toledo, Columbus OH, USA), 50 µl of cell 
lysate, 1,8-cineole (6 mM), cobalt- sepulchrate (5 mM) catalase (1500 U; Catalase from 
bovine liver, Sigma Aldrich). The reactions were performed for 2 h at 30°C in a MTP shaker 
(900 rpm, Microtone INFORS, Heinsbach, Germany). Reaction products were extracted with 
250 µL of ethyl acetate containing 800 µM thymol as an internal standard. The extracted 
reaction products were subsequently dried over NaSO4 and analyzed using automated TLC 
(Section 3.4.4) and subsequently using Gas Chromatography (Section 3.4.3). 
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3.3.2 Electrochemical Characterization of Fusion Proteins and its 
Variants 
 
Electrode-driven biocatalysis was performed in an electrochemical cell with a working 
volume of 2 mL. Platinum sheet (A=2 cm2) was used as working electrode (WE) and counter 
electrode (CE). Silver-Silver Chloride electrode served as the reference electrode (RE). The 
RE was inserted in a Haber-Luggin capillary (internal diameter 6 mm) filled with 0.5 M 
sodium sulphate. The reactions were performed in phosphate buffer (50 mM KXPO4, pH 7.4) 
at room temperature with 1 µM of CinA-linker-CinC fusion protein or its variant, 6 mM 1,8-
cineole, 1500 U catalase (Catalase from bovine liver, Sigma Aldrich) and 
Cobalt(III)sepulchrate (5 mM). To start the reaction, working electrode was polarized to -
750 mV and the reactions were performed under potentiostatic control. Reactions were 
performed for 10, 20, 30, 40, 50, 60 min and reaction products were extracted with 1 mL 
ethyl acetate containing 800 µM thymol as an internal standard. The organic phase 
containing the reaction products was dried over anhydrous NaSO4 and analyzed by GC-FID 
for quantification of 2-β-hydroxy-1,8-cineole. 
 
3.3.3 Purification of Components of P450cin and Fusion Proteins 
 
3.3.3.1 Purification of CinA and CinA-CinC Fusion Proteins 
 
Purification of CinA and CinA-CinC fusion protein variants was performed using ÄKTA 
prime plus protein purification system (GE Healthcare, München, Germany) and a 
preparative LC column internal diameter 15 mm, length 125 mm; KRONLAB Glass Columns, 
TAC 15/125 PE5-AB-2, YMC Europe GmbH, Dinslaken) by anion exchange chromatography 
using Toyopearl 650S-DEAE Sepharose matrix (Tosoh Biosciences, Tokyo, Japan) (bed size: 
15 mm x 110 mm). Expression of CinA and CinA-CinC fusion protein variants (400 ml TB 
media) was performed as described in section 3.2.7. All buffer used for purification were 
filtered (0.45 µm filters; vacuum pump) and degassed. Cell pellets obtained after expression 
of CinA were resuspended in loading buffer (25 mL, 50 mM Tris-HCl, pH 7.8) and lysed 
using ultrasonic homogenizer (40% amplitude, 30 sec x 4 cycles, SONICS, Vibra cell, VCX-
130, Zinsser Analytics, Frankfurt). A further lysis step was performed with a high pressure 
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homogenization (3 cycles; 1500 bar EmulsiFlux C3, Avestin Europe GmbH). Clear 
supernatant obtained after centrifugation (3200 g, 4°C for 30 min) was further cleared by 
filtration through a low protein binding filter (0.45 µm; Ministart RC 25 disposable syringe 
filters; Sartorius, Hamburg, Germany). The clarified and filtered supernatant (25 mL) was 
loaded (flow rate 1 mL/min on a pre-equilibrated (20 CVs; 50 mM Tris-HCl, pH 7.8) DEAE-
ion exchange column (DEAE Sepharose 650S, bed volume: 15 mm x 125 mm, 35 µM pore 
size; Tosoh Biosciences LLC, Tokyo, Japan). The column was washed (20 CVs loading buffer, 
flow rate 3 mL/min) to remove unbound protein. Protein elution was achieved by running a 
NaCl gradient (50 mM Tris-HCl pH 7.8; 1 M NaCl; gradient of 0% to 40% in 200 mL volume 
buffer, flow rate 1.5 mL/min, fraction size 1 mL). The eluted fractions were analyzed by 
SDS-PAGE (Size of CinA = 45 kDa, Size of CinA-CinC fusion protein = 61 kDa; 12% SDS-PAGE 
gel; current 20 mA; Mini-Protean Tetra Cell, Bio-Rad Laboratories GmbH, München 
Germany) to check the purity of the eluted protein. Purified protein samples obtained by 
ion exchange chromatography were concentrated using 10K Amicon Ultra-4 filters 
(Darmstadt, Germany) and subsequently desalted using a PD-10 desalting column (Matrix: 
SephadexTM G- 25, column bed volume: 8.3 cm, bed height: 5 mL; GE-healthcare, USA). The 
PD-10 column was equilibrated (5 CVs; 50 mM KHxPO4 buffer) and protein was eluted with 
elution buffer (3.5 mL; 50 mM KHxPO4 buffer). The desalted protein was further lyophilized 
for 16-18 h (Christ Alpha 1-2 LD Plus; Omnilab laborzentrum GmbH & Co. KG, Germany) 
and stored at -20°C. 
 
3.3.3.2 Purification of CinC 
 
Purification of CinC was performed by anion exchange chromatography using Toyopearl 
650S-DEAE matrix (Tosoh Biosciences, Tokyo, Japan) (bed size: 15 mm x 110 mm) like 
described for CinA with the following modifications. Column was equilibrated in loading 
buffer (20 CVs; 50 mM Tris-HCl, 50 mM KCl pH 7.4, flow rate 3mL/min). Subsequently, the 
filtered and clarified lysate (25 ml) was loaded on the column (flow rate 1 mL/min) and 
unbound protein was washed out with loading buffer (20 CVs, flow rate 1.5 ml/min). CinC 
was eluted using salt gradient (1 M KCl, 50 mM Tris-HCl, pH 7.4, gradient from 0% to 40% 
in 200 ml, flow rate 1.5 mL/min). Purified CinC was concentrated using 3K Amicon Ultra-4 
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filters (Darmstadt, Germany) and subsequently purified by a second size exclusion 
chromatrography step using G-Sephadex matrix (bed volume: 15 mm x 110 mm, pore size: 
100-300 µM; Sigma Aldrich, Taufkrichen, Germany) using a preparative LC column (internal 
diameter 15 mm, length 125 mm; KRONLAB Glass Columns, TAC 15/125 PE5-AB-2, YMC 
Europe GmbH, Dinslaken). The column was equilibrated (20 CVs, 50 mM Tris- HCl, pH 7.4, 
flow rate 3 mL/min) and pooled fractions containing CinC obtained after first purification 
step were loaded (flow rate 1 mL/min). CinC was eluted in buffer (50 mM Tris-HCl, pH 7.4; 
flow rate 1.5 mL/min, fraction size 1 ml). Purity was checked by SDS-PAGE like described 
above for CinA. The expected size of CinC is 16 kDa. Additionally, the purity was monitored 
by UV spectroscopy at 456 nm. Purified CinC was subsequently desalted in a third 
purification step using PD-10 desalting columns with 50 mM KHxPO4 buffer (Matrix: 
SephadexTM G- 25- 5 mL; GE-healthcare, USA). Finally, the desalted protein was lyophilized 
for 16 h (Christ Alpha 1-2 LD Plus; Omnilab laborzentrum GmbH & Co. KG, Germany) and 
stored at -20°C. 
 
3.3.3.3 Purification of E. coli Flavodoxin Reductase (Fpr)  
 
Purification of E. coli Fpr was performed as previously reported with the following 
modification to the protocol of Hawkes et al. Fpr was purified by two anion exchange 
chromatography steps. In the first step, using Toyopearl 650S-DEAE matrix (Tosoh 
Biosciences, Tokyo, Japan, bed size: 15 mm x 110 mm) and ÄKTA prime plus protein 
purification system (GE Healthcare, München, Germany) on a preparative LC columns 
(internal diameter 15 mm, length 125 mm; KRONLAB Glass Columns, TAC 15/125 PE5-AB-
2; YMC Europe GmbH, Dinslaken). Column matrix was equilibrated in loading buffer (20 
CVs; 50 mM Tris-HCl; pH 7.4, flow rate 3 mL/min). The filtered and clarified lysate (25 ml) 
was loaded on the column (flow rate 1 ml/min) and unbound protein was washed out with 
loading buffer (20 CVs, flow rate 1.5 mL/min). Protein was eluted by salt gradient in elution 
buffer (1 M NaCl, 50 mM Tris-HCl, pH 7.4, gradient from 0% to 40% in 200 ml, flow rate 
1.5 mL/min). Fractions containing Fpr were pooled and purified by a second 
chromatography step using hydroxyapatite column (Tosoh Biosciences LLC, Tokyo, Japan; 
bed volume: 15 mm x 100 mm) and LC columns (internal diameter 15 mm, length 125 mm; 
KRONLAB Glass Columns, TAC 15/125 PE5-AB-2, YMC Europe GmbH, Dinslaken). Column 
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was equilibrated in loading buffer (20 CVs; 1 mM KH2PO4, 100 mM NaCl; pH 7.2, flow rate 3 
mL/min). Pooled fractions containing Fpr obtained after first purification step were loaded 
on the column (flow rate 1 mL/min)and unbound protein was washed out using loading 
buffer (20 CVs, flow rate 1.5 mL/min). Fpr was eluted by phosphate gradient (500 mM 
KH2PO4, pH 7.2, gradient from 0% to 30% in 200 ml, flow rate 1.5 mL/min). Purity was 
checked by SDS-PAGE after each chromatography step (12 % SDS-gel; 20 mA, 50 W, 75 min; 
Mini-Protean Tetra Cell, Bio-Rad Laboratories GmbH, München Germany). Expected size for 
Fpr is 29 kDa. Purified Fpr was subsequently desalted in a third purification step using PD-
10 desalting column with 50 mM KHxPO4 buffer (Matrix: SephadexTM G- 25- 5 mL; GE-
healthcare, USA). Finally, the desalted protein was lyophilized for 18 h (Christ Alpha 1-2 LD 
Plus; Omnilab laborzentrum GmbH & Co. KG, Germany) and stored at -20°C. 
3.4 Analytical Methods 
 
3.4.1 Determination of P450 Concentration 
 
Concentration of active P450 monooxygenase in purified protein samples or crude cell 
lysates was determined by CO-differential spectrophotometric analysis according to Omura 
and Sato, 1964. The reduced heme-iron has an absorption maximum at 450 nm and the 
concentration of active P450 (heme) can be determined spectrophotometrically. The 
protein (crude cell lysate, purified or lyophilized protein) was diluted in phosphate buffer 
(50 mM KXPO4, pH 7.4, 3:1 dilution). The sample was subsequently reduced using sodium 
dithionite (approximately 2 mg). Absorption spectrum was recorded for the protein sample 
in the range from 400 to 500 nm with a Varian Cary 50 spectrophotometer (Agilent 
Technologies, Darmstadt, Germany) as reference measurement. Subsequently, the reduced 
sample was gently gassed with CO for 40 sec using a lecture bottle station (Sigma Aldrich, 
Steinheim, Germany) with subsequent recording of the differential spectrum (400 - 500 
nm). The amount of P450 was calculated from the following equation 
CP450 =
A450nm−A500nm
ε∙d
     X DF                                                               
: Extinction coefficient Heme-CO-complex: 91 mM-1cm-1 
d: Path length; 1cm 
DF: dilution factor 
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Figure 3.1.Typical CO-differential spectrum of an active P450 monooxygenase. The peak at 
450 nm represents active form of P450 bound to CO monoxide after reduction with sodium 
dithionite. 
 
3.4.2 Determination of FAD and FMN Concentration in CinC and E. coli Flavodoxin 
Reductase  
 
The concentrations of CinC and E. coli Fpr were determined by incubating the protein 
samples (cell lysate or purified proteins) in a boiling water bath for 10 min at 95°C to 
release free FMN and FAD content. Sample was prepared by mixing the protein with 
phosphate buffer (50 mM KXPO4, pH 7.4, 1:1 dilution) and its spectrum is recorded from 
400 nm to 500 nm. The sample was subsequently transferred to an Eppendorf tube and 
incubated in a water bath for 10 min. After cooling, the denatured protein was removed by 
centrifugation (20 min, 4°C, and 11,500g). The supernatant was recovered and the 
absorbance spectrum recorded. The concentrations of FAD and FMN were estimated by 
using molar extinction coefficients of 12.2 mM-1cm-1 for FMN at 446 nm and of 11.3 mM-
1cm-1 for FAD at 450 nm (Aliverti et al., 1999). 
3.4.3 Gas Chromatography 
 
3.4.3.1. Extraction of Reaction Products for GC Analysis 
The reaction products of P450cin conversions were extracted from the reaction mixture by 
two phase extraction employing ethyl acetate as extraction solvent. In order to compensate 
for errors due to evaporation and pipetting, a defined amount of internal standard - thymol 
(800 µM) was added to the extraction solvent.  Reactions performed in MTPs (250 µL) were 
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extracted with 250 µL of ethyl acetate whereas reactions performed in Eppendorf tubes (1 
mL) were extracted with 1 mL of ethyl acetate containing 800 µM of thymol as internal 
standard. After the completion of reactions, ethyl acetate was added to the reaction 
mixtures and it was mixed thoroughly (900 rpm, 15 min, RT). The organic phase was 
subsequently separated by centrifugation (4000 g, 10 min, RT). Next, the organic phase 
containing the product (2-β-hydroxy-1,8-cineole) was dried over Na2SO4 to remove traces 
of residual water. The water free organic phase was then centrifuged (4000 g, 5 min, RT) 
before injecting to the GC. 
 
3.4.3.2 Quantification of Product Amount by GC-FID 
 
Quantification of the reaction product (2-β-hydroxy-1,8-cineole) was performed using a 
Shimadzu GC-2010 gas chromatography coupled to a flame ionization detector (FID) 
(Shimadzu, Japan). 2-β-hydroxy-1, 8-cineole was detected with column FS-Supreme-5ms 
(5% Phenylpolysilphenylen-siloxane; 30 m x 0.25 mm x 0.25 µm film thickness; CS-
Chromatographic Service, GmbH Langerwehe, Germany) using nitrogen as the carrier gas. A 
calibration curve was generated using authentic 2-β-hydroxy-1,8-cineole from 10 µM to 
500 µM with a defined amount of internal standard (800 µM thymol). The separation of 2- 
β-hydroxy, 1, 8-cineole was achieved using following oven temperature program: from 80°C 
to 150°C with 5°C /min and hold at 300 °C for 1 min. The retention time of 2-β-hydroxy-1, 
8-cineole was determined to be 9.3 min. 
 
3.4.4 Thin layer chromatography 
 
Extracted reaction products (40 µL) were spotted on a pre-coated Silica gel 60 F254 plates 
(20 cm x 10 cm; Merck KGaA, Darmstadt, Germany) using an automatic TLC sampler 
(CAMAG automated TLC sampler 4, CAMAG, Muttenz, Switzerland). A hexane/ethyl acetate 
(17:3) mixture was employed for TLC separation by means of an automated developing 
chamber (ADC2). The chromatogram was stained using a p-anisaldehyde/glacial acetic 
acid/conc. H2SO4 (0.5:60:0.5) mixture. 2-β-hydroxy-1,8-cineole was visualized on the plate 
by heating the plate with a heat gun. Densitometry evaluation of the TLC plates was carried 
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out at a wavelength of 634 nm (TLC scanner 3, CAMAG, Muttenz, Switzerland) and data 
analysis was performed with WinCATS software. Calibration curve for 2-β-hydroxy, 1, 8-
cineole was generated in the range of 25 µM to 500 µM. 
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4. RESULTS AND DISCUSSION 
 
The results and discussion chapter is divided in six parts. Part I describes the development 
of a screening system for determination of activity for P450cin. It focuses on various 
strategies investigated to develop an assay for screening of P450cin mutant libraries. Part 
II focuses on the construction of CinA and CinC fusion protein with a linker of variable 
length from 1 to 16 amino acids. It also describes the screening of the linker library and 
activity determination of the linker library towards 1,8-cineole. Part III gives preliminary 
insights describing the role of the length of the linker region in the fusion protein and its 
effect on the activity of the fusion protein. Part IV describes directed evolution of P450cin 
fusion protein for mediated electron transfer. The part describes random mutagenesis of 
P450cin fusion variant for replacement of NADPH with Zn/Cobalt (III) sepulchrate. Part V 
reports the semi-rational evolution of P450cin for mediated electron transfer. It describes 
redesigning of P450cin active site rationally for improvement towards 
Zn/Cobalt(III)sepulchrate. Part VI describes preliminary electrochemical characterization 
of P450cin variants identified from random and semi-rational evolution of P450cin. The 
chapter accounts the use of platinum electrode and Cobalt(III)sepulchrate for electro-
biocatalytic conversion of 1,8-cineole to 2-β-hydroxy-1,8-cineole. 
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4.1. Development of Screening System for P450cin 
 
4.1.1 Aim of the Work  
 
Aim of the work described in this part of the thesis is to develop a suitable and sensitive 
screening system for detection of activity of P450cin towards 1,8-cineole in a 96 well 
microtiter plate. Screening systems employed in directed evolution experiments are usually 
based on the detection of substrate depletion or product formation and are typically 
performed on agar plates, 96 or 364 -well microtiter plates (Aharoni et al., 2005). Advanced 
and recently developed assay systems make use of techniques like cell surface display, 
emulsion technology and flow cytometry (Ruff et al., 2012). Most widely used screening 
systems for P450 monooxygenases are based on spectrophotometric detection of depletion 
of co-factor (NADH or NADPH) or are based on screening systems using surrogate 
substrates (e.g., pNCA) (Schwaneberg et al., 2000). However, the development of an assay 
for P450cin activity was challenging as no obvious change in fluorescence or absorbance is 
associated with hydroxycineole formation or 1,8-cineole depletion. Five different strategies 
were investigated for the development of a screening assay for P450cin activity towards 
1,8-cineole. 
 
4.1.2 NADPH Consumption Assay 
 
Determination of NADPH depletion is widely employed as a screening system in directed 
evolution of monooxygenases. In case of P450cin, the depletion of NADPH accompanied 
with formation of 2-β-hydroxy-1,8-cineole can be detected spectrophotometrically at 
340 nm. The reaction was performed using mixture of CinA, CinC and E. coli Fpr in the ratio 
1:1:1 and NADPH depletion was monitored spectrophotometrically at 340 nm.  
Figure 4.1.1 shows the NADPH depletion assay for P450cin using cell lysates. Activity was 
observed for P450cin; however the rate of reaction with a reaction time of 1 h was 
extremely slow. The reaction for EV and reaction without any cell lysate (negative control) 
did not show any depletion as expected. For the reaction without substrate there was a 
noticeable depletion in the absorbance of NADPH. This could be attributed to the fact that 
monooxygenases loose activity in absence of substrate. 
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The long reaction time can lead to a very high standard deviation. In addition, during the 
time period of 1 h, NADPH can undergo self-degradation and can lead to inaccurate 
measurements. Furthermore, uncoupling reaction associated with use of NADPH will 
further decrease the reliability for the screening system. Thus a product based detection 
system is favorable either using natural substrate or using a dummy substrate. As a result, 
the NADPH depletion assay was not investigated further. 
 
 
Figure 4.1.1. Spectrophotometric detection of NADPH at 340 nm using P450cin. 
 
4.1.3 Spectrophotometric Detection of Indigo Formation 
 
Güray Güven (Güray Güven 2010; PhD thesis, Jacobs University, Bremen) reported 
mutations at amino acid position Y81 in the heme domain (CinA) (Figure 4.1.2 A) resulting 
in mutants catalyzing the hydroxylation of indole to 3-hydroxyindole. 3-hydroxyindole 
undergoes spontaneous air oxidation to produce the insoluble dye indigo and indirubin 
(scheme 3). 
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Scheme 3. Hydroxylation of indole as catalyzed by P450cin. Adapted from Celik et al (Çelik 
et al., 2005). 
 
A)                                                                                               B) 
 
                                                                                                                               
                                                                                                                               
 
 
           
Figure 4.1.2. P450cin as indole hydroxylating catalyst. (A) Active site of P450cin depicting 
the amino acid position Y81; 1,8-cineole and heme. (B) Wells of a 96- well microtiter plate 
showing the formation of indigo dye from indole for detection at 600 nm. 
 
The detection of indigo (formation of blue colour - Figure 4.1.2 B) can be monitored at 600 
nm enabling a medium throughput screening using a microtiter plate. Indigo formation has 
been used in several directed evolution experiments as a pre-screening on solid phase or in 
microtiter plates (Çelik et al., 2005). 
In order to determine the amino acids responsible for activity towards indole a SSM library 
was generated at position Y81. Screening of the generated SSM library using whole cells of 
E. coli harboring mutation at position Y81 was performed. E. coli Fpr acted as the terminal 
Y81 
1,8-Cineole 
Heme 
                                                                                            Development of Screening System for P450cin 
56 
 
redox partner for conversion of indole to indigo in in vivo reactions. In vitro reactions were 
performed by adding equimolar mixtures of cell lysates of CinA (with mutation at Y81) + 
CinC+ E. coli Fpr. 
 
 
 
Figure 4.1.3. Activity profile for SSM variants for hydroxylation of indole to indigo using 
whole cells of E. coli harboring mutation in CinA (heme domain). 
 
 
   
 
Figure 4.1.4. Activity profile for SSM variants for hydroxylation of indole to indigo using 
cell lysates for CinA+CinC+Fpr. 
 
Figure 4.1.3 and figure 4.1.4 show the activity profile of in vivo and in vitro reaction for 
conversion of indole to hydroxy indole. The in vivo reactions displayed the activity of SSM 
variants and could be detected on a 96-well plate. However, when the assay was performed 
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using cell lysates the conversion of indole to indigo was very low. The detection limit of the 
assay was not suitable for setting up a screening system with a reliable detection on a 96-
well plate and hence it was not further investigated. 
 
4.1.4 Hydroxycineole dehydrogenase (CinD) based detection assay 
 
In the presence of an external electron transfer partner (e.g. E. coli Fpr) CinA and CinC 
catalyze the hydroxylation of 1,8-cineole to 2-β-hydroxy,1,8-cineole. The next step in 1,8-
cineole degradation is believed to be the oxidation of secondary alcohol to the 
corresponding ketone (i.e. ketocineole) (Scheme 4; boxed). 
 
 
 
Scheme 4. Proposed pathway for 1,8-cineole (1) degradation to hydroxycineole (2) and 
ketocineole (3). Adapted from Slessor et al (Slessor et al., 2010).  
  
Slessor et al., demonstrated that cinD gene from Citrobacter braaki exhibited a NAD+ 
dependent hydroxycineole dehydrogenase activity. It catalyzes the regio and 
enantiospecific conversion of hydroxycineole to ketocineole accompanied by the formation 
of NADH (Slessor et al., 2010). The latter can be detected by UV-spectroscopy and/or 
fluorescence measurements. By coupling the reaction of interest with ketocineole 
production, the levels of hydroxycineole can be indirectly monitored. Scheme 5 represents 
design of the screening system for detection P450cin activity indirectly by measuring the 
rate of formation of NADH. 
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Scheme 5. Representation of CinD based screening system. 2-β-hydroxycineole-1,8-cineole 
produced upon oxidation of 1,8-cineole using crude cell lysate of CinA, CinC and E. coli Fpr 
was coupled with CinD and NAD+ for the formation of ketocineole with concomitant release 
of NADH. The formation of NADH was monitored spectrophotometrically at 340 nm. 
 
Hydroxycineole produced upon oxidation of cineole using crude cell lysate of CinA, CinC and 
E. coli Fpr was coupled with CinD and NAD+ for the formation of ketocineole with 
concomitant release of NADH. The formation of NADH was monitored 
spectrophotometrically at 340 nm (Figure 4.1.5). 
  
 
Figure 4.1.5. Spectrophotometric detection of NADH at 340 nm by coupling the oxidation 
of hydroxycineole to ketocineole in presence of CinD and NAD+. 
 
Figure 4.1.5 show the formation of NADH overtime. The conversion rate of hydroxycineole 
to ketocineole was slow (60 min). This could be also due to slower rate of conversion of 
cineole to hydroxycineole limiting the subsequent coupled reaction. In addition to this, the 
background noise from crude cell lysate of EV was very high. High background noise and 
NADP+ NADPH 
1,8-Cineole 2-β-Hydroxy-1,8-cineole Ketocineole 
CinA+CinC+Fpr 
Hydroxycineole 
Dehydrogenase (CinD) 
NADH 
 
NAD+ 
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slow reaction rates made it difficult to develop a sensitive and reliable screening system on 
a 96-well plate and hence the CinD based assay was not pursued further. 
 
4.1.5 Thin Layer Chromatography 
 
The screening system using thin layer chromatography (TLC) is based on the detection of 
2 β-hydroxy-1,8-cineole by separating the extracted reaction products on a TLC plate and 
using a mixture of p-anisaldehyde/glacial acetic acid/91 % H2SO4 (0.5:60:0.5) as the 
staining reagent. A blue colored spot corresponding to 2-β-hydroxy-1,8-cineole was 
observed after the TLC plate is heated with a heat gun at 100 °C for 2-3 min (Figure 4.1.6). 
Lane 20 shows the formation of 2-β-hydroxy-1,8-cineole using WT enzyme; Lane 1-19 
shows the formation of 2-β-hydroxy-1,8-cineole using P450cin variants. 
 
 
    
 
Figure 4.1.6 Illustration of a TLC plate obtained after development in mobile phase (n-
hexane: ethyl acetate: 17:3) subsequent staining with p-anisaldehyde/glacial acetic 
acid/91 % H2SO4 and heating with a heat gun to develop colour for 2-β-hydroxy-1,8-cineole. 
Blue colored spot is 2-β-hydroxy-1,8-cineole and orange colored represents internal 
standard (thymol). Lane 20: formation of 2-β-hydroxy-1,8-cineole using WT enzyme; Lane 
1-19: formation of 2-β-hydroxy-1,8-cineole using P450cin variants. 
 
Validation of a screening system is an important parameter in order to determine its 
accuracy, efficiency and reproducibility. The proposed TLC method was validated in terms 
of detection range, linearity and relative standard deviation. Various parameters affect the 
performance of thin layer chromatography which includes material of the stationary phase, 
composition of the mobile phase and their interaction with the compound to be separated 
on the TLC. The stationary phase used for separation of 2-β-hydroxy,1,8-cineole was pre-
coated silica gel 60 F254 plates (Merck® TLC plates, Merck KGaA, Darmstadt, Germany). 
Extracted reaction products (40 µl) were spotted using automatic TLC sampler. A mobile 
Thymol 
2-β-hydroxy-1,8-cineole 
1    2     3    4    5     6    7    8     9   10  11 12  13  14  15 16 17  18  19  20 
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phase consisting of n-hexane: ethyl acetate (17:3) was used for development of TLC plates. 
Using this solvent, a RF value of 0.12 ± 0.1 were obtained for 2-β-hydroxy-1,8-cineole 
(Figure 4.1.7 A). Densitometric scans of the obtained bands for 2-β-hydroxy-1,8-cineole 
hydroxycineole was performed at the absorbance maxima at 634 nm (Figure 4.1.7 B). 
 
 
 
Figure 4.1.7. Analysis of 2-β-hydroxy-1,8-cineole using TLC. A) Graph showing the RF of 2-
β-hydroxy-1,8-cineole  (peak 2) after development in mobile phase (n-hexane: ethyl 
acetate: 17:3). B) Graph displaying the peaks corresponding to 2-β-hydroxy-1,8 cineole 
after densitometric scan at 634 nm. 
 
Excellent linearity was observed for calibration curve over the concentration range of 100 
µM to 500 µM) and coefficient of variation was determined with respect to area and height 
for 2-β-hydroxy-1,8-cineole (Figure 4.1.8). 
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B) 
 
 
Figure 4.1.8. Calibration curve for 2-β-hydroxy-1,8-cineole using automated thin layer 
chromatography in a concentration range of 100 µM to 500 µM. A) Determined with respect 
to area under curve B) Determined with respect to height of curve. 
 
 
The relative standard deviation was determined using multicomponent CinA+ CinC+ Fpr 
system. In vitro reactions were performed using NADPH containing cell lysates of CinA, CinC 
and Fpr for 2 h at 30 °C in all 96 wells of a 96- well microtiter plate. The extracted reaction 
products were spotted on the TLC plate and scanned at 634 nm. The amount of 2-β-
hydroxy-1,8-cineole formed in each well of the 96-MTP was determined on the basis of 
relative peak area and peak height for each sample. The relative standard deviation was 
determined to be 18.98 % and 15.7 % for regression with area and height respectively. 
The scheme for detection of 2-β-hydroxy-1,8-cineole using automated thin layer 
chromatography and then GC-FID is as shown in Figure 4.1.9. Though the standard 
deviation of the TLC based screening system was high, nonetheless it was a product based 
detetion system and allowed semi-quantification of 2-β-hydroxy-1,8-cineole. It allowed 
reliable differentiation between active and inactive clones and between WT and P450cin 
variants In order to quantify the amount of 2-β-hydroxy-1,8-cineole accurately, GC-FID 
could be employed subsequently. 
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CinA + CinC+ Fpr +         NADPH+ 1,8-cineole                            2-β-hydroxy-1,8-cineole   
 
                                           Extraction with ethyl acetate 
 
 
 
 
 
 
 
 
 
 
Figure 4.1.9. Steps involved in the detection of 2-β-hydroxy-1,8-cineole using automated 
thin layer chromatography.  
Or CinA-linker (1-16)-CinC 
Or Random libraries 
Or SSM libraries 
Spotting of reaction 
product on TLC 
Develpment of TLC plates 
Scanning and densitometric 
evaluation of TLC plates for 
semi-quantification of 2-β-
hydroxy-1,8-cineole   
Quantification of 2-β-hydroxy-1,8-
cineole using GC-FID  
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4.1.6 Gas Chromatography 
 
The TLC based screening system described above allowed semi-quantification of 2-β-
hydroxy-1,8-cineole. Since it was a product based detection assay expression mutants could 
not be omitted and distinguished from the improved mutants. As a result, variants 
identified as improved with respect to the wild type using the TLC based screening system 
were further analyzed using GC-FID with normalized amount of P450 monooxygenase in 
the reaction mixture. The GC-FID measurements also allowed accurate quantification of 2-
β-hydroxy-1,8-cineole. The retention time of 2-β-hydroxy-1, 8-cineole was determined to 
be 9.3 min. 
 
 
 
Figure 4.1.10. Calibration curve for 2-β-hydroxy,1-8-cineole using GC-FID in concentration 
range of 10 to 500 µM. 
Figure 4.1.10 shows the calibration curve for 2-β-hydroxy-1,8-cineole in concentration 
range of 10 µM - 500 µM. All measurements were performed in triplicate. The relative 
standard deviation was determined to be 6.32 % and the co-efficient of determination (R2) 
was obtained as 0.9998. 
 
4.1.7 Discussion 
 
One of the crucial steps in any directed evolution campaign is the development of a 
sensitive and reliable screening system for detection of enzymatic activity. Screening of a 
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random or focused mutant library using pre-screens like agar plate assay to identify active 
and inactive clones decreases screening efforts.  It is rightly believed in directed evolution 
experimets ‘‘you get what you screen for’’ (You and Arnold, 1996). For mutant libraries 
expressed in microorganisms, screening can be performed on colonies growing on a solid 
substrate such as agar. Solid phase screening relies on product solubilization followed by an 
enzymatic reaction resulting in halo formation (zone of clearance), a fluorescent product or 
a strong chromogenic product (Olsen et al., 2000). Subsequently, screening of selected 
active clones using 96- or 384- well microtiter plate based assay formats can be performed 
(Aharoni et al., 2005). Advanced and recently developed assay systems make use of 
techniques like cell surface display, emulsion technology and flow cytometry (Ruff et al., 
2012). The development of an assay for detection of P450cin activity was challenging as no 
obvious change in fluorescence or absorbance is associated with hydroxycineole formation 
or cineole depletion. Additionally, the substrate range for cytochrome P450cin is very 
narrow. Except for terpenoid 1,8-cineole P450cin does not accept any other substrates; not 
even closely related terpenoids like 1,4-cineole, α-pinene, limonene and camphor. 
NADPH depletion assay is a universal assay for monooxygenases and can be monitored 
spectrophotometrically by measuring absorbance of NADPH at 340 nm (Glieder and 
Meinhold, 2003). Using the P450cin system (equimolar mixture of CinA, CinC and E. coli 
Fpr) the depletion of NADPH was monitored at 340 nm. However, the reaction was 
extremely slow and required about 1 h to detect a decrease in absorbance. During this long 
reaction time, NADPH can undergo self-degradation as well as get uncoupled forming 
superoxide radical, water or hydrogen peroxide leading to inaccurate measurements. Thus 
detection of decrease in absorbance of NADPH this assay was not a reliable and efficient 
option for screening of mutant libraries. 
Another spectrophotometric assay which was tested was based on the detection of indigo 
formation of P450cin mutants at 600 nm. Several oxygenases and their mutants can form 
blue indigo dye after indole hydroxylation. Indigo formation can be monitored visually or 
spectrophotometrically at 600 nm (Çelik et al., 2005). E. coli colonies bearing indole 
hydroxylating enzymes turn blue when they grow on agar plates because indole is 
produced endogenously by E. coli (Gillam et al., 2000). Indigo detection assay is convenient 
and commonly used as a pre-screening on agar plates in several directed evolution 
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experiments to differentiate between active and inactive clones (Çelik et al., 2005). Indole 
can also be added to liquid cultures and the dye can be extracted for better quantification of 
the enzymatic activity than the agar plate assay (Gillam et al., 2000). In vivo reactions using 
P450cin harboring Y81 mutation demonstrated measurable indigo formation at 600 nm 
(Figure 4.1.3) whereas, when reactions using cell lysates were performed, the amount of 
indigo formation decreased dramatically (Figure 4.1.4). Owing to the low activity using cell 
lysate; this assay for detection of indigo was not suitable for screening of mutant libraries of 
P450cin for directed evolution. 
Coupled enzyme assays have been reported for a variety of enzymes including 
monooxygenases, dehydrogenases, transferases (Badalassi et al., 2000; Hendricks et al., 
2004; Joo et al., 1999a). The cinD gene from Citrobacter braaki exhibits a NAD+ dependent 
hydroxycineole dehydrogenase activity catalyzing conversion of hydroxycineole to 
ketocineole accompanied by the formation of NADH (Slessor et al., 2010). The latter can be 
detected by UV-spectroscopy and/or fluorescence measurements at 340 nm. However, the 
sensitivity of the screening systems was low, most likely due to the slow rate of conversion 
of cineole to hydroxycineole thus slowing down the subsequent reporter reaction. 
Detection of 2-β-hydroxy-1,8-cineole was best achieved with the thin layer chromatography 
system. Chromatographic based screening systems like manual TLC are not much prevalent 
in directed evolution campaigns. This can be attributed to the fact that they are laborious 
and often require a subsequent assay to be performed for product quantification. 
Nonetheless, the automated TLC (CAMAG, Muttenz, Switzerland) employed in this thesis 
could be used like general MS-methodologies with a throughput of hundreds of clones per 
day (Geier et al., 2013). The assay was based on derivatization of hydroxyl group in the 
presence of p-anisaldehyde, sulfuric acid and glacial acetic acid which formed a blue colored 
product after heating at 100 °C. The derivatized product could be detected and the amount 
quantified by scanning at 643 nm using a TLC scanner. The relative standard deviation of 
18.98 % and 15.7 % for regression with area and height respectively were in the acceptable 
range for screening of random libraries generated for cytochrome P450cin. TLC was 
subsequently used for screening of random libraries of P450cin as described in Chapter 4, 
section 4.4 and 4.5. 
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4.1.8 Conclusion 
 
It is very crucial in a directed evolution campaign to differentiate between WT and 
improved variant with the screening system. However, for the assays based on detection of 
depletion of NADPH at 340 nm, indigo detection at 600 nm and spectrophotometric 
detection of NADH at 340 nm, the difference between the wild type and the mutant enzyme 
was not sufficient enough for accurate quantification of enzymatic activities. 
A medium throughput screening system based on detection of 2-β-hydroxy-1,8-cineole 
using a thin layer chromatographic detection system was established. It allowed screening 
of up to 200 clones / day. Since it is product detection based assay it could be applied for in 
vivo as well as in vitro reaction conditions. Though the throughput of the screening system 
was low, nonetheless it allowed accurate semi-quantification of 2-β-hydroxy-1,8-cineole 
with a standard deviation of was 18.98 % and 15.7 % for regression with area and height 
respectively. This is the first reported TLC based activity assay employed for screening of 
mutant libraries in a directed evolution campaign. Since the assay is based on the 
derivatization of hydroxyl group with p-anisaldehyde, sulfuric acid and acetic acid it can 
also be useful for discovering and isolating newer oxygenases. The TLC based screening 
system can also be useful to a range of other substrates (steroids, sugars, phenols, terpenes) 
were a colorimetric or fluorometric screening system is not available. 
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4.2 P-Link: A Method for Generating Multi-component Cytochrome P450 
Fusions with Variable Linker Length  
 
Part of this chapter has been previously published as Ketaki D. Belsare, Anna Joëlle Ruff, 
Ronny Martinez, Amol V. Shivange, Hemanshu Mundhada, Dirk Holtmann, Jens Schrader 
and Ulrich Schwaneberg; P-LINK: A Method for Generating Fusion Proteins with Variable 
Linker Length, BioTechniques 57: 13-20; July 2014; doi 10.2144/000114187. 
 
4.2.1 Aim of the Work 
 
Despite the fascinating catalytic abilities, the multi-component nature of majority of 
cytochrome P450 system limits their applicability in synthesis, especially in cell-free 
applications. Generating efficient P450 enzymes by fusing the heme and redox partners 
with an optimized linker length is an attractive approach to overcome this challenge. Most 
of the currently available protocols for generation of fusion proteins are enzymatic methods 
with time consuming, low efficiency and complicated protocols. In this chapter a technically 
simple, robust and enzyme free method P-Link (P-LinK; Protein fusion with variable Linker 
insertion) for generation of multicomponent cytochrome P450 fusions with variable linker 
lengths using multicomponent cytochrome P450cin as a model enzyme system is reported. 
Cytochrome P450cin consists of CinA (Heme active center), CinC (FMN containing 
reductase) and CinB (FAD containing reductase). P-Link was used to generate a fusion 
protein of CinA and CinC with a variable length from 1 to 16 amino acids between the fused 
domains. 
CinB (cindoxin reductase) is not expressible in an active form and is replaced in activity 
assays measurements with E. coli Fpr which is highly expressed in an active form in E. coli.  
The generation of fusion protein is based on principle of phosphorothioate ligase 
independent cloning method, called PLICing which was previously developed by Blanusa et 
al (Blanusa et al., 2010). PLICing allows sequence independent cloning of DNA fragments 
with high efficiency and a low background of false positive colonies. PLICing employs 
phosphorothioated nucleotides for amplification of target gene and vector (step 1). The use 
of chemical cleavage step using iodine and ethanol (step 2) to generate specific 
complementary DNA overhangs for subsequent hybridization reaction (step 3) circumvents 
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the limitations of the widely employed restriction ligation cloning. Figure 4.2.1 is the 
schematic representation of the steps involved in PLICing cloning technique. 
 
 
 
Figure 4.2.1. Schematic representation of PLICing method. (A) DNA backbone with a 
normal phosphodiester (top part) and a phosphorothiodiester bond in which one oxygen at 
α- phosphate is replaced by a sulfur atom (bottom part); B- protein backbone (B) PLICing 
method comprises of three steps: amplification, cleavage and hybridization (Figure taken 
from (Blanusa et al., 2010). 
 
4.2.2 Generation of Fusion Protein 
 
Generation of fusion protein is based on PLICing cloning technique. In the first step, 
amplification of genes (cinA and cinC) and vector (pALXtreme-1a) was achieved with 
modified phosphorothioated primers employing standard PCR protocol (step 1) and 
subsequently chemically cleaved in an Iodine-ethanol solution generating specific 
complementary overhangs (step 2). The cleaved DNA fragments were hybridized in the 
next step generating the CinA-CinC-pALXtreme construct (step 3). Figure 4.2.2 is the 
schematic representation of the steps involved in generation of CinA-CinC fusion protein. 
cinA (gene size 1.2 kbp) was amplified using phosphorothioated primers FA1 and RA1, 
whereas cinC (gene size 471 bp) was amplified using phosphorothioated primers FC1 and 
RC1. Vector backbone pALXtreme-1a (vector size 2.3 kbp) was amplified separately using 
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phosphorothioated primers RP1 and FP1 (Figure 4.2.2; see Appendix for primer sequences; 
Table 2A). The primers FA1 and RP1 introduce complementary phosphorothioated 
nucleotides at the 5´ and 3´ end of the cinA gene and plasmid backbone. Primers RA1 and 
FC1 introduced complementary phosphorothioated nucleotides at the 3’ and 5’ end of cinA 
and cinC respectively. Oligonucleotides RC1 and FP1 introduced complementary 
phosphorothioated nucleotides at the 3´ of cinC and 5´ end of vector backbone. 
 
 
 
Figure 4.2.2. Steps involved in generation of the CinA-CinC fusion protein. cinA gene was 
amplified using primers RA1 and FA1 and cinC gene was amplified using primers RC1 and 
FC1. The vector pALXtreme-1a was amplified using primers RP1 and FP1. Primer FA1, RP1 
and primers RC1 and FP1 contained 12 complementary nucleotides. Subsequently the 
amplified products were cleaved using alkaline iodine and ethanol solution. Further 
hybridization of the vector and the genes generated cinA-cinC fusion protein. 
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PCR was performed for amplification of gene and vector sequence as described in chapter 
3; section 3.2.2. The amplification of the gene and vector was verified on a 0.8% agarose gel. 
Amplified PCR products corresponding to gene size of cinA (1.2 kbp), cinC (471 bp) and 
vector pALXtreme-1a (2.1 kbp) were observed (Figure 4.2.3). The PCR products were 
digested with DpnI (4 h, 10 U, 37 °C) and subsequently purified using Macherey-Nagel 
NucleoSpin ExtractII DNA purification kit (Düren, Germany). The purified PCR products 
were cleaved in the presence of alkaline iodine/ethanol solution in a thermocycler as 
described in chapter 3; section 3.2.2 and subsequently hybridized in one PCR tube in order 
to generate CinA-CinC fusion protein. The hybridization mixture was transformed in 
chemically competent E.coli BL-21 Gold (DE3) lacIQ1 cells. 
 
 
 
 
 
 
 
 
 
 
Figure 4.2.3. 0.8% agarose gel for step 1 in P-Link protocol. PCR amplification of genes 
(cinA and cinC) and vector (pALXtreme-1a). A) Lane 1: 1 kbp DNA ladder; lane 2: amplified 
cinA (1.2 kbp); lane 3: 10 kbp DNA ladder; lane 4: amplified cinC (417 bp). B) Lane 1 & 2: 
amplified pALXtreme-1a (2.1 kb); lane 3: 1 kbp DNA ladder. 
 
4.2.3 Identification of Positive Clone for Fusion Protein 
 
The clones obtained after the transformation of hybridized product of cinA-cinC genes and 
pALXtreme-1a vector were analyzed by colony PCR and sequencing analysis to identify a 
positive construct containing CinA- CinC fusion protein. 
A) B) 
 1        2        3        4   1             2           3     
250 bp 
1000 bp 
3000 bp 
5000 bp 
250 bp 
2000 bp 
5000 bp 
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4.2.3.1 Colony PCR 
Sixteen isolated colonies were picked from agar plate for colony PCR in order to determine 
a positive clone containing CinA-CinC fusion construct. Colony PCRs were performed as 
described in chapter 3, section 3.2.3 and analyzed by agarose gel electrophoreses (Chapter 
3, section 3.1.3). The primers used for amplification of target gene in the fusion protein 
construct were primers FA1 and RC1 (Appendix; Table 2A for primer sequences) which 
amplified only the fused CinA-CinC gene (total size ~ 1.7 kb) and not the vector sequence. 
An expected size of ~1.7 kb was obtained in 14 out of 16 analyzed clones (Figure 4.2.4). 
 
 
 
 
 
 
 
 
Figure 4.2.4. 0.8% agarose gel for colony PCR of fusion protein for identification of positive 
constructs. Lane 1-16: Colony PCR products for 16 individual colonies for identification of 
positive clone for CinA-CinC fusion protein; Lane 17: 1 kb DNA ladder. 
 
4.2.3.2 Sequence Analysis of Fusion Protein 
 
Three positive colonies identified from colony PCR for CinA-CinC fusion were sent for 
sequencing and obtained sequencing data was analyzed by Clone Manager software. 
Figure 4.2.5 shows nucleotide sequence of the CinA-CinC fusion construct.  
 
 
 
 
Figure 4.2.5. Nucleotide sequence of the cinA-cinC fusion constructs. The black box 
indicates the direct joining of the nucleotide sequence in cinA-cinC genes. Stop codons after 
the cinA gene were removed during amplification of cinA gene in Step 1 of P-Link (Chapter 
4; section 4.2.2). 
250 bp 
2000 bp 
5000 bp 
 1     2     3     4     5     6      7      8    9   10    11  12    13   14   15  16   17 
cgattatttt tccgaaaggc aaacgtctga cgcttgcgaa atggg taatgccctg attttatatg gcacg 
gctaataaaa aggctttccg tttgcagact gcgaacgctt taccc attacgggac taaaatatac cgtgc 
 
>.......................cinA............>>>>...........cinC.................> 
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Sequence analysis confirmed the nucleotide sequence of cinA was directly joined with the 
nucleotide sequence of cinC (highlighted by a black box in Figure 4.2.5) thus making a 
fusion of cinA and cinC genes (Chapter 4; section 4.2.2). Stop codon after cinA gene was 
removed during amplification in step 1 of P-Link in order to facilitate protein synthesis and 
subsequent expression of the CinA-CinC fusion protein. All three clones sequenced were 
positive and contained the desired CinA-CinC fusion however, only one positive clone 
verified by colony PCR and sequencing was used for further experiments. 
 
4.2.4. Determination of Activity for CinA-CinC Fusion Protein 
 
Next step after construction and expression of CinA-CinC fusion protein was determination 
of its activity towards 1,8-cineole. Preparation of crude cell lysate and activity assay was 
performed as described in chapter 3; section 3.2.9 and 3.3.1. Control reactions consisting of 
cell lysates of only CinA, only CinC and empty vector (1 µM each) as negative control and 
unfused CinA+CinC (1 µM each) as positive control in the presence of E. coli Fpr (1 µM) and 
NADPH (0.4 mM) were performed. Reactions for CinA-CinC fusion protein as well as those 
containing only CinA and only CinC did not show any measurable conversion of 1,8-cineole 
to 2-β-hydroxy,1,8-cineole. However, on the other hand, equimolar mixture of unfused CinA 
and CinC protein was active. The activity profiles for CinA-CinC fusion protein and control 
reactions are as shown in Table 4.2.1. 
 
Table 4.2.1. Conversion of 1,8-cineole performed using CinA-CinC fusion protein 
supplemented with E. coli Fpr (1 µM) and NADPH (0.4 mM) as a reduction equivalent. 
Control reactions were performed using unfused CinA and CinC domains and empty vector 
pALXtreme-1a. (n.c. = no conversion detected). 
 
Construct/Enzyme Active/Inactive Amount of 2-β-hydroxy,1,8-
cineole obtained (µM) 
Coupling 
(%) 
CinA-CinC fusion Inactive n.c. n.c. 
CinA Inactive n.c. n.c. 
CinC Inactive n.c. n.c. 
CinA + CinC Active 315 ± 13.88 79 ± 3.47 
Empty vector Inactive n.c.  n.c. 
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The direct fusion (C terminal CinA - N terminal CinC) was inactive and conversion of 1,8-
cineole to 2-β-hydroxy,1,8-cineole could not be detected. The natural fusion protein P450 
BM3 has a linker sequence separating the heme and the reductase domain (Govindaraj and 
Poulos, 1995, 1996). Various previous studies show that separating an artificial fusion 
protein with a short stretch of amino acid linkers can have a considerable effect on the 
activity of fusion protein (Arai et al., 2001; Robin et al., 2009). 
Most of the methods for insertion of linker sequences in a fusion protein are based on 
overlap extension PCR or using enzymes (restriction endonuclease and ligase). However 
they are not very efficient and only one linker length can be constructed at a time. Since the 
CinA-CinC fusion protein constructed was inactive; inserting linkers of different length 
could possibly lead to activity of the fusion protein. Thus based on PLICing cloning 
technique linkers of variable length from 1 to 16 amino acid residues were inserted in the 
CinA-CinC fusion protein. 
4.2.5 Insertion of Linker Sequence in CinA-CinC Fusion Protein 
 
For generation of CinA-CinC fusion library with a variable linker length from 1 to 16 amino 
acids, the plasmid containing cinA-cinC direct fusion construct (prepared in section 4.2.2) 
was used as template for subsequent PCRs (10 ng). The amino acids sequence of the linker 
to be inserted in CinA-CinC fusion protein was Pro-Ser-Pro-Ser-Thr-Asp-Glu-Ser-Pro-Ser-
Thr-Gly-Asp-Ala-Val-Ala (PSPSTDQSPSTGDAVA). Steps involved in the insertion of linker in 
CinA-CinC fusion protein are amplification of cinA-cinC fusion construct (linker length 0) 
using phosphorothioate primers, subsequent cleavage of the phosphorothioated base pair 
in presence of alkaline Iodine-ethanol solution and finally hybridization (Figure 4.2.6). 
The insertion of linkers in CinA-CinC fusion protein was performed in three PCRs using 
CinA-CinC fusion plasmid as template (Figure 4.2.6; PCR subsets i, ii, and iii). 
To insert a linker length of 1 -5 amino acids (Figure 4.2.6 PCR i), a reverse primer (RL1) and 
a mixture of forward primers (FL1-FL5) was employed. RL1 includes a 34 bp sequence 
complementary to the 3’ end of cinA, and contains 12 phosphorothioated nucleotides (nts) 
at the 5’ end. FL1 contains a nucleotide sequence complementary to the first codon of the 
linker, flanked by a cinC specific sequence at the 3’ end and a phosphorothioated nt 
sequence complementary to the phosphorothioated sequence of RL1 at the 5’ end. Similarly, 
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primers FL2, FL3, FL4, and FL5 were designed to include nucleotide sequences encoding for 
amino acids 2, 3, 4, and 5 of the linker. All forward primers (FL1-FL5) include at the 5’ end a 
12 phosphorothioated nts sequence complementary to the phosphorothioated sequence of 
the primer RL1 (See Appendix for primer sequence, Table 2B). 
 
 
 
Figure 4.2.6. Steps involved in insertion of linkers of variable length between the fused 
CinA-CinC protein domains. Three individual PCRs were performed for insertion of linker 
length from 1 – 16 amino acids. PCR i performed using forward primer RL1 and mixture of 
reverse primers (FL1 – FL5) inserted linker length between 1 - 5, PCR ii performed using 
forward primer RL2 and mixture of reverse primers (FL6 – FL11) inserted linker length 
between 6 - 11 and PCR iii performed using forward primer RL1 and mixture of reverse 
primers (FL1 – FL5) inserted linker length between 12 – 16. 
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In PCR ii, for the insertion of an amino acid linker length 6 - 11, the reverse primer RL2 was 
designed to include a sequence coding for linker amino acid 1 - 5 (Figure 4.2.6 ii) and 
forward primers FL6 - FL11 were employed using the same strategy as in PCR i to generate 
constructs with linker length 6 - 11. 
In PCR iii, the design of the primers to insert linkers with a length of 12 - 16 amino acids 
employs the reverse primer RL3, coding for linker amino acids 1 to 10 and primers FL12 – 
FL16 including the sequence coding for linker amino acids 11 to 16 (Figure 4.2.6 iii) (See 
Appendix for primer sequence, Table 2B). The amplification of genes from PCR i, ii and iii 
was verified on a 0.8% agarose gel (Figure 4.2.7). The predicted size of 3.8 kbp for the PCR 
product corresponding to the whole construct [gene (1.7 kbp) and vector (2.1 kbp) + 
linkers] was observed on the agarose gel (Figure 4.2.7). 
 
 
 
 
 
 
 
 
 
Figure 4.2.7. 0.8% agarose gel for amplification of fused cinA-cinC gene construct for 
insertion of linkers of variable length.  Lane 2-4: Products from PCR i (for insertion of linker 
length 1 - 5-; lane 2), PCR ii (for insertion of linker length 6 - 11; lane 3) and PCR iii (for 
insertion of linker length 12 - 16; lane 3); Lane 1: 1 kb DNA ladder. 
 
 
Amplified products obtained after PCR were digested with DpnI to cleave the parental DNA 
and were subsequently purified using Macherey-Nagel NucleoSpin ExtractII DNA 
purification kit for subsequent cleavage. The purified PCR fragments containing the library 
of cinA-cinC fusion with linker lengths from 1 - 5 amino acids (PCR i), linker lengths from 6 - 
11 amino acids (PCR ii) and linker lengths from 12 - 16 amino acids (PCR iii) were cleaved 
(0.6 pmol each) in three separate PCR tubes by alkaline Iodine-ethanol solution as 
described in chapter 3; section 3.2.2 and subsequently hybridized in one PCR tube in order 
 1         2        3         4 
5000 bp 
3000 bp 
1000 bp 
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to generate cinA-cinC fusion gene construct with linker lengths from 1 - 16 amino acids. 
Next, the hybridization mixture representing the CinA-linker(1-16)-CinC library was 
transformed in chemically competent E. coli BL-21 Gold (DE3) lacIQ1 cells (Chapter 3; 
section 3.1.4). 
4.2.5.1 Screening of the Linker Library  
 
To determine the optimal linker length for the CinA-CinC fusion protein, the CinA-linker(1-
16)-CinC library was screened using E. coli Fpr and NADPH as reduction equivalent. 
Expression and preparation of crude cell lysate of CinA-CinC linker library was performed 
as described in chapter 3; section 3.2.7 and 3.2.9. 
In total, 270 CinA-Linker(1-16)-CinC variants were screened for production of 2-β-hydroxy-
1,8-cineole in a 96 well microtiter plate using an automated thin layer chromatography 
sampler (Camag; Muttenz Switzerland). The 32 most active variants were analyzed to gas 
chromatography (GC-2010, Schimadzu) analysis to quantify 2-β-hydroxy-1,8-cineole 
formation. 
The product formation of a single variant of each linker length was measured in triplicate. 
Linker length between 8 to 12 amino acids proved for the CinA-CinC fusion to be optimal in 
terms of 1,8-cineole hydroxylation. A maximum in hydroxylation activity is found at a linker 
length of ten amino acids (176 µM µM-1 P450). Interestingly a plateau is reached for 
variants having linker lengths of 13 - 16 amino acids (Figure 4.2.8). Fusion proteins with a 
linker length of 4 or less were inactive with no detectable conversion of 1,8-cineole. The 
activity of the CinA-linker10aa-CinC was still lower than the activity for equimolar mixture (1 
µM each) of CinA, CinC and Fpr (315 µM of 2-β-hydroxy-1,8-cineole) (Figure 4.2.8). 
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Figure 4.2.8. 2-β-hydroxy-1,8-cineole formation of CinA-CinC fusion proteins generated by 
P-Link versus linker length from 0-16 amino acids and unfused CinA+CinC+Fpr. 
Concentration of CinA-CinC fusion proteins are normalized to 1 µM by carbon monoxide 
differential scanning spectroscopy, supplemented with E. coli Fpr (1 µM)  and reactions 
were initiated by addition of NADPH (0.4 mM final concentration). Highest product 
formation (176 µM) was reached at a linker length of 10 amino acids. In control reactions 
(CinA+Fpr (1 µM each), CinC+Fpr (1 µM each), empty vector+Fpr (1 µM each)) no product 
formation was detected. Three independent experiments were performed for variant of 
each linker length (1 to 16). Figure adapted from (Belsare et al., 2014). 
 
4.2.5.2 Sequencing of Active Clones from Linker Library 
 
Sequence analysis of the 32 most active and 15 inactive variants confirmed that all 16 
possible linker lengths were generated. The CinA-CinC fusion proteins with a linker length 
of 4 and shorter were inactive and did not show any measurable conversion of 1,8-cineole 
to 2-β-hydroxy-1,8-cineole (Figure 4.2.8). Exemplary sequencing result for a fusion protein 
for linker length of 10 aa is shown in figure 4.2.9. Sequence analysis confirmed the 
nucleotide sequence of cinA was joined with the nucleotide sequence of linker (highlighted 
by a black box in Figure 4.2.9) followed by nucleotide sequence of cinC gene (highlighted by 
a blue box in Figure 4.2.9). The insertion of linker length from 1 - 16 amino acids was 
confirmed by sequence analysis. One clone for each linker length verified by sequencing 
was used for further experiments. 
P-Link: A Method for Generating Multicomponent Cytochrome P450 Fusions with Variable 
Linker Length 
78 
 
 
 
 
 
 
 
Figure 4.2.9. Nucleotide sequence of the cinA-cinC fusion constructs with a linker length of 
ten amino acids between the CinA and Cinc protein domains. cinA was joined with the 
nucleotide sequence of linker (highlighted by a black box) followed by nucleotide sequence 
of cinC gene (highlighted by a blue box). Sequencing analysis confirmed the insertion of 
linker sequence in CinA-CinC fusion protein. 
 
4.2.6 Purification of CinA-CinC Fusion Proteins, E. coli Fpr, CinA and CinC 
for Characterization 
 
Characterization of linker variants which showed optimum product formation (CinA-
linker(9-11)-CinC was performed using purified fusion proteins. In addition, CinA, CinC and 
E.coli Fpr were also purified by anion exchange chromatography (chapter 3; section 3.3.4). 
Purity for all purification steps was monitored by SDS-PAGE analysis (chapter 3; section 
3.1.2). Concentration of active P450 was determined by CO-differential spectroscopy 
(chapter 3; section 3.4.1) and concentration of active FAD and FMN was determined as 
described in chapter 3; section 3.4.2. Additionally, determination of total protein amount 
with the BCA assay was used to determine the purity of the purified protein. In all cases the 
purity was above 90 %. 
 
4.2.6.1 Purification of CinA and CinA-linker (9-11)-CinC 
The purification of CinA and CinA-CinC linker variants was achieved by using anion 
exchange chromatography and eluting the protein with a salt gradient described in chapter 
3; section 3.3. 4). Size of CinA is 45 kDa and for CinA-CinC linker variants is 61 kDa. 
Exemplary chromatogram of the anion exchange purification step and the SDS-PAGE 
analysis for purification of CinA-linker10aa-CinC is shown in Figure 4.2.10 A. 
 
tgtgc cgattatttt tccgaaaggc aaacgtctga cgcttgcgaa ccttc tccatctact  
acacg gctaataaaa aggctttccg tttgcagact gcgaacgctt ggaag aggtagatga  
                                                          
>.............................CinA..............>>    Linker 10 
 
 gaccaatccc cttct atggg taatgccctg attttatatg gcacggagac  
 ctggttaggg gaaga taccc attacgggac taaaatatac cgtgcctctg 
 
                  >>....................CinC............> 
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A) 
 
 
 
 
 
  B) 
 
 
 
 
 
 
 
 
 
   C) 
 
 
 
 
 
 
Figure 4.2.10. A) 12% SDS-PAGE gel for eluted fraction from anion exchange 
chromatographic step of CinA-linker10aa-CinC. 3 µl of eluted sample mixed with 4X loading 
dye was loaded in each well of the gel. Lane 1: protein loaded on column; lane 2-7: eluted 
fractions from the purification step; lane 8: pre-stained protein ladder from NEB.  B) 
Chromatogram monitored during the purification of CinA-linker10aa-CinC on ÄKTA by anion 
exchange chromatography. Blue line: UV detector signal at 280 nm; red line: conductivity; 
green line: concentration of elution buffer. Peak 1: impurities in the sample; peak 2: elution 
of CinA-CinC linker protein at 210 mM NaCl; peak 3: column washing with 1 M NaCl. C) 12% 
SDS-PAGE gel for eluted fraction from anion exchange chromatographic step of CinA.  Lane 
1: pre-stained protein ladder from NEB; Lane 2: protein loaded on column; lane 3: flow 
through; lane 4-10: eluted fractions from the purification steps. 
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The unbound proteins and impurities were washed with the loading buffer (Figure 4.2.10 B; 
peak 1) and the elution of the CinA-CinC linker protein was achieved with a concentration 
of 210 mM NaCl (Figure 4.2.10 A lanes 2-7 and Figure 4.2.10 B peak 2). All remaining 
proteins on the column were washed with 1 M NaCl (peak 3). CinA was purified in a similar 
manner as for CinA-linker10aa-CinC and elution with NaCl gradient (Chapter 3; section 3.3.4; 
Figure 4.2.10 C). 
 
4.2.6.2 Purification of CinC 
 
Purification of CinC was performed as described in chapter 3; section 3.3.4. Size of CinC is 
15 kDa. CinC was eluted with a salt gradient using anion exchange chromatography. The 
second step was a size exclusion step with isocratic elution in salt solution and the final step 
of buffer exchange with PD-10 desalting columns (GE healthcare Life Sciences). 
 
 
 
 
 
 
 
Figure 4.2.11. 12% SDS-PAGE gel for eluted fraction from anion exchange 
chromatographic step CinC. 3 µl of eluted sample mixed with 4X loading dye was loaded in 
each well of the gel. Lane 1 - 8: eluted fractions from the purification step; lane 9: protein 
loaded on column; lane 10: pre-stained protein ladder from NEB. 
 
4.2.6.3 Purification of Fpr 
 
Purification of E. coli Fpr was performed as described in chapter 3; section 3.3.4. The size of 
Fpr is 29 kDa. Fpr was purified in two steps. The first step was an anion exchange 
chromatography and the protein was eluted at 240 mM NaCl. Subsequently, the protein was 
purified in second step using size exclusion chromatography and final step of buffer 
exchange with PD-10 desalting columns (GE healthcare Life Sciences). 
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A)    Gel 1     Gel 2 
 
 
 
 
 
B) 
           
 
 
Figure 4.2.12. A) 12% SDS-PAGE gel for eluted fractions from anion exchange 
chromatographic step of E.coli Fpr. 3 µl of eluted sample mixed with 4X loading dye was 
loaded in each well of the gel.  Gel 1; Lane 1: unbound fraction of sample; lane 2: protein 
fractions from purification step 2; lane 3 & 6: pre-stained protein ladder from NEB; lane 4: 
protein fractions from purification step 1. Gel 2; Lane 1 & 15: pre-stained protein ladder 
from NEB; lane 2: fractions from peak 1; Lane 3-11: fractions from peak 2; lane 12-14: 
fractions from peak 3. B) Chromatogram monitored during the purification of E. coli Fpr on 
ÄKTA by size exclusion chromatography. Blue line: UV detector signal at 280 nm; red line: 
conductivity; green line: concentration of elution buffer. Peak 1: impurities with lower 
affinity for the matrix in the sample; peak 2: elution of Fpr; peak 2: impurities with higher 
affinity for the matrix in the sample.  
 
4.2.7 Determination of Product Formation and Coupling Efficiency 
 
Reactions using purified CinA-CinC fusion proteins were performed using the NADPH 
depletion assay. NADPH depletion associated with 2-β-hydroxy-1,8-cineole formation (1,8-
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cineole depletion) was monitored by spectrophotometric measurement at 340 nm (Tecan 
Microtiter plate reader; Tecan Sunrise). 
 
   
 
Figure 4.2.13. Depletion of NADPH monitored spectrophotometrically at 340 nm for 
reaction of purified CinA-CinC fusion protein with 10 amino acid linker for determination of 
2-β-hydroxy-1,8-cineole formation and coupling efficiency.  The graph shows the time point 
for addition of NADPH (initiation of reaction) and time point for termination of reaction. 
 
The depletion (i.e. oxidation) of NADPH does not necessarily generate stoichiometric 
amount of product (termed coupling) but also certain reaction by-products (termed 
uncoupling). These reaction by-products are superoxide, water or hydrogen peroxide. High 
coupling (product formation) is not only desired for higher productivities but also to avoid 
reactive oxygen species that could potentially inactivate the enzyme. In order to determine 
the product formation and coupling efficiency reactions were performed using purified 
CinA-linker(9-11)-CinC protein using NADPH (final concentration 0.4 mM) and purified E. coli 
Fpr. The depletion of NADPH was monitored at 340 nm and reactions were terminated at 
700 sec by addition of 1 ml of ethyl acetate containing 800 µM thymol as internal standard. 
2-β-hydroxy-1,8-cineole formed was determined by GC (Chapter 3; Section 3.4.3). The 
coupling efficiency (in percentage) was calculated as the ratio of NADPH used for substrate 
oxidation to the total amount of NADPH consumed by P450 in the reaction. The NADPH 
depletion for reaction of CinA-CinC fusion protein with 10 amino acid linker monitored at 
340 nm is shown in figure 4.2.13 for determination of 2-β-hydroxy-1,8-cineole formation 
Addition of NADPH 
Termination of reaction 
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and coupling efficiency. The graph shows the point where NADPH was added to the 
reaction and the point of termination of the reaction. 
 
Figure 4.2.14. Coupling efficiency of CinA-linker (1-16)-CinC fusion proteins generated by P-
Link versus linker length from 0-16 amino acids and unfused CinA+CinC+Fpr. The coupling 
efficiency (in percentage) was calculated as the ratio of NADPH used for substrate oxidation 
to the total amount of NADPH consumed by P450 in the reaction. 
 
4.2.8 Correlation Between Thin Layer Chromatography and Gas Chromatography  
 
TLC screening and Gas chromatography was used for screening of CinA-linker(1-16)-CinC 
library as described in chapter 3, section 4.1.5 and 4.1.6. TLC screening was used as a pre-
screen to differentiate between active and inactive clones using crude cell lysates. 
TLC allowed quantification of amount (in µM) of 2-β-hydroxy-1,8-cineole formed in steps of 
50 µM (Table 4.2.2). Additionally, TLC could quantify only 100 µM or more 2-β-hydroxy-
1,8-cineole. As a result GC-FID was used to accurately quantify the amount of 2-β-hydroxy-
1,8-cineole formed by each linker construct using purified enzyme. This section of the thesis 
describes the correlation between the two assay systems used for quantification of 2-β-
hydroxy-1,8-cineole. 
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Figure 4.2.15. Correlation between measurement of amount of 2-β-hydroxy-1,8-cineole 
calculated by TLC and GC-FID for CinA-linker(6-16)-CinC (calculated as µM 2-β-hydroxy-1,8-
cineole µM-1 P450). 
 
Table 4.2.2. Amount of 2-β-hydroxy-1,8-cineole calculated by employing TLC and GC-FID . 
2-β-hydroxy-1,8-cineole formed is calculated as µM µM-1 P450 in a reaction time of 2 h. 
 
Linker 
length 
Amount of 2-β-hydroxy-1,8-
cineole formed [µM µM-1 P450] in 
2 h 
         GC-FID                        TLC                                                                            
6 88.34 100.00 
7 102.03 100.00 
8 116.12 100.00 
9 140.00 150.00 
10 176.67 200.00 
11 154.26 150.00 
12 128.17 150.00 
13 95.54 100.00 
14 105.61 100.00 
15 105.49 100.00 
16 105.64 100.00 
 
Screening using TLC was performed in a 96- well microtiter plate without normalizing the 
amount of P450 in a reaction whereas in case of purified enzymes, reactions were 
performed using normalized amounts of P450 (1 µM). Table 4.2.2 shows the amount of 2-β-
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hydroxy-1,8-cineole as calculated by TLC and GC-FID. Quantification using TLC assay could 
determine the amount of 2-β-hydroxy-1,8-cineole only in steps of 50 µM and therefore it 
was necessary to use GC-FID for accurate quantification of 2-β-hydroxy-1,8-cineole. As seen 
in figure 2, a good co-relation was observed while detection of 2-β-hydroxy-1, 8-cineole 
using the TLC and GC-FID. 
 
4.2.8 Discussion 
 
Generation of fusion proteins is an attractive approach to simplify the multicomponent 
system (P450 part and reductase partner) of cytochrome P450s on genomic level. In 
addition, it is also an excellent technique to explore the catalytic potential of P450s in which 
the natural redox partners are still unknown. Generating fusion proteins cannot only ease 
handling of the system, facilitate expression studies but also simplify the system on a 
genetic level which can be used in directed evolution campaigns. Most of the currently used 
methods for generating fusion proteins are enzymatic which are time consuming, tedious 
and have low efficiency.  In this section of the thesis P-Link a robust, technically simple and 
easy method for generation of fusion proteins is developed and described. P-Link employs 
amplification of gene using (step 1) primers containing phosphorothioated nucleotides for 
fusion generation and insertion of linker of variable length. The use of chemical cleavage 
step using iodine and ethanol (step 2) to generate specific complementary DNA overhangs 
for subsequent hybridization reaction (step 3). 
The critical step in P-Link is the cleavage step to generate single stranded DNA overhangs 
using Iodine-ethanol to ensure efficient fusion generation. The chemical cleavage with 
Iodine-ethanol under alkaline conditions (pH 9.0) specifically cleaves PTO nucleotides. 
Eckstein and Gish have reported the cleavage mechanism of phosphorothioated nucleotides 
in DNA and RNA and its application in DNA sequencing (Eckstein and Gish, 1989; Gish and 
Eckstein, 1988). The proposed cleavage mechanism for phosphorothioated nucleotides 
through alkylation is highly regioselective and does not lead to cleavage or modification of 
natural phosphodiester bonds (Figure 4.2.15). 
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                                                        Alkylation  Chain breakage 
 
Figure 4.2.16. Mechanism of chemical cleavage of phosphorothioated nucleotides in 
presence of Iodine and ethanol under alkaline conditions based on the mechanism given by 
Eckstein and Gish 1989 and Gish and Eckstein 1988. 
 
 
Purification step can be omitted prior to transformation since Iodine and ethanol do not 
interfere with hybridization of complementary single stranded DNA (Blanusa et al., 2010). 
Various methods previously reported for insertion of linkers make use of enzymes 
(restriction endonuclease and ligase) (Robin et al., 2009; Sibbesen et al., 1996) or based on 
overlap extension PCR (Urban et al., 1997) in contrast to P-Link which is based on chemical 
cleavage of phosphorothioate bonds of PCR products amplified using phosphorothioated 
primers. 
P-Link is simple (no enzymatic digestion and ligation step as compared to enzymatic 
approached) and less laborious (16 PCRs and 16 transformation reactions for overlap 
extension PCR in comparison to 3 PCRs and 3 transformation for P-Link). 
An alternative to P-Link would be using methods based on overlap extension PCR, P-Link 
can however very likely be expanded to vary linker sequence or to include different vector 
backbones in a single tube experiment, thereby exploring more alternatives for expression 
of fusion constructs. An additional advantage of P-Link is the expansion of P-Link to fuse 
three and four multi-component systems at once which are very likely much less efficient in 
case of overlap extension PCR. 
The first artificial fusion protein for bacterial P450 monooxygenases was described for 
cytochrome P450cam (Sibbesen et al., 1996) which oxidize camphor to 5-exo-
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hydroxycamphor. The fusion protein was constructed between P450cam, putidaredoxin 
(Pd) and putidaredoxin reductase (PdR), the natural reductase partners of P450cam. 
Several fusion proteins were constructed in which the order of three fusing domains and 
the linkers between them were varied. The highest product formation rate of 30 µM min-1 
µM fusion protein-1 was obtained for fusion construct Pdr-Pd-P450cam separated by linkers 
with amino acid composition TDGASSS and PLEL respectively. 
One important parameter that governs the activity of fusion proteins is the orientation of 
the fused protein domains and the length of the linker separating these domains (Robin et 
al., 2009; Sibbesen et al., 1996). In case of P450 BM3, naturally fused cytochrome P450, the 
C-terminal of heme domain is fused to the N-terminal of the reductase domain via short 
stretch of amino acid residues. The role of the linker region is not clear however, it is 
commonly postulated that the linker region acts as a flexible hinge allowing recognition and 
interaction between the two domains (Hannemann et al., 2007; Sevrioukova et al., 1999). 
Furthermore, Munro et al., reported that the linker region might be also responsible for 
stabilization of the active dimeric form of P450 BM3 (Munro et al., 2007). Previous reports 
establish that the length of the linker is decisive for activity of fusion proteins rather than 
the amino acid composition of the linker. In two individual studies Govindraj and Poulos 
reported that changing Arg-Lys-Lys stretch in the middle of the linker sequence in P450 
BM3 to Ala-Ala-Ala does not alter the functional properties of either of the two domains. 
However, deleting three or six amino acids leads to drastic effect on the hydroxylation 
activity of the enzyme. The three amino acid deletion mutant exhibited 10% of the 
hydroxylation activity while the six amino acid deletion mutant showed nearly 
undetectable levels of fatty acid hydroxylase activity (Govindaraj and Poulos, 1995, 1996). 
Robin et al., fused the P450cam domain from Pseudomonas putida to the reductase domain 
of P450RhF from Rhodococcus sp. Strain NCIMB 9784 with linker lengths varying from 1 
to 7 amino acids, named P450cam-RhFFRed L1-L7. No conversion of camphor (final 
concentration used = 3 mM) to 5-exo-hydroxycamphor was detected for P450cam-RhFFRed 
L1. P450cam-RhFFRed L2, L3 and L4 showed a conversion of 5 ± 2 % and 3.5 ± 1 % 
respectively after 24 h of reaction using whole cells. The conversion rate increased with the 
increase in length of the linker with highest product formation observed for P450cam-
RhFFRed L7 showing a conversion of 83 ± 11.5% and 100% for reactions after 24 h and 
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48 h respectively (Robin et al., 2009). The study thus showed that the linker length is of 
crucial significance in determining the activity of a fusion protein. 
Owing to the similarity in redox partners between P450 BM3 and P450cin, we anticipated 
that the orientation of CinA and CinC should be similar to that of P450 and reductase 
partners in P450 BM3. Thus the C terminal of CinA was fused to the N terminal of CinC and 
a length of upto 16 amino acids residues were chosen for insertion. 
In order to predict the linker sequence to be inserted between the CinA and CinC domains, 
secondary structure prediction of the reported P450 BM3 linker (PSPSTDQSAKKVRKKA) 
was performed using the Chou-Fasman parameters (Chou and Fasman, 1974a, b). 
 
Table 4.2.3. Secondary structure predictions of the linkers using the Chou-Fasman 
parameters (http://www.biogem.org/tool/chou-fasman/). The percentage possibility for 
secondary structure of each linker sequence has been classified in Helix, Sheet and Turn. 
 
Linker Sequence Probability of 
sequence to form 
(%) 
  Helix Sheet Turn 
BM3 PSPSTDQSAKKVRKKA 62.5 0.0 25.0 
First eight amino acids of P450 BM3 PSPSTDQS 0.0 0.0 37.5 
Last eight amino acids of P450 BM3 AKKVRKKA 87.5 0.0 25.0 
Last eight amino acids new designed 
linker 
PSTGDAVA 0.0 0.0 12.5 
New designed linker PSPSTDQSPSTGDAVA 0.0 0.0 25 
 
The prediction showed a 62.5% probability of α-helix formation; the last eight amino acids 
of the P450 BM3 linker (AKKVRKKA) had an 87.5% probability of α-helix formation 
whereas the secondary structure formation probability of the first eight amino acids 
(PSPSTDQS) is only 37.5% (Table 4.2.2). To avoid introducing a linker prone to form 
secondary structures, the sequence of the first eight amino acids of the P450 BM3 were 
selected for CinA-CinC linker generation. The sequence of the subsequent eight amino acids 
was chosen (SPSTGDAVA) by analyzing frequently occurring sequences in natural fusion 
proteins which did not generate any secondary structure (George and Heringa, 2002; 
Wriggers et al., 2005). The chosen amino acid sequence for the full linker length of 16 
amino acids between CinA and CinC was Pro-Ser-Pro-Ser-Thr-Asp-Glu-Ser-Pro-Ser-Thr-Gly-
Asp-Ala-Val-Ala (PSPSTDQSPSTGDAVA). 
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P-Link can also be employed for insertion of linker lengths longer than 16 amino acid 
residues. It can be assumed that the efficiency of the insertion will not decrease since the 
insertion of linkers depend primarily on the cleavage of phosphorothioate bonds in 
amplified products using Iodine-ethanol and is not an enzymatic reaction. 
Additionally P-Link can also be employed to vary the amino acid sequence within linkers 
(e.g. two positions with NNK codons) in the primer sequence can be incorporated to explore 
and tune flexibility of the linker sequence and thereby increase activity of the fusion 
protein. In this case, one suitable high throughput screening campaign based on flow 
cytometry (Ruff et al., 2012) or even based on agar based screening systems can be 
employed (Çelik et al., 2005) to screen the fusion protein linker library to identify the active 
constructs. 
Slessor et al., reported construction of vectors for the polycistronic coexpression of P450cin 
and cindoxin (CinC) with or without terminal redox partner (E. coli Fpr). E. coli Fpr is used 
in P450cin mediated biocatalytic reactions since its natural redox partner CinB cannot be 
expressed in an active form. However, when Fpr was coexpressed with P450cin and 
cindoxin, the expression levels of cindoxin were drastically decreased presumably due to 
competition between cindoxin and Fpr for flavin cofactors. The coexpression system also 
decreased the expression levels of P450cin (Slessor et al., 2012). Whereas the fusion 
protein proposed in this thesis posed no difficulties in expression levels, neither for CinA or 
CinC. Use of fusion protein not only facilitates the expression but also simplifies P450cin 
system on genetic level making it suitable for directed evolution experiments. 
Structural studies of linker regions of fusion proteins are very challenging. The length, 
flexibility, sequence of amino acids can have dramatic effects on the activity and structural 
stability of the fused domains. Given their high flexibility, loops tend to have an ambiguous 
conformation in crystal structures and their behavior and interactions with the fused 
domains are difficult to predict. Therefore, optimal linker lengths for protein fusion are 
difficult to design in a rational manner, and usually a single length is probed and used for 
generating fusion proteins, dramatically reducing their success rate. P-Link gives the 
possibility to generate a library of variable linker lengths increasing the likelihood to obtain 
an active fusion protein. 
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The direct fusion CinA-CinC (no linker) showed no measurable conversion of 1, 8-cineole. 
The latter is also the case for fusion proteins with a linker length of four and shorter 
however an equimolar mixture of unfused CinA and CinC show activity in presence of E. coli 
Fpr and NADPH (Table 4.2.1). One possible reason for the inactivity might be due to the 
misfolding of CinA or CinC or both CinA and CinC. Linker lengths less than 5 amino acids, 
possibly introduces restriction of movement of individual or both of the fused protein 
domains (results presented and discussed in chapter 4; section 4.3). This restriction on the 
movement of fused domains can limit efficient electron transfer in turn affecting the 
hydroxylation activities. However, at the current stage, without a crystal structure it is 
difficult to speculate the actual reason for the trend observed in hydroxylation activities of 
linker variants. A more detailed characterization in combination with computational and 
crystallographic studies might possibly give some insights regarding the observed activity 
trend. 
 
4.2.9 Conclusion 
 
In summary, a robust, technically simple and enzyme free method (P-LinK-Protein fusion 
with variable linker insertion) was developed for generating fusion proteins with variable 
linker length. The generation of fusion proteins and insertion of inter-domain linker of 
variable length can be achieved in a single experiment and screened for optimal properties, 
such as expression or enzymatic activity. CinC was fused to the C terminal end of CinA 
through sixteen different linker lengths in a single experiment employing three PCRs. The 
resulting CinA-CinC linker library was screened using a TLC based screening system to 
identify the most active CinA-linker10aa-CinC construct. 
Although the fusion protein generated in this study shows lower activity compared to 
equimolar mixture of its individual component, the use of fusion proteins simplifies the 
multicomponent system on genetic level and enables its use in protein engineering 
campaigns. The latter can be used to obtain fusion protein variants with improved activity 
or with non-natural enzymatic properties. 
P-LinK is a straight forward approach which minimizes experimental efforts and reduces 
significantly time demands and is therefore technically simple and robust. It is further likely 
that P-LinK can be expanded iteratively to at least three component systems in which a 
P-Link: A Method for Generating Multicomponent Cytochrome P450 Fusions with Variable 
Linker Length 
91 
 
third electron transfer partner of monooxygenase systems can be fused. The method can 
also be used for cytochrome P450s where native electron transfer partners are unknown. 
P -LinK is not only limited to P450 enzymes and can be of general interest to generate 
fusion enzymes to perform, for instance, cascade reactions. 
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4.3 Preliminary Insights into Role of Linker in Cytochrome P450cin 
Fusion Protein 
 
4.3.1 Aim of the Work 
 
The CinA-CinC fusion protein with a linker length of ten amino acids (CinA-linker10aa-CinC) 
was identified as the most active variant for hydroxylation of 1,8-cineole (Chapter 4; section 
4.2.5.1). Screening of CinA-linker (1-16) - CinC library also revealed linker length of four or 
less amino acids was determined to be inactive. This part of the result section, addresses 
two important aspects of the CinA-CinC fusion protein. (i) Role of length of linker sequence 
in modulating the activity of CinA-CinC fusion protein. (ii) The interaction of CinA and CinC 
in the fusion protein and its impact on the activity of the CinA-CinC fusion protein. 
 
4.3.2 Construction of Homology Model of CinA - CinC Fusion Protein with 
Linker of Variable Length 
 
Chapter 4, section 4.2 described the construction and activity determination of CinA and 
CinC fusion protein with a linker length of 1 to 16 amino acids. In order to visualize how the 
introduced linkers would translate into protein structure, homology models of the fusion 
and linker variants were generated using YASARA (Krieger et al., 2002). The template for 
construction of homology model was based on the coordinates of CinA (PDB id: 1T2B) 
(Meharenna et al., 2004). The crystal structure of CinC was not available during the time 
when this study was initiated. As a result a homology model of CinC was generated using 
YASARA. The template selected for construction of homology model of CinC was the FMN 
binding domain of human cytochrome P450 reductase (PDB id: 1B1C) (Zhao et al., 1999) 
with a sequence identity of 37%. Subsequently, CinA and CinC were used for modelling of 
linkers between the CinA-CinC fusion protein. 
Madrona et al., recently reported the crystal structure of Cindoxin (CinC), the P450cin redox 
partner (PDB id: 4OXX) (Madrona et al., 2014). In order to evaluate if the homology model 
of the CinA-linker-CinC(homology)§ constructed is similar to that of homology model of the 
                                                          
§ Homology model of CinA-linker-CinC constructed in YASARA using homology of CinC based on FMN binding 
domain of human cytochrome P450 reductase (PDB id: 1B1C) as template. 
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CinA-linker-CinC(crystal)**; a homology model for CinA-linker10aa-CinC(crystal) using the 
coordinates from crystal structure of CinC was constructed. The CinA-linker10aa-CinC(crystal) 
homology model was compared to the CinA-linker10aa-CinC(homology), however no significant 
difference were observed between the two models. Thus, the models generated using 
CinC(homology) were used for subsequent studies and analysis. The homology models of CinA - 
CinC fusion proteins with various linker lengths (6-16) are shown in figure 4.3.1. 
 
 
Figure 4.3.1: Hypothetical interactions and conformation between fused CinA and CinC. A) 
Intramolecular interaction. CinA forms a functional unit with the corresponding fused CinC. 
B) Intermolecular interaction. CinA forms a functional unit with a CinC domain from 
another fusion construct (blue), and conversely CinC from the first molecule (red) interacts 
with the remaining CinA. The modeled linkers of variable lengths for each configuration are 
represented in different color. 
                                                          
** Homology model of CinA-linker-CinC constructed in YASARA using coordinated from crystal structure of 
Cindoxin (CinC) (PDB id: 4OXX). 
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For linker lengths shorter than 6 amino acid residues it was difficult to model them in the 
fusion protein using YASARA. The length of the linkers was too short to give a correctly 
oriented and reliable homology model. 
Interestingly, the resulting models indicated that the linkers identified as most active (9, 10, 
11 amino acids long) between CinA and CinC would not allow the domains to achieve a 
proper orientation (based in P450 BM3 crystal structure) without significant structural 
changes (Figure 4.3.1). This suggests that the optimum linker length of ten amino acids 
might not be sufficient for domains from the same polypeptide chain to achieve electron 
transfer and an intermolecular electron transfer mechanism is plausible. Intermolecular 
electron transfer mechanism, meaning that a given heme domain would interact with a 
FMN domain coming from a different molecule and vice versa. Kitazume et al., proposed a 
similar mechanism for electron transfer in P450 BM3 (Kitazume et al., 2007) Experimental 
results based on site directed mutagenesis studies suggested that electron-transfer 
pathway in P450 BM3 passes through both protein molecules in the dimer during a single 
turnover, traversing from the FAD domain of one molecule into the FMN domain of the 
other molecule before passing to the heme domain (Kitazume et al., 2007). 
 
4.3.3 Investigation of Intermolecular or Intramolecular Electron 
Transfer in CinA-CinC Fusion Protein 
 
In order to elucidate if the P450cin fusion variants work as an intramolecular or as an 
intermolecular complementation system, we designed an experimental setup selectively 
knocking out the activity of individual domains as described below. Two SDM mutants of 
the CinA- linker10aa-CinC variant were constructed. The first variant (A91F) was designed 
to have an inactive heme domain (named as Heme (-)). The second variant (G594D) 
comprised an inactive FMN domain (named as FMN (-)). 
The amino acid substitution G570D leads to inactivation of FMN domain in P450 BM3 
(Kitazume et al., 2007). A structural alignment of P450cam, P450cin and P450 BM3 was 
performed, identifying position G594 as the structural homolog in P450cin for the 
construction of FMN (-). In the Heme (-) variant, alanine 91 was replaced by a bulkier 
phenylalanine residue which hindered the access of 1,8- cineole to the enzyme active site, 
leading to an inactive enzyme variant.  
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4.3.4 Site Directed Mutagenesis for Construction of Heme (-) and FMN (-) 
Variants 
 
Two step site directed mutagenesis protocol was employed for construction of Heme (-) 
and FMN (-) variant as described in chapter 3; section 3.2.5 employing primers as 
mentioned in Appendix; Table 3. PCR products were run on 0.8% agarose gel (Figure 4.3.2) 
to confirm the amplification of the gene. An expected size of 3.8 kbp was observed on the 
agarose gel. 
 
 
Figure 4.3.2. 0.8% agarose gel for site mutagenesis at position A91 and G594. Lane 1 = 1 
kbp DNA ladder; lane 1 = SDM at position 81, lane 2 = SDM at position 594 (expected size 
~ 3.8 kbp). 
 
The amplified PCR products were digested and transformed in chemically competent E. coli 
BL-21 Gold (DE3) lacIQ1 cells as described in chapter 3. The mutation at sites A91 and G594 
were confirmed by sequencing analysis. Expression and purification of the Heme (-) and 
FMN (-) variants was performed as described in chapter 3. 
 
4.3.5. Determination of Activity of Heme (-) and FMN (-) Mutants to 
Analyze Electron Flow in CinA-CinC Fusion Protein 
 
The activity of Heme (-) and FMN (-) variants were tested for activity towards 1,8-cineole. 
E. coli Fpr was used to reconstitute the system and NADPH (0.4 mM) was used as reduction 
equivalent using 1 µM P450 with a reaction time of 2 h. The reactions were performed as 
described in chapter 3, section 3.3.1.4 and the amount of 2-β-hydroxy-1,8-cineole formed 
was quantified using GC-FID as described in chapter 3, section 3.4.3. 
Activity determination was performed for the flowing set of variants (i) Heme (-)-linker 
10 aa-CinC; (ii) CinA-linker 10 aa-FMN (-) (iii) combination of Heme (-)-linker 10 aa-CinC 
1   2                  3 
5000 bp 
3000 bp 
1000 bp 
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and CinA-linker 10 aa-FMN. All reactions were performed in triplicate. The activity profile 
for all the reactions is presented in table 4.3.1. The Heme (-)-linker 10 aa-CinC and CinA-
linker 10 aa-FMN (-) were individually inactive towards 1,8-cineole (Table 4.3.1). However, 
the combination of purified Heme (-) and FMN (-) variants, however, showed a 
hydroxylation activity comparable to the CinA- linker 10 aa- CinC fusion protein, strongly 
supporting the presence of intermolecular interaction between CinA (Heme) and CinC 
(FMN). These experimental results support the theory based on computational analysis 
(Figure 4.3.1). 
 
Table 4.3.1 2-β-hydroxy-1,8-cineole formation for Heme (-) and FMN (-) mutants. Heme (-) 
mutant had mutation A91F and FMN (-) mutant had mutation G594D individually in heme 
and CinC domain in CinA-linker10aa-CinC fusion protein. Reactions were performed with 
E.coli Fpr, NADPH [final concentration = 0.4 mM] and 1 µM P450 for a reaction time of 2 h. 
All reactions were performed in triplicate.  n.d. = no product detected. 
 
Variant Amount of 2-β-hydroxy-1,8-cineole 
 formed[µM µM P450-1] 
CinA-linker 10aa-CinC 176.7±2.4 
Heme(-)-linker 10 aa-CinC n.d. 
CinA-linker 10 aa-FMN(-) n.d. 
Heme(-)-linker 10 aa-CinC +  
CinA-linker 10 aa-FMN(-) 
174.0±8.7 
 
 
An illustration of plausible electron transfer pathway in CinA-CinC fusion protein is shown 
in Figure 4.3.3. Shown in this figure, the FMN (-) domain was not able to transfer electrons 
from NADPH to CinA (heme domain) for conversion of 1,8-cineole to 2-β-hydroxy-1,8-
cineole (Figure 4.3.3 B). Similar is the case with heme (-) domain where no product 
formation was detected (Figure 4.3.3 A). However, when the Heme (-)-linker 10 aa-CinC 
was combined with CinA-linker 10 aa-FMN (-), it showed a hydroxylation activity 
comparable to the CinA- linker 10 aa- CinC fusion protein. Figure 4.3.3 C shows the 
plausible electron transfer pathway from FMN of one molecule to the heme of another 
molecule strongly supporting inter-molecular electron transfer in P450cin fusion proteins. 
These results substantiate the theory based on computational analysis for CinA-linkers (6-16)-
CinC constructs.  
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Figure 4.3.3 Illustration of electron transfer pathway in CinA-CinC fusion protein. Domains 
are arranged in order of reduction potential with most positive on top (FAD) followed by 
FMN and most negative at the bottom (P450). Alignment of the two domains is not intended 
to imply structural relationships but is consistent with the data obtained.  (A) Heme (-) 
carries mutation A91F in the heme domain (CinA domain). (B) FMN (-) carries mutation 
G594D in the FMN domain (CinC domain). (C) Heme (-) mutant and FMN (-) mutant were 
mixed together in a single reaction tube to determine the activity. It also shows plausible 
intermolecular electron transfer pathway. Fpr = E. coli Flavodoxin reductase, FMN = CinC 
domain, Heme = P450cin. Arrows show possible electron transfer pathway. Cross 
represents no electron transfer.  
 
The data obtained also suggests the possibility of presence of dimeric structure for P450cin 
fusion protein with the transfer of electrons from one monomer to another monomer. 
However, additional experiments to support the presence of dimeric structure for P450cin 
fusion protein were not performed and hence it can only be speculated with the data 
available.  Studies based on determination of molecular mass, cross linking studies using 
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glutaralehyde or a simple native PAGE experiment might provide indication regarding the 
dimeric or monomeric form of the P450cin fusion protein. 
 
4.3.6. Investigation of Role of Linker Length on the Activity of CinA-CinC 
Fusion Protein 
 
Using the evidence supporting intermolecular activation provided by the experimental data, 
a remaining question regarding the inactive linker variants was addressed. For CinA-CinC 
fusion protein linker lengths shorter than 4 amino acids were inactive with no detectable 
conversion of 1,8-cineole to 2-β-hydroxy-1,8-cineole. 
In order to determine if the fusion proteins with linker length 4 or less are inactive due to 
misfolding or due to the inability of CinA to interact in the right configuration with the fused 
CinC, the inactive linker variants were supplemented with 1 µM CinA or CinC, E. coli Fpr and 
NADPH [final concentration = 0.4 mM] and product formation and coupling were measured 
using GC- FID measurements as described previously in chapter 3, section 3.4.3. Table 4.3.2 
shows the amount of 2-β-hydroxy-1,8-cineole formed by supplementing the inactive linker 
variants (direct CinA-CinC fusion and  CinA- CinC with linker lengths of  1 – 4) with 1 µM of 
CinA or 1 µM of CinC.  
Interestingly, all inactive fusion variants (direct CinA-CinC fusion and CinA - CinC with 
linker lengths of 1 – 4) recovered activity by either supplementing CinA or CinC (Table 
4.3.2), suggesting that in all tested constructs, the CinA and CinC partners are folded in an 
active form. The direct fusion, however, only recovered approximately 33 % of the activity 
of the reconstituted unfused CinA + CinC system, whereas the CinA-CinC fusion proteins 
with linker 1 to 4 recovered approximately 95% of the reconstituted unfused system (Table 
4.3.2). 
By observing these results, it is clear that there are two main parameters governing the 
activity of the different fused partners. The first is the correct folding of each individual 
partner when fused, which seems to be, by the results of the above activity assay, correct in 
all investigated variants, even in the direct fusion of CinA and CinC. The second parameter 
and the more crucial one, is the length of the linker, which appears to govern the activity of 
the fused partners. The difference in the activity of the CinA-CinC fusion proteins can be 
concluded to be due to the difference in the linker length. 
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Table 4.3.2. Activity profile for inactive linker variants (direct CinA-CinC fusion and CinA - 
CinC with linker lengths of 1 – 4). Reactions were performed with E.coli Fpr, NADPH [final 
concentration = 0.4 mM] and 1 µM P450, 1 µM CinC for a reaction time of 2 h. All reactions 
were performed in triplicate. n.d. = no product detected. Product formed refers to the 
formation of 2-β-hydroxy-1,8-cineole formed (µM µM-1 P450). The coupling efficiency (%) 
was calculated as the ratio of NADPH used for substrate oxidation to the total amount of 
NADPH consumed by P450 in the reaction. 
 
  + 1 µM CinA + 1µM CinC 
Construct 
Product 
formed  
Coupling 
efficiency 
(%) 
Product 
formed  
Coupling 
efficiency 
(%) 
Product 
formed  
Coupling 
efficiency 
(%) 
CinA n.d. n.d. n.d. n.d. 300±13 75.0±3.4 
CinC n.d. n.d. 299±11 74.8±3.5 n.d. n.d. 
CinA-0-CinC n.d. n.d. 106±11 26.6±2.8 105±11 26.5±2.8 
CinA-1-CinC n.d. n.d. 292±2 73.1±0.3 293±0 73.3±0.0 
CinA-2-CinC n.d. n.d. 268±4 67.0±1.1 270±6 67.6±1.4 
CinA-3-CinC n.d. n.d. 269±7 67.3±1.7 272±2 68.2±0.4 
CinA-4-CinC n.d. n.d. 250±11 62.5±2.9 257±11 64.2±2.6 
CinA-5-CinC 22.0±3.2 5.5±0.1 246±6 61.5±1.2 247±5 61.7±1.3 
 
4.3.7 Discussion 
 
Homology modelling of CinA-linker-CinC proteins (described in section 4.3.2) revealed that 
a linker length of 9 - 11 amino acids which was determined to be optimum for 
hydroxylation of 1,8-cineole might not sufficient for electron transfer between heme and 
FMN domains form the same polypeptide chain. In this case there are two possibilities, one 
the electron transfer will be between two molecules (intermolecular) or P450cin exists as a 
dimer and electron transfer is between the dimers, in a similar way as reported for P450 
BM 3. 
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Figure 4.3.4. (A) and (B) represent the hypothetical model for electron transfer pathway in 
P450cin fusion protein. (A) Putative dimeric form of P450cin fusion protein. The electron 
transfer pathway in dimeric form might occur between the FMN of one monomer to the 
heme of another monomer. (B) Putative model for intermolecular electron transfer 
pathway in P450cin fusion protein. 
 
A 
B 
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Kitazume et al proposed a mechanism for electron transfer in P450 BM3. P450 BM 3 exists 
as a dimer and experimental results based on site directed mutagenesis studies suggest that 
electron-transfer pathway in P450 BM3 passes through both protein molecules in the dimer 
during a single turnover, traversing from the FAD domain of one molecule into the FMN 
domain of the other molecule before passing to the heme domain (Kitazume et al., 2007). In 
order to determine if the electron transfer pathway in P450cin is similar to that observed in 
P450 BM 3, two site directed mutants were generated to knock out the activity of individual 
domains. The individual inactive domains (Heme (-) and FMN (-)) were found to be inactive 
and no hydroxylation activity was detected. However, for an equimolar mixture of 
individual inactive domains (Heme (-) + FMN (-)) formation of 2-β-hydroxy-1,8-cineole was 
detected. Figure 4.3.4 shows the hypothetical models for electron transfer pathways in 
P450cin fusion protein supporting intermolecular electron transfer. In case of mammalian 
fusion enzyme nitric oxide synthase (NOS), the catalytically active site form of the enzyme is 
a homodimer with dimerization solely via the heme binding oxygenase domain, where as in 
case of P450 BM3, the protein dimerizes via the reductase domain. With the experimental 
evidence obtained for the study in this thesis for P450cin it is however difficult to speculate 
if P450cin exists as a dimer or a monomer. Additional characterization of the fusion protein 
with electrospray ionization mass spectroscopy (ESI-MS), using nuclear magnetic 
resonance (NMR), cross linking studies with glutaralehyde, fluorescence anisotropy, etc. 
will provide further evidence if the P450cin fusion protein exists as a monomer or a dimer. 
Another interesting observation from the experimental result was that the linker length 
was of crucial significance in the activity of the fusion protein. The role of the linker region 
is not clear however, it is commonly postulated that the linker region acts as a flexible hinge 
allowing recognition and interaction between the two domains (Hannemann et al., 2007; 
Sevrioukova et al., 1999). Previous reports demonstrate that the length of the linker is 
decisive for activity of fusion proteins rather than the amino acid composition of the linker. 
In two individual studies Govindraj and Poulos reported that changing Arg-Lys-Lys stretch 
in the middle of the linker sequence in P450 BM3 to Ala-Ala-Ala does not alter the 
functional properties of either of the two domains. However, deleting three or six amino 
acids leads to drastic effect of the hydroxylation activity of enzyme. The three amino acid 
deletion mutant exhibited 10 % of the hydroxylation activity while the six amino acid 
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deletion mutant showed nearly undetectable levels of fatty acid hydroxylase activity 
(Govindaraj and Poulos, 1995, 1996). In a similar study by Robin et al., where the P450cam 
domain from Pseudomonas putida was fused to the reductase domain of P450RhF from 
Rhodococcus sp. Strain NCIMB 9784 with linker lengths varying from 1 to 7 amino acids, 
named P450cam-RhFFRed L1-L7.(Robin et al., 2009). No conversion of camphor (final 
concentration used = 3 mM) to 5-exo-hydroxycamphor was detected for P450cam-RhFFRed 
L1. The conversion rate increased with the increase in length of the linker with highest 
product formation for P450cam-RhFFRed L7 (Robin et al., 2009). 
Similar results were obtained with the CinA-CinC fusion protein where increase in 
hydroxylation activity was observed with the increase in linker length. The lower length 
linker (length less than 4 amino acids) however were inactive. External addition of cell 
lysate of CinA and CinC to inactive linkers showed hydroxylation of 1,8-cineole to 2-β-
hydroxy-1,8-cineole. Thus, the folding of CinA and CinC were in the correct orientation 
however, the length of the linkers was not sufficient to hold the fused CinA and CinC 
domains in the required orientation. 
 
4.3.8 Conclusion 
 
To conclude, experimental evidence from our study suggests that the electron transfer in 
CinA-CinC fusion protein predominantly is intermolecular. The plausible electron transfer 
pathway is from FMN domain of one molecule to the heme domain of another molecule. 
Additional investigations show that the CinA and CinC domain in the fusion protein are 
correctly folded and the length of the linker separating the fused domains is crucial for 
activity of the fusion protein. 
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4.4 Directed Evolution of P450cin Fusion Protein for Mediated Electron 
Transfer 
 
4.4.1 Aim of the Work 
 
Reactions catalyzed by P450 monooxygenase are stereo- and regio- selective and can be 
performed in water, at room temperature and under atmospheric pressure which is often 
difficult to achieve using chemical catalysts. One of the main hurdle for catalytic 
applications of cell free P450 catalyzed reactions is the requirement of NAD(P)H, as a 
reduction equivalent for each catalytic cycle. Using random protein engineering approach 
cytochrome P450cin fusion protein (CinA-linker10aa-CinC) was evolved for mediated 
electron transfer using Zinc and Cobalt(III)sepulchrate†† as an alternative and cost-effective 
cofactor system. 
4.4.2 Generation of Random Mutagenesis Libraries  
 
Two iterative rounds of random evolution employing SeSaM were performed to identify the 
residues which modulate the activity of cytochrome P450cin towards 1,8-cineole while 
using alternative cofactor system Zn/Co(III)sepulchrate. The first round of random 
mutagenesis was performed with low mutational load as described in chapter 3 section 
3.2.4. The template used for construction of SeSaM library was a fusion protein variant 
identified as the most active fusion variant identified for hydroxylation of 1,8-cineole (CinA-
linler10aa-CinC) (Chapter 4, section 4.1.5.1). Template for SeSam library II was a double 
mutant Q385H/V386S, an improved variant identified from the first SeSaM library. 
Electrophoretic analyses of steps involved in SeSaM technique used for mutant library 
generation are shown in figure 4.4.2. Preliminary step was performed for generation of 
template for step 1 and step 3 (Figure 4.4.2 A). The concentration of dATPαS [A forward- 
30%, G forward- 25%] and dGTPαS [A reverse- 30%, G reverse- 25%] were selected in step 
1 of SeSaM based on the fragmentation pattern (Figure 4.4.2 B and C). The selected 
concentrations were used in step 1 for construction of both SeSaM libraries. Step 2 is the 
TdT catalyzed incorporation of dPTαP at the 3’-OH of a 5’-FITC labelled oligonucleotide. The 
                                                          
†† Thanks to Dr. Freddi Philippart, Prof. Dr. J. Okuda (Chair of Organometallic Chemistry, RWTH Aachen) and 
Dr. Markus Reichelt (Lehrstuhl für Makromolekulare Materialien und Oberflächen; DWI – Leibniz-Institut für 
Interaktive Materialien) for synthesis and NMR analysis of Cobalt(III)sepulchrate. 
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number of incorporated P nucleotides was analyzed on a 36% acrylamide gel and visualized 
using a phosphorimager. Figure 4.4.2 D shows the TdT catalyzed incorporation of dPTPαS. 
Figure 4.4.2 E shows the amplification of gene after step 4 of SeSam. The PCR products 
obtained after step 4 were cloned in pALXtreme-1a by PLICing (50 ng each)(described in 
chapter 3; section 3.2.2) and transformed in chemically competent E. coli BL-21 Gold (DE3) 
LacIQ1 cells (chapter 3; section 3.1.4). 
 
Figure 4.4.1. Electrophoretic analyses of steps in SeSaM technique used for mutant library 
generation. (A) Preliminary step- PCR amplification to generate template for step 1 and 
step 3. Lane 1= 1 kbp DNA ladder. (B) and (C) Determination of optimal phosphorothioate 
percentage using different concentrations of dATPαS or dGTPαS (lane 2 = 10, lane 3 = 15, 
lane 4 = 20, lane 5 = 25, lane 6 = 30, lane 7 = 35, lane 8 = 40 percent) for A_forward library 
(black), G_forward library (blue). (lane 1 = 10, lane 2 = 15, lane 3 = 20, lane 4 = 25, lane 5 = 
30, lane 6 = 35, lane 7 = 40 percent, lane 8 = 1 kbp DNA ladder) for A_reverse library 
(green) and G_reverse library (green). (D) Phosphorimager analysis of 3’-tailed FITC 
oligonucleotide separated on 36 % acrylamide gel. Lane 1 = FITC catalyzed stepwise 
incorporation (+1, +2, +3) of dPTαP; lane 2 = FITC only (negative control). (E) Step 4 of 
SeSam; replacement of universal bases; L = 1 kbp DNA ladder; lane 1= A_forward library; 
lane 2 = G_forward library; lane 3: A_reverse library; lane 4 = G_reverse library. 
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Table 4.4.1: Sequencing analysis of random clones from SeSaM library I and SeSaM library 
II 
A) SeSaM Library I 
Mutant C1 C2 C3 C4 C5 
Nucleotide 
changes 
CT->AC 
 
GT-
>TC 
T->C 
T->G 
C->T 
 
C->T 
G->T 
 
- 
Amino acid 
changes 
L520T  V417S 
S439S 
S445S 
A53V L357F - 
Position of 
mutation 
CinC 
domain 
CinA 
domai
n 
CinA 
domain 
CinA 
domain 
 
No. of nucleotide  
changes 
 
2 
 
4 
 
1 
 
 
2 
- 
Single Ts 0 1 1 1 - 
Single Tv 0 1 0 1 - 
TvTs 1 1 0 0 - 
Deletions 0 0 0 0 - 
 
B) SeSaM Library II 
Mutant C1 C2 C3 C4 C5 
Nucleotide 
changes 
G->T G->T 
 
G->T 
 
- - 
Amino acid 
changes 
G57V  E113ST
OP 
W46C - - 
Position of 
mutation 
CinA 
domain 
CinA 
domain 
CinA 
domain 
-  
No. of 
nucleotide  
changes 
 
1 
 
1 
 
1 
 
- - 
Single Ts 1 1 1 - - 
Single Tv 0 0 0 - - 
TvTs 0 0 0 - - 
Deletions 0 0 0 - - 
 
Quality of the generated mutant library was verified by sequencing of five random clones. 
Sequencing revealed 60% transitions (Ts), 20% transverion followed by transitions (TvTs; 
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subsequent mutation) and 20% wild type for SeSaM library I (Table 4.4.1 A) and 60% 
transitions (Ts) and 40% wild type for SeSaM library II (Table 4.4.1 B). Diversity generated 
in the both the SeSaM libraries as reveled by sequencing analysis matched the requirement 
of a mutant library and hence were used for subsequent screening. 
 
4.3.3 Screening of SeSaM library I 
 
Screening of approximately 2700 clones using TLC based screening system (described in 
chapter 4; section 4.1.4.3) for detection of 2-β-hydroxy-1,8-cineole was performed using 
NADPH as reduction equivalent. The activity assay was performed as described in chapter 
3; section 3.3.1 using crude cell lysates (prepared as described in chapter 3; section 3.2.9). 
Subsequently 200 clones were selected which showed activity higher than 20% compared 
to wild type for rescreening. Following rescreening 16 clones were selected and expressed 
in expression flask (200 ml) and reactions for these clones were performed using crude cell 
lysate using normalized amount of P450 in the reaction. 2-β-hydroxy-1,8-cineole formation 
was quantified using GC-FID for the selected 16 clones of which four clones showed 
improvement in activity compared to wild type (CinA-linker10aa-CinC). Two out of the four 
selected were wild type enzyme and the other two variants carried single mutation each. 
Screening of first round of SeSaM library yielded two improved mutants with single 
substitution each (Q385H and V386S). KB1 (Q385H) and KB2 (V386S) showed a 1.5 and 2 
fold improvement in hydroxylation activity as compared to the wild type variant (CinA-
linker10aa-CinC) while using NADPH as a reduction equivalent. (Figure 4.4.2, Table 4.4.2). 
Variants KB1 and KB2 identified from SeSaM library round I were subsequently tested for 
activity using Zinc dust and Cobalt (III) Sepulchrate (described in chapter 3, section 3.3.1.4). 
The amount of 2- β-hydroxy-1,8-cineole formed for variants KB1, KB2 and WT (CinA-linker 
10aa- CinC) is shown in Table 4.4.2 and Figure 4.4.3. The improvement in activity observed 
with Zinc dust and Cobalt(III)sepulchrate was however only 1.5 and 1.2 fold for variants 
KB1 and KB2 respectively (Figure 4.4.3 and Table 4.4.2). 
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Figure 4.4.2. 2-β-hydroxy-1,8-cineole formed for P450cin variants identified from SeSaM 
library round I. KB1 variant (Q385H) and KB2 variant (V386S) showed a 1.5 and 2 fold 
improvements in activity with NADPH (0.4 mM final concentration) as reduction 
equivalent. 
 
 
Table 4.4.2. Activity profile for variants KB1 (Q385H) and KB2 (V386S) identified after 
SeSaM round I. Reactions using NADPH [0.4 mM] as well as reactions using Zinc dust [5 mg] 
and Cobalt(III)sepulchrate [5 mM] were performed for 2 h at 30 °C using 1 µM P450. All 
reactions were performed in triplicate. Reaction products were extracted with ethyl acetate 
and analyzed by GC-FID for determination of 2-β-hydroxy-1,8-cineole. 
 
 
Variant 2-β-hydroxy-1,8-cineole with 
NADPH  
(µM µM-1 P50) 
2-β-hydroxy-1,8-cineole with 
Zinc dust and 
Cobalt(III)sepulchrate 
(µM µM-1 P50) 
WT 88.67± 2.36 82.67 ± 4.94 
KB1 134.30 ± 1.95 109.87 ± 2.38 
KB2 220.67 ± 3.48 135.70 ± 6.06 
KB3 298.89 ± 6.30 202.59 ± 1.95 
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Figure 4.4.3 2-β-hydroxy-1,8-cineole formed for P450cin variants identified from SeSaM 
library round I (KB1-Q385H and KB2- V386S) and KB3 (Q385H/V386S) identified from site 
saturation library at position Q385 and V386. All measurements were performed in 
triplicate using NADPH [0.4 mM] or using Zinc dust [5 mg] and Cobalt(III)sepulchrate 
[5 mM] and were performed for 2 h at 30 °C using 1 µM P450. 
 
Though the improvement in activity of P450cin mutants identified in SeSaM library round I 
was not as expected for alternative cofactor system Zinc and Cobalt(III)sepulchrate 
nonetheless, the amino acid positions identified were used for generation of a site 
saturation mutagenesis library (see section 4.4.3.1). The primary reason for difference in 
improvement of activity for variants KB1 and KB2 using NADPH as electron source and 
alternative electron transfer system Zn/Cobalt(III)sepulchrate is due to the fact that the 
screening was performed using NADPH and not Zn/Cobalt(III)sepulchrate. It is an 
established fact in directed evolution campaigns ‘‘you get what you screen for’’ (You and 
Arnold, 1996). 
 
4.4.3.1 Site Saturation Mutagenesis at Positions Q385 and V386  
 
The two positions identified (Q385 and V386) in the first round of random mutagenesis 
were subjected to simultaneous site saturation mutagenesis in order to identify the most 
beneficial substitution at each position using NNK codon degeneracy in the primer 
sequence (Appendix, Table 4). However, screening of approximately 450 clones using TLC 
                            Directed Evolution of P450cin Fusion Protein for Mediated Electron Transfer 
109 
 
based screening system and NADPH as reducing equivalent (see Chapter 3, Section 3.3.1.4) 
could not yield a mutant which was more active than combination of individual mutations 
(Q385H/V386S) (Table 4.4.2, Figure 4.4.3). This double mutant (Q385H/V386S or KB3) 
was subsequently used as a template for generation of round II of SeSaM. 
 
4.4.4 Screening of SeSaM library II 
 
Screening was performed for approximately 1350 clones using Zinc dust and 
Cobalt(III)Sepulchrate as electron transfer system and TLC screening system using crude 
cell lysate (as described in Chapter 3, Section 3.3.1.4). 100 clones showing an improvement 
in 2-β-hydroxy-1,8-cineole formation by 20% compared to WT enzyme (Q385H/V386S) 
were selected for re-screening. Re-screening was performed in a 96-well deep well plate 
using crude cell lysate and amount of 2-β-hydroxy-1,8-cineole formed was semi-quantified 
using TLC screening system. Subsequently, reactions with normalized amount of P450 was 
performed for 15 best clones and the amount of 2-β-hydroxy-1,8-cineole formed was 
quantified using GC-FID. 
 
 
Figure 4.4.4. Activity profile for P450cin variants identified from SeSaM library round II 
(KB1-Q385H and KB2- V386S) and mutant KB3 (Q385H/V386S) identified from Site 
saturation library at position Q385 and V386. Variants KB4 (Q385H/V386S/T77C) and KB5 
(Q385H/V386S/L88N) were identified from SeSaM library round II. All measurements 
were performed in triplicate using Zinc dust [5 mg] and Cobalt (III) Sepulchrate [5 mM] and 
were performed for 2 h at 30 °C using 1 µM P450. 
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Screening yielded two improved variants with single mutation each (KB4 and KB5). 
Variants KB4 (Q385H/V386S/T77C) and KB5 (Q385H/V386SL88N) exhibited a 3.5 fold 
improvement in hydroxylation activity in comparison to WT (CinA-linker 10aa-CinC) 
(Figure 4.4.4). 
 
4.4.4.1 Site Saturation Mutagenesis at Positions T77 and L88 
 
The amino acid positions identified from SeSaM library round II were subjected to 
simultaneous site saturation mutagenesis. PCR was performed (described in chapter 3; 
section 3.2.5) using mixture of four primers containing NNK degeneracy in the sequence of 
the forward primer (Appendix, Table 4). Five random clones were sequenced in order to 
determine randomization of amino acid residues at positions 77 and 88. 
 
 
 
Figure 4.4.5. 0.8% agarose gel for simultaneous site saturation mutagenesis at position 77 
and 88. Lane 1 = 1 kbp DNA ladder; lane 2 = PCR product for SSM at position 77 and 88 
(expected size ~ 3.8 kbp). 
Table 4.4.3. Sequencing analysis of random clones from simultaneous SSM library at 
position 77 and 88. 
Clone Position 
77 
Position 
88 
WT acc ctg 
1 acc att 
2 cgt act 
3 act acg 
4 ccg tcg 
5 act tgt 
3 kbp 
1         2       
4 kbp 
1 kbp 
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Sequencing analysis of five random clones showed randomization of amino acids at position 
77 and 88 (Table 4.4.3). The simultaneous site saturation library was screened using 
Zinc/Cobalt(III)sepulchrate (described in chapter 3; section 3.3.1.4). Screening of about 450 
clones was performed using the TLC based screening system. Mutants showing activity 
improvement by about 2 folds were selected for rescreening. The rescreening of the 
selected clones (30 clones) was performed using normalized amount of P450 (1 µM) in the 
reaction mixture and the formation of 2-β-hydroxy-1,8-cineole was determined using GC-
FID measurements. Simultaneous SSM library generated three mutants KB6 
(Q385H/V386S/T77S/L88C), KB7 (Q385H/V386S/T77C/L88Y) and KB8 
(Q385H/V386S/T77N/L88R) with improvement in activity by about 5 folds (Figure 4.4.6) 
compared to WT (CinA-linker10aa-CinC). 
 
 
 
Figure 4.4.6. 2-β-hydroxy-1,8-cineole formed for P450cin variants identified after 
screening of SSM library at amino acid position 77 and 88. KB5 (Q385H/V386S/L88N) were 
identified from SeSaM library round II. Variant KB6 (Q385H/V386S/T77S/L88C), KB7 
(Q385H/V386S/T77C/L88Y) and KB8 (Q385H/V386S/T77N/L88R) were identified from 
SSM library at amino acid position T77 and L88. All measurements were performed in 
triplicate using Zinc dust [5 mg] and Cobalt(III)sepulchrate [5 mM] and were performed for 
2 h at 30 °C using 1 µM P450. 
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4.4.5. Comparing Activities of P450cin Variants with NADPH and 
Zn/Cobalt(III) sepulchrate 
 
In order to compare the activities of P450cin variants identified after two iterative rounds 
of SeSaM for electron source Zn/Cobalt(III)sepulchrate and NADPH, amount of 2-β-
hydroxy,1,8-cineole formed was determined for WT (CinA-linker10aa-CinC), variants KB1- 
KB8 and an equimolar mixture of individual component of P450cin system 
(CinA+CinC+Fpr). 
Table 4.4.4 gives a comparison of the product formation of equimolar mixture of individual 
components of P450cin (CinA+CinC+Fpr) and KB8. Variant KB8 showed around 2.2 times 
increased 2-β-hydroxy-1,8-cineole formation (501.56 ± 9.19 µM µM P450-1) using electron 
donor system Zn/Cobalt(III)sepulchrate compared to an equimolar mixture of 
CinA+CinC+Fpr (222.22 ± 3.23 µM µM P450-1). In addition mutant KB8 displayed a 1.5 
times improvement in activity (501.56 ± 9.19 µM µM P450-1) using 
Zn/Cobalt(III)sepulchrate compared to the equimolar mixture of CinA+CinC+Fpr (315 ± 
13.88 µM µM P450-1) using NADPH as reduction equivalent (Table 4.4.4 and Figure 4.4.7).   
 
Table 4.4.4. Activity profile for variant KB8 and equimolar mixture of individual 
components of P450cin (CinA+CinC+Fpr). Reactions using NADPH [0.4 mM] as well as 
reactions using Zinc dust [5 mg] and Cobalt(III)sepulchrate [5 mM] were performed for 2 h 
at 30 °C using 1 µM P450 in triplicate. Reaction products were extracted with ethyl acetate 
and analyzed by GC-FID for determination of 2-β-hydroxy,1,8-cineole. 
 
Variant 2-β-hydroxy-1,8-cineole formed  
[NADPH]  
(µM µM P50-1) 
2-β-hydroxy-1,8-cineole formed 
[Zinc dust and Cobalt (III) 
Sepulcharte] 
(µM µM P50-1) 
CinA+CinC+Fpr 315 ± 13.88 222.22 ± 3.23 
WT 88.67± 2.36 82.67 ± 4.94 
KB8 680 ± 5.5 501.56 ± 9.19 
 
 
The amount of 2-β-hydroxy-1,8-cineole formed WT enzyme and variants KB1 – KB8 is 
shown in Figure 4.4.5. The variants identified from two iterative rounds of SeSaM exhibited 
improvement in activity with NADPH as well as with Zinc dust and Cobalt(III)sepulchrate 
(Figure 4.4.7). 
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Figure 4.4.7. Amount of 2-β-hydroxy-1,8-cineole for P450cin variants identified after two 
iterative rounds of SeSaM libraries using NADPH and Zinc dust and Cobalt(III)sepulchrate 
as electron source. All measurements were performed in triplicate using NADPH [0.4 mM] 
or using Zinc dust [5 mg] and Cobalt(III)sepulchrate [5 mM] and were performed for 2 h at 
30 °C using 1 µM P450. WT (CinA-linker 10aa-CinC), KB1 (Q385H), KB2 (V386S), KB3 
(Q385H/V386S), KB4 (Q385H/V386S/T77C), KB5 (Q385H/V386S/L88N), 
KB6 (Q385H/V386S/T77S/L88C), KB7 (Q385H/V386S/T77C/L88Y) and KB8 
(Q385H/V386S/T77C/L88Y). 
 
 
Thus the improvement in activity for all the identified P450cin variants was observed for 
both electron transfer systems employed- NADPH as well as Zinc dust and 
Cobalt(III)sepulchrate. Based on these results, improving activity of enzyme variants for 
Cobalt(III)sepulchrate as alternative cofactor system instead of NADPH only states 
increased product formation and improved activity of the CinA-CinC fusion protein towards 
1,8-cineole but an assertion about electron transfer rates cannot be postulated. 
Subsequently, variants KB3 and KB8 were selected for determination of kinetic parameters 
(kcat and Km) because they had the highest improvements in reactions performed with 
Zn/CoIII-Sep as alternative cofactor system (see section 4.4.6). Improvement in activity for 
the identified P450cin variants was also validated using bioelectrocatalytic reaction set up 
(discussed in Chapter 4, section 4.6). 
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4.4.6. Characterization of WT and Improved Variants (KB3 and KB8)  
 
Characterization of WT (CinA-linker10aa-CinC) and two improved variants KB3 and KB8 
was performed employing electron donor systems Cobalt(III)sepulchrate. Purification of 
these variants was performed as described in chapter 3; section 3.3.4. In order to determine 
the range of substrate concentration for determination of Vmax and Km, the substrate 
concentration was changed from 10 µM to 5 mM and enzyme concentration (P450 
concentration) of 1 µM (Figure 4.4.8). Kinetic parameter (Vmax and Km) were calculated on 
basis of non-linear regression based on Michaelis -Menten model using GrahPad Prism 
software. 
 
 
 
Figure 4.4.8. Activity profile of reaction using 1,8-cineole concentration range from 10 µM 
to 5 mM for determination of kcat and Km.  Reactions were performed using purified WT 
enzyme (1 µM; CinA-linker10aa-CinC). Reaction products were extracted with ethyl acetate 
after 20, 40, 60, 80, 100 and 120 min and analyzed by GC-FID. 
 
Figure 4.4.8 shows the 2-β-hydroxy-1,8-cineole formation profile for WT enzyme using 1,8-
cineole concentration range from 10 µM to 5 mM. The concentration of enzyme used for 
reaction was 1 µM (normalized to P450 concentration). However, using this substrate and 
enzyme concentration, a linear curve was not obtained (Figure 4.4.8). The reaction reached 
saturation within 20 min of reaction time. As a result, the concentration of enzyme was 
decreased to 0.25 µM and the concentration range of 1,8-cineole from 100 µM to 3 mM 
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(Figure 4.4.9). 1,8-cineole concentration range of 100 µM to 3 mM and enzyme 
concentration of 0.25 µM showed a linear range for product formation (Figure 4.4.9). 
 
 
 
Figure 4.4.9. Activity profile of reaction using 1,8-cineole concentration from 100 µM to 3 
mM for determination of kcat and Km. Reactions were performed using purified WT enzyme 
(0.25 µM; CinA-linker10aa-CinC). Reaction products were extracted with ethyl acetate after 
20, 40, 60, 80, 100 and 120 min and analyzed by GC-FID. 
 
Determination of the kinetic parameters (kcat and Km) was thus performed with enzyme 
concentration of 0.25 µM (normalized to P450 concentration) and 1,8-cineole concentration 
range of 100 µM to 3 mM. Table 4.4.4 summarizes the kinetic parameters for variants KB3 
(Q385H/V386S) and KB8 (Q385H/V386S/T77C/L88Y) with improved activity towards 1,8-
cineole with electron donor system Cobalt(III)sepulchrate in comparison to wild type 
(CinA-linker10aa-CinC). Variant KB3 showed a 2 fold improvement in kcat values (1.38 µM 
min-1) and variant KB8 showed a 3.7 fold increase (2.5 µM min-1) in comparison to the WT 
(0.67 µM min-1). However the Km value was unchanged (90 µM) (Table 4.4.5 and Figure 
4.4.9). 
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Table 4.4.5: Kinetic parameters for WT (CinA-linker 10aa-CinC), KB3 (Q385H/V386S) and 
KB8 (Q385H/V386S/T77C/L88Y). Kinetic parameters (Vmax and Km) were obtained by non-
linear regression based on the Michaelis- Menten model using GraphPad Prism software 
package. TTN (total turnover numbers) were obtained after a reaction time of 24 h and 
were calculated as µM product/µM enzyme. TTN were determined for two different 
concentrations of 1,8-cineole (1 mM and 5 mM). 
 
Variant Kcat 
[µM/min] 
Km 
[mM] 
Kcat/Km 
[µM min-1 mM-1] 
TTN 
1 mM                       5 mM  
WT 0.67 0.09 7.4 60 ± 2 260 ± 5 
KB3 1.328 0.1 13.28 200 ± 4 562 ± 7.5 
KB8 2.5 0.09 27.77 480 ± 2.5 1170 ± 6.5 
 
Another kinetic parameter as a measure of catalytic performance of a P450 system is its 
total turnover number (TNNs). TTNs were determined using non optimized reaction 
conditions. Table 4.4.5 gives the total turnover numbers for the WT enzyme and the 
engineered variants KB3 (Q385H/V386S) and KB8 (Q385H/V386S/T77C/L88Y) which was 
calculated as µM product µM-1 P450 for a reaction time of 24 h employing two different 1,8-
cineole concentrations (1 mM and 5 mM). Employing mutants KB3 and KB8 more than 4 
fold product concentrations were obtained as compared to the WT. 
 
 
Figure 4.4.10. Kinetic characterization WT (CinA-linker 10 aa-CinC), KB3 (Q385H/V386S) 
and KB8 (Q385H/V386S/T77C/L88Y) for determination of kcat and Km with electron source 
Cobalt(III)sepulchrate. 
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To summarize the results, values determined for kcat and Km for P450cin variants performed 
using purified enzyme confirmed the screening data. Variant KB3 showed a 2 fold 
improvement in kcat values (1.38 µM min-1) and variant KB8 showed a 3.7 fold increase (2.5 
µM min-1) in comparison to the WT (0.67 µM min-1). However the Km value was unchanged 
(90 µM) (Table 4.4.5 and Figure 4.4.10). 
 
4.4.7 Discussion 
 
Redox proteins by natural design are not suitable for use with alternative co-factor systems. 
Redox active sites are often embedded deeply in the protein core with tight regulation over 
the electron transfer mechanism (Wong and Schwaneberg, 2003). Directed protein 
evolution allows overcoming this challenge by redesigning and improving of redox proteins 
for alternative cofactor systems without the knowledge of protein structure or electron 
transfer mechanism. One of the main hurdle in employing P450 monooxygenases for 
preparative chemical synthesis using cell free systems is their requirement for expensive 
cofactors such as NA(D)PH. Of many approaches to circumvent this problem is to use an 
alternative electron system using a mediator which shuttles electrons between a cheap 
electron source and active site of the protein.  
Figure 4.4.11 summarizes the directed P450cin evolution campaign generating a final 
variant KB8 carrying four mutations (Q385H/V386S/T77N/L88R) with 3.8 times higher 
catalytic efficiency (kcat/Km)(27.77 µM-1 min-1) compared to WT enzyme (7.4 µM-1 min-1) 
and an increase in kcat from 0.67 µM min-1 for WT to 2.5 µM min-1 for mutant KB8. 
     
 
 
 
Figure 4.4.11. Summary of the directed P450cin evolution campaign. P450cin was evolved 
for alternative co-factor system Cobalt(III)sepulchrate to replace NADPH in cell free 
reactions. Two rounds of directed evolution using SeSaM and Site Saturation Mutagenesis 
was performed. 
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In this thesis, electron transfer system Zinc dust with mediator Cobalt(III)sepulchrate was 
employed as alternative reduction equivalents for conversion of 1,8-cineole to 2-β-hydroxy-
1,8-cineole using P450cin fusion protein variants. 
Screening of first round of random library was performed using NADPH as reducing 
equivalent. NADPH was used since the detection limit for TLC was high (100 µM or more) 
and using Zinc dust and Cobalt(III)sepulchrate about 82 µM µM-1 P450 for WT enzyme 
(CinA-linker 10aa- CinC) was obtained. Consequently, the screening for first round of SeSaM 
library was performed using NADPH to identify a variant with increased activity for 1,8-
cineole which could be further used in subsequent rounds of random mutagenesis for 
evolution towards Zinc dust and Cobalt(III)sepulchrate. Screening of mutant libraries in 
subsequent round of SeSaM and site saturation mutagenesis libraries was achieved using 
Zinc dust and Cobalt(III)sepulchrate. The amino acid positions identified from two iterative 
rounds of random mutagenesis are shows in Figure 4.4.12. 
 
 
 
 
                                                        
 
 
 
 
 
 
 
 
 
Figure 4.4.12. Crystal structure of P450cin (CinA; PDB id: 1T2B); showing the positions 
Q385, V386, T77 and L88 identified after two round of random evolution of P450cin fusion. 
 
 
P450cin closely resembles P450cam not only in size, structure but also the chemical 
composition of 1,8-cineole and camphor, their respective substrates (Meharenna et al., 
1,8-cineole 
Heme 
Q385 
V386 
T77 
L88 
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2004). Extensive protein engineering studies have been reported on P450cam enabling the 
understanding of role of active site residues in cofactor binding and substrate specificity 
(Fasan, 2012;Urlacher et al., 2004). In substrate-protein contact regions where the 
secondary structural elements are conserved between P450cin and P450cam there is in 
general a one-to-one correspondence in the location, but not identity, of residues contacting 
the substrate. Amino acid residues T77, L88, L237, V386 and A285 constitute the substrate 
binding pocket for P450cin (Meharenna et al., 2004). Amino acid Val386 which is a part of 
the nonpolar substrate pocket in P450cin, correspond to Val396 in P450cam. Whereas, 
residues T77 and L88 in P450cin correspond to amino acid residues F87 and F98 in 
P450cam (Meharenna et al., 2004). Amino acids residues F87, F98, V396 in P450cam are 
responsible for access of camphor to the active (Poulos et al., 1987). Due to correspondence 
in the location of amino acids in P450cam and P450cin it can be speculated that the amino 
acids identified to be improved for activity for P450cin might influence the access or 
binding of 1,8-cineole in the active site of the enzyme. 
In case of mutant KB3 (Q385H/V386S), amino acids with different chemically properties 
was substituted only at one the position. The uncharged amino acid residue glutamine was 
replaced with histidine, a positively charged amino acid. However, property of amino acid 
at position 385 remained unchanged (valine to serine). 
In case of mutant KB8 (Q385H/V386S/T77N/L88R), the non-polar aliphatic residue at 
position 88 (leucine) was substituted with polar positively charged arginine whereas the 
property of the amino acid remained unchanged at position 77 (threonine to asparagine). 
The binding of the mediator Cobalt(III)sepulchrate in the protein matrix or the amino acid 
residues crucial for electron transfer in cytochrome P450cin have not been elucidated yet. 
Two possible hypotheses can be stated for the interaction between the mediator and the 
protein, one in which the mediator does not enter the protein matrix but transfers electrons 
to the electron transfer chain in the protein matrix (Nazor, 2007; Ruff, 2012) like as 
reported in P450 BM3. Another possible hypothesis could be that the mediator binds in 
close proximity to the electron transfer chain or near the heme-FMN interface and the 
electron transfer proceeds through electrostatic interaction between the mediator and 
protein matrix. A molecular understanding on how amino acids substitutions identified in 
this report contribute to increase in activity with Zinc dust and Cobalt(III)sepulchrate is 
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however challenging and extensive computational as well as crystallographic studies might 
provide insights regarding the same would further allow to verify the obtained 
experimental data.  
The optimal ratio reported for P450cin using reconstituted system consisting of CinA, E. coli 
Fpr and CinC is 1:2:8 (Hawkes et al., 2010). Furthermore they reported a catalytic efficiency 
(kcat/Km) of 21 µM min -1 µM -1 P450 with a ratio of 1:1:1 (CinA: Fpr: CinC) using NADPH as 
electron source. Using P450cin variant KB8 (CinA:CinC ratio 1:1), a comparable catalytic 
efficiency of 27.77 µM min -1 µM -1 P450 with electron transfer system Zinc dust and 
Cobalt(III)sepulchrate was obtained (Table 4.4.5). Consequently mutant KB8 in 
combination with Zinc dust and Cobalt(III)sepulchrate can efficiently replace the 
reconstituted P450cin system and NADPH. 
Slessor et al., reported construction of vectors for the polycistronic co-expression of 
P450cin and cindoxin (CinC) with or without terminal redox partner (E. coli Fpr). However, 
when Fpr was coexpressed with P450cin and cindoxin, the expression levels of cindoxin 
were drastically decreased presumably due to competition between cindoxin and Fpr for 
flavin cofactors. The co-expression system also decreased the expression levels of P450cin 
(Slessor et al., 2012). Whereas the fusion protein reported in this thesis posed no difficulties 
in expression levels, neither for CinA or CinC (see Chapter 3, Section 3.3.4). Use of fusion 
protein not only facilitates the expression but also simplifies P450cin system on genetic 
level making it suitable for directed evolution experiments. The use of Zinc dust and 
Cobalt(III)sepulchrate in combination with CinA-CinC fusion protein not only circumvents 
the use NADPH but also of CinB, a non-expressible natural redox partner of P450cin. 
The identified P450cin variants for improvement in activity with Zinc and 
Cobalt(III)sepulchrate were further validated with electrobiocatalytic reaction set up. The 
results are presented and discussed in Chapter 4, Section 4.6. 
4.4.8 Conclusion 
 
In order to improve the fusion of P450cin protein (CinA-linker 10 aa-CinC) for mediated 
electron transfer system (Zinc dust and Cobalt(III)sepulchrate) two random mutagenesis 
libraries were generated with the SeSaM method. Screening of the SeSaM libraries 
performed using a validated TLC based screening system determined four positions Q385, 
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V386, T77 and L88 to be crucial for improvement in activity towards 1,8-cineole. Variant 
KB8 (Q385H/V386S/T77N/L88R) (keff = 27.77 µM min-1 mM-1) exhibited having a catalytic 
efficiency (kcat/Km) 3.8 times as the starting variant (CinA-linker10aa-CinC) (keff = 7.4 µM 
min-1 mM-1). Variant KB3 (Q385H/V386S) showed nearly 2 fold improvement in kcat values 
(1.38 µM min-1) and variant KB8 showed a 3.7 fold increase (2.5 µM min-1) in comparison to 
the WT (0.67 µM min-1) with no significant change in the Km value (90 µM). Additionally the 
total turnover numbers for the variants KB8 were determined to be 1170 and 480 under 
non optimized conditions employing Zinc dust and Cobalt(III)sepulchrate and 5 mM and 1 
mM 1,8-cineole concentration respectively. Variant KB8 showed a 1.5 times (electron 
source: Zinc dust and Cobalt(III)sepulchrate) improvement compared to optimal equimolar 
mixture of CinA, CinC and Fpr (electron source: NADPH). The fusion of CinA and CinC has a 
ratio of 1:1 compared to the optimal ratio of 1:2:8 for CinA: Fpr: CinC. Furthermore, CinA-
CinC fusion protein in combination with Zinc and Cobalt (III) sepulchrate omits the use of 
CinB, the natural redox partner of P450cin which is yet to be expressed in an active form. 
 
 
   Semi-rational Evolution of Cytochrome P450Fusion Protein for Mediated Electron Transfer 
122 
 
4.5 Semi-Rational Design of Cytochrome P450cin Fusion Protein for 
Mediated Electron Transfer 
 
4.5.1. Aim of the Work 
 
Semi-rational approach has been used extensively in directed protein evolution campaigns 
(Kardashliev et al., 2013; Martinez et al., 2013) for improving enzyme properties. Semi-
rational approaches target, specific amino residue(s) to mutate on the basis of prior 
structural or functional information to create ‘smart’ libraries with reduced screening 
efforts that are more likely to yield positive results (Chica et al., 2005). This chapter focuses 
on the semi-rational approach used for engineering of P450cin fusion protein for mediated 
electron transfer. 
4.5.2 Homology Modeling for P450cin Fusion Protein 
 
A homology model of CinA-linker10aa-CinC was generated using homology modeling 
routine of the YASARA software (Krieger et al., 2002). Homology model of CinA-linker10aa-
CinC was generated as described in Chapter 4, Section 4.3.2. P450cin was aligned with the 
crystal structure of P450 BM3 in complex with cobalt sepulchrate (Shehzad et al., 2013) 
(unpublished results). Although, the similarity between P450 BM3 and P450cin is < 20%; 
P450 BM3 was selected for structural alignment since both P450cin and P450 BM3 have 
FAD and FMN containing redox partners. Crystal structure of P450cin was aligned with 
crystal structure of P450 BM3 in complex with cobalt-sepulchrate both based in a full 
sequence alignment and a partial aligment based in the loop region of P450 BM3 (residues 
187 to 198) (residues 175 to 179 in P450cin) in order to estimate the position of simulation 
box for docking for Cobalt(III)sepulchrate. The charge of cobalt ion was fixed to +3 and the 
sepulchrate cage was placed around the cobalt ion. A total of 100 docking runs were 
performed and the highest ranked docking poses were selected for further analysis. (Figure 
4.5.1 A and B). 
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Figure 4.5.1. Structural alignment of P450 BM3 (green) and P450cin homology model 
(blue). (A) Helix of P450cin was aligned with helix of P450 BM3. (B) Loop of P450cin was 
aligned with loop of P450 BM3. 
Loop aligned 
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4.5.3 Docking of Cobalt(III)sepulchrate in P450cin Fusion Protein 
 
Cobalt(III)sepulchrate was docked in the constructed homology model using YASARA on 
the basis of the crystal structure of P450 BM3 in complex with cobalt(III)sepulchrate as 
reported by Shehzad et al., 2013 (unpublished results). The charge of cobalt ion was fixed to 
+3 and the sepulchrate cage was placed around the cobalt ion. YASARA uses a similar 
method for docking of ligands in protein matrix like Autodock (Goodsell et al., 1996) with 
certain additional features. It allows interactively placing the simulation cell around the 
active site to focus docking on the most important region and to perform rigid as well as 
flexible docking. Simulation cell defines the space and position in the protein structure 
where a target substrate or molecule will be docked. Two approaches were used to 
determine the position of simulation cell in the P450cin structure for docking of Cobalt(III) 
sepulchrate using YASARA. In the first approach, structural alignment of CinA-linker10aa-
CinC and P450 BM3 was used. P450 BM3 contained the Cobalt(III)sepulchrate docked to it. 
A simulation cell was placed around the Cobalt(III)sepulchrate and the structure of P450 
BM3 was deleted leaving the homology model of CinA-linker10aa-CinC with a simulation 
cell. Cobalt(III)sepulchrate was subsequently docked in this simulation cell using YASARA 
docking routine. 
 
Figure 4.5.2. Homology model of CinA-linker10aa-CinC with the simulation cell for docking 
of Cobalt(III)sepulchrate. The box represents the simulation cell. 1,8-cineole is shown in 
yellow and heme is shown in red. 
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In the second approach, the homology model constructed for CinA-linker10aa-CinC was 
used and the simulation cell was set up in the active site of the enzyme. Using this, docking 
of Cobalt(III)sepulchrate was performed. In total 100 docking runs were performed using 
both the approaches. The results obtained from both the approaches were similar and the 
position of Cobalt(III)sepulchrate was exactly in the same position. Figure 4.5.2 shows a 
homology model of CinA-linker10aa-CinC and the position of the simulation cell. 
Another set of homology models for docking of Cobalt(III)sepulchrate were prepared in 
which only the crystal structure of CinA (PDB id: 1T2B) was used, since all the mutations 
identified from random mutagenesis library were found in the heme domain (CinA). The 
docking of Cobalt(III)sepulchrate in the crystal structure of CinA was performed using 
YASARA in a similar way as described above for CinA-CinC fusion protein with linker length 
of 10 amino acids. The model generated after docking of Cobalt(III)sepulchrate for CinA 
was compared to the model generated for CinA-CinC fusion protein with linker length of 10 
amino acids. However, no significant changes were observed in both the generated models. 
 
4.5.4 Selection of Amino Acid Residues 
 
Docking results were analyzed taking into consideration the first five docking poses of 
Cobalt(III)sepulchrate. The docking poses are ranked according to the most stable 
conformation to the least stable configuration (lowest energy to highest energy). For 
instance pose 1 will have more stability and less energy than pose 2 and hence will be 
favored. The results of docking for Cobalt(III)sepulchrate were analyzed for first five ‘best’ 
poses. Figure 4.5.3 shows five different poses of Cobalt(III)sepulchrate ( represented by 
shades of purple). 
Amino acid residues identified from random muatagenesis (Q385, V386, T77, and L88) 
along with the proposed docked Cobalt(III)sepulchrate pose in P450cin are shown in Figure 
4.5.3 and Figure 4.5.4. Upon evaluation of the proposed docking site for 
Cobalt(III)sepulchrate, residues 79, 80 and 81 were selected as they were in close proximity 
from both the amino acid positions identified by random mutagenesis (77 and 88) and in 
direct contact with Cobalt(III)sepulchrate. In this way, residues 79, 80 and 81 could 
complete a putative ‘path’ between Cobalt(III)sepulchrate and the active site. 
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Figure 4.5.3. Five best docking poses for Cobalt(III) sepulchrate along with positions 
identified from random mutagenesis (Q385, V386, T77 and L88). The figure also shows the 
position selected for saturation by semi-rational approach (amino acid positions 79, 80 and 
81). 
 
 
 
 
 
 
 
 
 
 
Figure 4.5.4. Best docking pose for Co (III) sepulchrate along with positions identified from 
random mutagenesis (Q385, V386, T77 and L88). The figure also shows the position 
selected for saturation by semi-rational approach (amino acid positions 79, 80 and 81). 
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The amino acid residues 79, 80 and 81 were selected on assumption that the binding of 
Cobalt(III)sepulchrate would occur at a position similar to that observed in the docking 
model (Figure 4.5.4). This would in turn facilitate the transfer of electrons from Zinc via 
Cobalt(III)sepulchrate through the selected amino acid residues (79, 80 and 81) towards 
heme for conversion of 1,8-cineole to 2-β-hydroxy-1,8-cineole. 
 
4.5.5 Generation of Simultaneous Site Saturation Mutagenesis Library at 
Position 79, 80, and 81 
 
The positions selected (79, 80, and 81) after docking of Cobalt(III)sepulchrate were 
simultaneously saturated using a two-step protocol as described in chapter 3, section 3.2.5. 
The primers used contained NNK codon degeneracy and are listed in table 5; appendix 
section. Variant KB3 (Q385H/V386S) was used as template for generation of simultaneous 
SSM library at position 79, 80, and 81. Mutant KB3 was obtained after simultaneous site 
saturation at positions Q385 and V386 identified after SeSaM round I. The amplification of 
target gene was confirmed on a 0.8% agarose gel which showed a band at the expected size 
of 3.8 kbp (Figure 4.5.5). The PCR product was digested with DpnI and transformed in 
chemically competent E. coli BL- 21 Gold (DE3) lacIQ1 cells (Chapter 3, Section 3.1.4). Three 
random clones were sequenced before library was screened to identify an improved variant 
with alternative cofactor system. The sequencing result showed randomization of all three 
amino acid positions (Table 4.5.1). 
 
 
Figure 4.5.5. 0.8% agarose gel for simultaneous site saturation mutagenesis at position 79, 
80 and 81. Lane 1 = SSM at position 79, 80 and 81 (expected size ~ 3.8 kbp). Lane 2 = 1 kbp 
DNA ladder. 
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Table 4.5.1. Sequence analysis for three random clones from the simultaneous site 
saturation mutagenesis library at position 79, 80, and 81 (WT = wild type enzyme). 
 
 Position 
Clone no 79 80 81 
1 cat atg agt 
2 ccg cat gag 
3 tct cgt ttt 
WT ccg cgt tat 
 
4.5.6 Screening of Simultaneous Site Saturation Mutagenesis Libraries 
 
Screening of 450 clones from the simultaneous SSM library was performed using thin layer 
chromatography using crude cell lysates in a microtiter plate using electron source 
Cobalt(III)sepulchrate (described in chapter 3; section 3.3.2). The clones with 
hydroxylation activity higher than 20% of WT (Q385H/V386S) towards 1,8-cineole were 
selected for rescreening. For Rescreening of 30 clones was perfomed by expressing the 
selected variants in 200 mL TB media (described in chapter 3, section 3.2.8) and reactions 
were performed using known amount of P450 (1 µM) as described in chapter 3; section 
3.3.2 and analyzed by GC-FID (chapter 3; section 3.4.3). 
 
Figure 4.5.6. 2-β-hydroxy-1,8-cineole formation for five best mutants identified from 
simultaneous saturation library at position 79, 80, and 81. 
   Semi-rational Evolution of Cytochrome P450Fusion Protein for Mediated Electron Transfer 
129 
 
Only 450 clones from the simultaneous saturation library were screened owing to the low 
throughput screening capacity using the TLC based detection (~200 clones /day) covering 
about < 0.0001% fraction of the theoretical sequence space (Reetz et al., 2008). Figure 4.5.6 
shows the hydroxylation activity of five best variants identified after screening of SSM 
library at position 79, 80, and 81. Mutant KB9 (Q385H/V386S/P79G/R80D/Y81S) was 
identified which showed approximately 1.5 times activity as that of starting variant KB3 
(Q385H/V386S) (Figure 4.5.6) for reactions using cell free lysates. 
In order to study the cooperative effect of combining the ‘‘key beneficial’’ mutation 
identified by random and rational evolution; amino acid positions of identified variants KB8 
(Q385H/V386S/T77N/L88R) and KB9 (P79G/R80D/Y81S) were combined by site directed 
mutagenesis to generate mutant KB10(Q385H/V386S/T77N/L88R/P79G/R80D/Y81S). 
However, interestingly the mutant showed no hydroxylation activity (Table 4.5.2). 
 
Table 4.5.2. Activity profile for variants KB8, KB9 and KB10. Reactions were performed for 
2 h at 30 °C using 1 µM P450; Zinc dust [5 mg] and Cobalt(III)sepulchrate [5 mM] in 
triplicate. Reaction products were extracted with ethyl acetate and analyzed by GC-FID for 
determination of 2-β-hydroxy- 1,8-cineole. 
 
Variant 2-β-hydroxy-1,8-cineole with Zinc 
dust and Cobalt (III) Sepulchrate 
(µM µM P50-1) 
KB8 (Q385H/V386S/T77N/L88R) 501.56 ± 9.15 
KB9 (Q385H/V386S/P79G/R80D/Y81S) 408.13±1.8 
KB10 (Q385H/V386S/T77N/L88R 
/P79G/R80D/Y81S) 
inactive 
 
4.5.7. Discussion 
 
Semi-rational approach has been used extensively in directed protein evolution campaigns 
(Kardashliev et al., 2013; Martinez et al., 2013) for improving enzyme properties. Semi-
rational approach targets, specific amino residue(s) on the basis of prior structural or 
functional information to create ‘smart’ libraries that are more likely to yield positive 
results (Chica et al., 2005). Using homology modelling, amino acid residues (79, 80 and 81) 
which could have an impact on the activity of the fusion protein were identified (Figure 
4.5.3). These amino acids were in close proximity to the docked Cobalt(III)sepulchrate 
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which would in turn facilitate the transfer of electrons from Zinc via Cobalt(III)sepulchrate 
through the selected amino acid residues (79, 80, and 81) towards heme for conversion of 
1,8-cineole to 2-β-hydroxy-1,8-cineole. The chemical properties of amino acid residues 
identified from the SSM library were drastically different. In case of the best mutant KB9 
(Q385H/V386S/P79G/R80D/Y81S), cyclic proline was replaced to an aliphatic glycine, 
acidic aspartic acid replaced the basic arginine and aromatic tyrosine was substituted by 
non-aromatic serine. In other identified mutants a similar pattern of substitution was 
observed. In mutant Q385H/V386S/P79H/R80K/Y81I, cyclic proline was substituted with 
basic positively charged histidine, arginine with lysine, amino acids with similar properties 
and aromatic tyrosine with an aliphatic isoleucine. The mutant 
Q385H/V386S/P79S/R80D/Y81G showed a substitution from cyclic to non-aromatic at 
position 79, basic amino acid substituted with acidic amino acid at position 80 and an 
aromatic tyrosine substituted with aliphatic glycine. 
However no particular amino acid or amino acids with similar properties was found to be 
favored at a particular amino acid position. As a result it is difficult draw a decisive 
conclusion regarding the role and effect of each amino acid substitution at positions 79, 80, 
and 81. A further look at any identified amino acid substitution was performed using 
YASARA where models for protein with amino acid substitution identified at position 385, 
386, 77, 88, 79, 80 and 81 were generated. The protein models were generated with an aim 
to determine if the amino acid substitutions influence any structural or conformational 
changes in the active site or protein structure. The generated models were then compared 
to the wild type enzyme in order to observe if the substitutions led to a drastic effect on the 
orientation, conformation or structure of the active site of the enzyme. However, no major 
structural changes or formation or disruption of hydrogen bonds, were observed. The 
binding of the mediator Cobalt(III)sepulchrate in the protein matrix or the amino acid 
residues crucial for electron transfer in cytochrome P450cin have not been elucidated yet. A 
molecular understanding on how amino acids substitutions identified in this report 
contribute to increase in activity with Zinc and Cobalt(III)sepulchrate is however 
challenging and extensive computational as well as crystallographic studies might provide 
insights regarding the same would further allow to verify the obtained experimental data. 
 
   Semi-rational Evolution of Cytochrome P450Fusion Protein for Mediated Electron Transfer 
131 
 
4.5.8. Conclusion 
 
Semi-rational approach for selection of amino acid residues was based on the docking of 
Cobalt(III)sepulchrate in P450cin fusion protein. Amino acid residues 79, 80 and 81 were 
selected as they were in close proximity from the amino acid positions identified by random 
mutagenesis (77 and 88) and were in direct contact with Cobalt(III)sepulchrate. In this way, 
residues 79, 80 and 81 could complete a putative ‘path’ between Cobalt(III)sepulchrate and 
heme in the active site of the enzyme. Screening of simultaneous site saturation library 
(position 79, 80, and 81) identified a variant KB9 (Q385H/V386S/P79G/R80D/Y81S) with 
about 1.5 times increased hydroxylation activity (408.13±1.8 µM µM P450-1 of 2-β-hydroxy-
1,8-cineole) compared to variant KB3 (Q385H/V386S) (501.56 ± 9.19 µM µM P50-1 of 2-β-
hydroxy-1,8-cineole). 
Though the improvement is not significant, semi-rational approach of P450cin however 
demonstrates that it is possible to improve catalytic activity of P450cin towards 1,8-cineole. 
Further investigations focusing on combined mutations and molecular modeling attempts 
will help to reveal structure-function relationships for a molecular understanding and role 
of identified amino acid positions in P450cin. 
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4.6 Electrochemical Investigation of Identified P450cin Variants‡‡ 
4.6.1 Aim of the Work 
 
Electrochemical approaches for replacement of NAD(P)H have been described for 
cytochrome P450cam, cytochrome P450 BM3. This part of the thesis focuses on 
electrochemical investigations of P450cin variants identified to be improved in solution 
with Zinc dust and Cobalt(III)sepulchrate. 
 
4.6.2 Electrochemical Set Up 
 
The electrochemical reaction set up used for performing electrobiocatalytic reactions for 
the identified P450cin variants is as described in Chapter 3, Section 3.3.2. All the 
experiments described in this chapter were performed according to an optimized protocol 
established at Dechema Research Institute, Frankfurt, Germany. The concentration of 
Cobalt(III)sepulchrate, potential applied, concentration of enzyme used in the reaction was 
as described previously (Çekiç et al., 2010). 
Cobalt(III)sepulchrate was selected as the mediator since its redox potential (-615 mV vs 
Ag/AgCl) was more negative than the redox potential of the enzymes active site (P450cin-   
-402 mV vs Ag/AgCl and cindoxin— -430 mV vs Ag/AgCl) (Andersson et al., 1997; Kimmich 
et al., 2007). The concentration of mediator for performing the reaction was selected as 
5 mM and the potential applied was -750 mV as reported to be optimum for P450cin 
catalyzed electrobiocatalytic conversion of 1,8-cineole (Çekiç et al., 2010). The reaction set 
up used for electrobiocatalytic mediated reaction using P450cin is as shown in Figure 4.6.1. 
 
 
 
 
 
                                                          
‡‡ The work was performed in collabration with Dr. Dirk Holtmann at Dechema Research Institute, Frankfurt, 
Germany. 
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Figure 4.6.1. Electrochemical reaction set up for P450cin mediated conversion of 1,8-
cineole to 2-β-hydroxy-1,8-cineole. 
 
4.6.3 Effect of Luggin Capillary Diameter 
 
The luggin capillary was available in two different sizes with internal diameter of 4 mm and 
6 mm. The effect of the internal diameter of luggin capillary on amount of 2-β-hydroxy-1,8-
cineole formation was determined. The luggin capillary is used to control the placement of 
the reference electrode relative to the working electrode. The luggin capillary holds an 
electrolyte, in this case, 0.5 M sodium sulphate. 
 
 
 
 
 
 
 
 
Figure 4.6.2. Electrochemical reaction set up showing the arrangement of electrodes 
(reference, cathode, and anode), luggin capillary and reaction mixture. 
Luggin capillary 
Reaction mixture 
Platinum electrodes 
  
Pt electrodes 
Reaction mix 
 
 
 
Reference electrode 
Cathode 
Anode 
Luggin capillary 
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The luggin tip is significantly smaller than the reference electrode itself. It allows sensing of 
the solution potential close to the working electrode without the adverse effects that occur 
when the large reference electrode is placed near the working electrode. The resistance of 
this electrolyte adds to the reference electrode impedance. Larger diameter, shorter Luggin 
capillaries have lower impedance than narrow bore, longer capillaries. 
 
Figure 4.6.3. Influence of luggin capillary internal diameter (4mm and 6 mm) on formation 
of 2-β-hydroxy-1,8-cineole. The amount of 2-β-hydroxy-1,8-cineole formed was determined 
using GC-FID for variant KB8 (Q385H/V386S/T77N/L88R) over 6 h of reaction time using 1 
µM P450, 5 mM Cobalt(III)sepulchrate and platinum electrodes polarized to -750 mV. 
 
The internal diameter of the luggin capillary did not have significant influence on the 
formation of 2-β-hydroxy-1,8-cineole (Figure 4.6.3). Formation of 2- β-hydroxy-1,8-cineole 
was fairly constant using luggin capillary with different diameter. Since, the internal 
diameter did not influence the product formation, luggin capillary with an internal diameter 
of 6 mm was chosen for further experiments. 
 
4.6.4 Effect of Electrode Surface Area 
 
In order to determine the effect of electrode surface area on product formation the surface 
area of electrode was increased from 1 and 2 cm2. A proportional increase was observed in 
the amount of 2-β-hydroxy-1,8-cineole formation (Figure 4.6.4). This results show that 
mediator driven bioelectrocatalysis with P450cin is most probably limited by electrode 
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surface area. Mediator reduction rate could also become easily the limiting step in the 
whole reaction and mediator reduction can be limited by electrode surface. 
 
 
 
 
 
 
 
 
 
 
Figure 4.6.4. Effect of electrode surface area on the formation of 2-β-hydroxy-1,8-cineole. 
The surface area of the electrode was altered from 1cm2 to 2 cm2. The amount of 2-β-
hydroxy-1,8-cineole formed was determined using GC-FID for variant KB8 
(Q385H/V386S/T77N/L88R) over 6 h of reaction time using 1 µM P450, 5 mM 
Cobalt(III)sepulchrate and platinum electrodes polarized to -750 mV. 
 
4.6.5 Stability of CinA and CinC in Electrochemical Reaction 
 
Enzymes upon interaction with the electrode surface usually loose activity. The instability 
of the enzyme on the surface of the electrode can be attributed to the lower conversion of 
substrates to products (Holtmann and Schrader, 2007). Thus it was essential to study and 
monitor the effect of electrochemical reaction set up used in the study on the stability and 
activity of the P450cin fusion enzyme mutants.   
Stability of CinA and CinC in the fusion protein under the applied electrochemical 
conditions was determined. For this purpose, the two variants Heme (-) and FMN (-) were 
used (See Chapter 4, section 4.3 for details). The mutant heme (-) had a mutation A91F in 
heme or CinA domain rendering the heme domain inactive. The FMN (-) mutant had a 
mutation G594D in the FMN or CinC domain making the FMN domain inactive. 
Crude cell lysate for Heme (-) mutant was used to set up a reaction in 50 mM potassium 
phosphate buffer (pH 7.4) and 1500 U/ml catalase in an electrochemical cell where the 
working electrode was polarized to −750 mV vs Ag/AgCl for 24 h. At time intervals of 1, 2, 3, 
1 cm
2
 electrode surface area 
2 cm
2
 electrode surface area 
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4, 8, 12 and 24 h aliquots of samples were taken and mixed with CinA, E. coli Fpr, 1,8-
cineole and NADPH and the amount of 2-β-hydroxy-1,8-cineole formed was analyzed by GC-
FID. Formation of 2-β-hydroxy-1,8-cineole could be detected for a period of about 5 h. after 
this time interval no product was detected on GC-FID showing that the activity of CinC was 
lost  almost completely after 5 h of reaction time. 
Similarly to determine the stability of CinA, crude cell lysate of FMN (-) mutant was used to 
set up a reaction in an electrochemical cell polarized to -750 mV vs Ag/AgCl electrode. At 
time intervals of 1 , 2 , 3 4 ,8 , 12 and 24 h aliquots of samples were taken and mixed with 
CinC, E. coli Fpr, 1,8-cineole and NADPH and the amount of 2-β-hydroxy-1,8-cineole formed 
was analyzed by GC-FID. Formation of 2- β-hydroxy-1,8-cineole could be detected upto 8 h 
of reaction time. 
 
4.6.6 Effect of External Addition of CinA and CinC in the Electrochemical 
Reaction  
 
The results obtained above showed that stability of CinC and CinA in the electrochemical 
cell was lost after a reaction time of 5 h and 8 h respectively. Previously it has been 
reported for various enzymes systems that the enzyme loses its stability and hence activity 
on an electrode surface. In order to check if external addition of CinA and CinC will affect 
the product formation the following reactions were performed using mutant KB8 
(Q385H/V386S/T77N/L88R). 
The electrochemical reaction was set up as described in chapter 3, section 3.3.2. In one set 
of experiment, 1µM, 2 µM and 3 µM of crude cell lysate of CinC was added additionally to 
the electrochemical reaction. The amount of 2-β-hydroxy-1,8-cineole formed slightly 
increased when 1 µM of P450cin was added in the reaction. However, addition of 2 µM and 
3 µM of P450cin did not significantly increase the 2- β-hydroxy-1,8-cineole formation 
(Figure 4.6.5 A). In another set of experiment, 1 µM, 2 µM and 3 µM of crude cell lysate of 
CinC was added additionally to the electrochemical reaction. A similar pattern was 
observed for CinC as that observed when P450cin was externally added. The amount of 2- 
β-hydroxy-1,8-cineole formed increased when 1 µM of CinC was added in the reaction. 
However the product amount did not double or triple for addition of 2 µM and 3 µM CinC 
(Figure 4.6.5 B). 
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Figure 4.6.5. Effect of external addition of P450cin and CinC in electrobiocatalytic reaction 
system. A) Amount of 2-β-hydroxy-1,8-cineole formed in 2 h and 4 h when 1µM, 2µM and 
3µM P450cin was added to the reaction mixture in comparison to when no P450cin was 
added. B) Amount of 2-β-hydroxy-1,8-cineole formed in 2 h and 4 h when 1µM, 2µM and 
3µM CinC was added to the reaction mixture. All reactions were performed under 
potentiostatic control at-750 mV vs Ag/AgCl for mutant KB8 (Q385H/V386S/T77N/L88R). 
 
These results suggest that the CinA and CinC domains in the fusion protein might not be 
optimally orientated with respect to each other for use in electrochemical reaction setup. 
However the stability and orientation of protein are not the only factors which can 
contribute to the productivity of an enzyme system in an electrobiocatalytic reaction. There 
are numerous other factors to be considered like availability of oxygen, potential applied, 
surface area of electrode, time of reaction which significantly contributes to the formation 
of product in an electrobiocatalytic reaction system. 
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4.6.7. Electrochemical Reaction for Identified P450cin Variants 
 
Using the optimized electrochemical reaction conditions 2-β-hydroxy-1,8-cineole formation 
was investigated for WT and improved variants (KB1- KB9). The reactions were performed 
using Platinum electrodes as electron source and Cobalt(III)sepulchrate as mediator as 
described in chapter 3, section 3.3.2. 
The mutants identified to be improved with Zinc dust and Cobalt(III)sepulchrate in solution 
(KB1- KB9) were tested using electrochemical cell. The aim of the study was to substitute 
NADPH in P450cin catalysed reaction systems using platinum electrode as electron souce. 
The use of electrode systems for P450 catatlysed reactions can be utilized for deveoplement 
of biosensors and bioelectronics.  
 
 
Figure 4.6.6. 2-β-hydroxy-1,8-cineole formed by P450cin variants in electrobiocatalytic 
reaction set up. 
2-β-hydroxy-1,8-cineole formed by P450cin variants in electrobiocatalytic reaction 
employing Platinum electrodes as electron source and Cobalt(III)sepulchrate as mediator 
using 1 µM P450, 6 mM 1,8-cineole, 5 mM Cobalt(III)sepulchrate. Product formation was 
determined against -700 mV vs Ag/AgCl in a reaction time of 6 h. WT (CinA-linker10aa-
CinC); KB1(Q385H); KB2 (V386S); KB3 (Q385H/V386S); KB4 (Q385H/V386S/T77C); KB5 
(Q385H/V386S/L88N); KB6 (Q385H/V386S/T77S/L88C); KB7 
(Q385H/V386S/T77C/L88Y); KB8 (Q385H/V386S/T77N/L88R); KB9 
(Q385H/V386S/P79G/R80D/Y81S). 
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Maximum 2-β-hydroxy-1,8-cineole formation was observed for mutant KB8 (61.5 ± 1.09 µM 
µM-1 P450) after a reaction of 6 h which was approximately 3 times higher than the WT 
variant (23.51± 2.5 µM µM-1 P450) (Figure 4.6.6). The rate of product formation for variant 
KB8 (0.16 nmol (nmol) P450-1 min-1 cm-2) was also 3 folds higher than the WT variant 
(0.038 nmol (nmol) P450-1 min-1 cm-2). Control reaction without any Cobalt(III)sepulchrate 
and without any application of potential and using crude cell lysate of empty vector 
(pALXtreme-1a) did not shown 2-β-hydroxy-1,8-cineole formation. 
 
4.6.8. Discussion 
 
Electrobiocatalytic mediated conversion of substrates is a well-known approach for 
substitution of NAD(P)H in P450 group of enzymes (Fleming et al., 2006; Hollmann et al., 
2006; Holtmann and Schrader, 2007; Shumyantseva et al., 2007; Shumyantseva et al., 
2005). In most of the studies previously reported a mediator was used in combination with 
electrodes in bioelectrochemical reaction set up. Mediators are artificial electron 
transferring agents which shuttle electrons from the surface of an electrode to the redox 
center of enzymes. A suitable mediator should fulfil several requirements (Holtmann and 
Schrader, 2007): 
 It should be stable under required working conditions and should not participate in 
the side reactions during electron transfer. 
 It should show electrochemically reversible reaction kinetics and should be stable 
under oxidized and reduced forms.  
 It must be soluble under reaction conditions. 
 The redox potential of the mediator should be more negative than the redox 
potential of the enzyme’s active site for reductive biocatalysis. 
 
The mediator Cobalt(III)sepulchrate has previously been described to be used in P450 BM 3 
and P450cam catalyzed electrobiocatalytic reactions. (Faulkner et al., 1995; Nazor et al., 
2008; Nazor and Schwaneberg, 2006; Shumyantseva et al., 2005). Cobalt(III)sepulchrate 
was suitable for use in cytochrome P450cin catalyzed reactions since the redox potential of 
Cobalt(III)sepulchrate is more negative than P450cin and CinC (cindoxin) (Table 4.6.1). 
Also, it is soluble under the used reaction conditions. 
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Table 4.6.1. Standard potential of Co (III) sep , P450cin and Cindoxin vs Ag/AgCl.  
Mediator/prosthetic 
group/protein 
Standard potential 
vs Ag/AgCl [mV] 
Structure Reference 
P450cin -402 - Kimmich et al., 2007 
Cindoxin -430 - Kimmich et al., 2007 
Cobalt (III) 
sepulchrate 
-615 
 
Anderson et al., 
1997 
 
With a limited screening capacity using a potentiostat the screening of the whole P450cin 
mutant library using the above said electrochemical set up was not feasible. So screening of 
P450cin variants which displayed an improvement in activity for Zinc dust and 
Cobalt(III)sepulchrate was performed of which mutant KB8 showed the highest product 
formation (61 µM µM-1 P450) in a reaction time of 6 h with Platinum and 
Cobalt(III)sepulchrate (Figure 4.6.2). 
Cekic et al., reported a conversion rate of 6.50 nmol (nmol) P450-1 min-1 cm-2 using CinA, 
CinC (ratio 1:3) and Cobalt(III)sepulchrate (5 mM) (Çekiç et al., 2010). Using mutant KB8 
(Q385H/V386S/T77N/L88R) conversion rate of 0.16 nmol (nmol) P450-1 min-1 cm-2 which 
was approximately 3 times higher than the WT variant 0.038 nmol (nmol) P450-1 min-1 cm-2 
was obtained. The turnover rates using fusion protein reached only about 2% of the activity 
as reported by Cekic et al., for reconstituted cytochrome P450cin system consisting of CinA, 
CinC and E. coli Fpr (ratio 1:8:2). 
One possible reason for low activity of the fusion protein employing the electrochemical set 
up could be the stability of the fusion protein or the fused CinA and CinC might not be 
optimally orientated with respect to each for use in electrochemical reaction set up. 
Experimental evidence support that CinA and CinC lose their activity after 5 and 8 h 
respectively in the fusion protein. Cekic et al reported 80% and 20% of initial activity for 
CinA after 4 h and 24 h respectively under identical electrochemical reaction condition used 
in this study (Çekiç et al., 2010). Cobalt(III)sepulchrate is highly stable in both oxidized and 
reduced forms. The peak currents were 70% after 500 CVs compared to the initial cycle 
(Cekic 2012, PhD thesis, RWTH Aachen University). Subsequently, external addition of 
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crude cell lysate of CinA and CinC in the reaction mixture did not significantly increase the 
activity of the fusion protein. This suggests that the stability and orientation of protein are 
not the only factors which can contribute to the productivity of an enzyme system in an 
electrobiocatalytic reaction. There are numerous other factors to be considered like 
availability of oxygen, potential applied, surface area of electrode, time of reaction which 
significantly contributes to the formation of product in an electrobiocatalytic reaction 
system. 
The comparison of 2-β-hydroxy-1,8-cineole formed using P450cin variants employing 
NADPH, Zinc dust and Cobalt(III)sepulchrate and electrobiocatalytic reaction set up is as 
shown in figure 4.6.7. Activity of the P450cin variants using electrochemical approach is 
still far less compared to the activity obtained using NADPH as well as Zinc dust and 
Cobalt(III)sepulchrate. 
 
 
 
Figure 4.6.7. Comparison of activity of P450cin variants using NADPH, Zinc dust and 
Cobalt(III)sepulchrate and electrobiocatalytic reaction set up. WT (CinA-linker10aa-CinC); 
KB1(Q385H); KB2 (V386S); KB3 (Q385H/V386S); KB4 (Q385H/V386S/T77C); KB5 
(Q385H/V386S/L88N); KB6 (Q385H/V386S/T77S/L88C); KB7 
(Q385H/V386S/T77C/L88Y); KB8 (Q385H/V386S/T77N/L88R). 
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Recent report by Tosstorff et al., describe the effect of molecular oxygen on oxidation-
reduction of cobalt-sepulchrate. A difficulty occurring during the use of 
cobalt(III)sepulchrate in electrobiocatalytic reactions is the oxidative uncoupling of the 
mediator oxidation as molecular oxygen can re-oxidize the mediator (Tosstorff et al., 2014). 
Another challenge while developing an enzyme for electrobiocatalytic application is a high 
throughput screening system. Screening using a combination of electromicrotiter plates 
(eMTPs) (Ley et al., 2013) or colorimetric or fluorometric assays based on change in 
oxidation state of mediator can provide the necessary throughput for screening of mutants 
for electrobiocatalytic properties. Additionally improved set-up of the electrochemical cell, 
e.g. by use of packed bed flow cell can increase the productivity of the cytochrome P450cin 
system. 
 
4.6.9. Conclusion 
 
In summary, preliminary electrochemical investigation of selected P450cin variants (KB1- 
KB8), identified KB8 which showed the highest product formation (61 µM µM-1 P450) in a 
reaction time of 6 h with Platinum and Cobalt(III)sepulchrate. Using mutant KB8 
(Q385H/V386S/T77N/L88R) conversion rate of 0.16 nmol (nmol) P450-1 min-1 cm-2 which 
is approximately 3 times higher than the WT variant 0.038 nmol (nmol) P450-1 min-1 cm-2 
was obtained. The activity and productivity of the P450cin variants is still lower by a 
magnitude of about 6-7 folds lower than for NADPH. Nonetheless, this study shows that it is 
possible to redign the P450 monooxygenases for electrobiocatalytic applications using 
directed evolution strategy. 
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5. SUMMARY AND CONCLUSION 
 
Over the past decade, protein engineering has been used for the improvement of various 
enzyme classes like proteases, lacasses, glucose oxidase, cytochrome P450s for industrial 
applications. Protein engineering studies also provide useful structural and functional 
insights for development of newer and innovative biocatalysts. 
The work described in this thesis tackles two major hurdles in the application of 
cytochrome P450cin for industrial biocatalysis using protein engineering approach. The 
two obstacles of using cytochrome P450cin are- first the complex multicomponent nature 
of P450cin and second the requirement of NADPH, an expensive cofactor for hydroxylation 
of its substrate 1,8-cineole. 
The first part of the thesis describes a novel, robust, technically simple and enzyme free 
method (P-LinK-Protein fusion with variable linker insertion) for generating fusion 
proteins with variable linker length. P-Link was successfully applied for fusion of CinC 
domain to the C terminal end of CinA of P450cin system through sixteen different linker 
lengths in a single experiment employing three PCRs. The resulting CinA-CinC linker library 
was screened using a TLC based screening system for detection of 2-β-hydroxy-1,8-cineole 
to identify the most active fusion protein construct. Linker lengths between 8 to 12 amino 
acids were determined to be the most optimal for CinA and CinC fusion protein with a 
maximum observed for fusion protein with a linker length of 10 amino acids. Fusion 
proteins with a linker length of 4 amino acids or less were determined to be inactive. 
Although the fusion protein generated in this study shows lower activity (176 µM µM-1 
P450) compared to equimolar mixture of its individual component (315 µM µM-1 P450), the 
use of fusion proteins simplifies the multicomponent system on genetic level and enables its 
use in protein engineering campaigns. P-Link can also be employed to vary the amino acid 
sequence within linkers (e.g. two positions with NNK codons) in the primer sequence can 
be incorporated to explore and tune flexibility of the linker sequence and thereby increase 
activity of the fusion protein. It is further likely that P-LinK can be expanded iteratively to at 
least three component systems in which a third electron transfer partner of 
monooxygenase systems can be fused. 
The P-LinK method is the first reported method which can be used to fuse two or more 
protein domains and also vary the length of the linker between the fused domains in a 
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single experiment. P-Link is not only limited to P450 enzymes and can be of general interest 
to generate fusion enzymes to perform, for instance, cascade reactions. The use of P-Link 
method simplifies multicomponent enzyme system on genetic level and enables its use in 
protein engineering. 
Subsequently, characterization of the fusion protein with 10 amino acid linker length was 
performed using computational and experimental approach. It was performed in order to 
elucidate the electron transfer pathway and the role of linker length in the activity of the 
fusion protein. Individual mutants FMN (-) with mutation G594D in the FMN domain and 
heme (-) with a mutation A91F in the heme domain were determined to be inactive and did 
not show formation of 2-β-hydroxy-1,8-cineole. However, for an equimolar mixture of 
individual inactive domains (Heme (-) + FMN (-)) formation of 2-β-hydroxy-1,8-cineole was 
detected. This suggests that the electron transfer in the CinA-CinC fusion protein occurs 
predominantly in an intermolecular manner from heme domain of one molecule to the FMN 
domain of the other molecule in the dimeric P450cin fusion protein. This is the first report 
in which the fusion protein of CinA and CinC (a cytochrome P450 from plant origin) has 
been reported to be dimeric in structure and the electron transfer pathway described to be 
from heme domain of one molecule to the FMN domain of the other molecule in the dimeric 
protein. 
In order to engineer the P450cin fusion protein (CinA-linker 10 aa-CinC) for alternative 
electron transfer system (Zinc dust and Cobalt(III)sepulchrate) two rounds of random 
mutagenesis libraries were generated with the SeSaM method. Screening of SeSaM libraries 
using a validated TLC based screening system determined four positions Q385, V386, T77 
and L88 to be crucial for improvement in activity towards 1,8-cineole using Zinc dust and 
Cobalt(III)sepulchrate as an alternative electron transfer system. A final variant KB8 
(Q385H/V386S/T77N/L88R) was identified which exhibited a catalytic efficiency (keff = 
27.77 µM min-1 mM-1) (kcat/Km) 3.8 times higher as the starting variant (CinA-linker10aa-
CinC) (keff = 7.4 µM min-1 mM-1). Variant KB8 showed a 3.7 fold increase in kcat value (2.5 µM 
min-1) in comparison to the WT (0.67 µM min-1) with no significant change in the km value 
(90 µM). Additionally the total turnover numbers were determined under non optimized 
conditions for Zinc and Cobalt(III)sepulchrate to be 1170 and 480 for mutant KB8 using 
5 mM and 1 mM 1,8-cineole concentration respectively. 
  SUMMARY AND CONCLUSION 
145 
 
A semi-rational approach was used to rationally select amino acid positions 79, 80, and 81 
in P450cin fusion protein after docking of Cobalt(III)sepulchrate in the active site of the 
enzyme. Residues 79, 80, and 81 were selected as they were in close proximity to the amino 
acid positions identified by random mutagenesis (77 and 88) and were in direct contact 
with Cobalt(III)sepulchrate. In this way, residues 79, 80, and 81 could complete a putative 
‘path’ between Cobalt(III)sepulchrate and heme moiety in the active site of the enzyme. 
Screening of simultaneous site saturation mutagenesis library identified a variant KB9 
(Q385H/V386S/P79G/R80D/Y81S) with about 1.5 times increased hydroxylation activity 
compared to variant KB3 (Q385H/V386S). This is a first report describing positions which 
were identified from random mutant libraries (amino acid residues Q385, V386, T77, L88) 
and rationally designed mutant libraries (amino acid residues 79, 80, and 81) using an 
alternative cofactor system. The amino acid residues and the substitution pattern identified 
in this work can be further extrapolated to other P450s for development of improved P450 
catalysts. 
As a final step, preliminary electrochemical investigations of selected P450cin variants 
(KB1- KB8) were performed.  Mutant KB8 showed the highest product formation (61 µM 
µM-1 P450) in a reaction time of 6 h with Platinum and Cobalt(III)sepulchrate. Product 
formation rate of 0.16 nmol (nmol) P450-1 min-1 cm-2 which is approximately 3 times higher 
than the WT variant 0.038 nmol (nmol) P450-1 min-1 cm-2 was obtained in a total reaction 
time of 6 h. 
Results obtained in this work show that efficient P450cin fusion constructs can be designed 
and optimized by directed evolution and semi-rational design. The developed concepts of 
screening system, the P-Link method for construction of fusion proteins and identified 
amino acid residues build a foundation for potential application of P450s in biosensors, 
biofuels and biocatalysis. 
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6.4. List of Primers 
 
Chapter 2 
Table 1. List of nucleotides used for construction of SeSaM libraries. 
 
Primer 
Name 
  Sequence  Purpose 
P1 cgcctgtcaccgactcactataggggaattgtgagcgga Template generation_SeSaM step 1 
P2 gtgtgatggcgtgaggcagccgggctttgttagcagccggatctcag Template generation_SeSaM step 1 
P3 cacactaccgcactccgtcgcgactcactataggggaattgtgagcgga Template generation_SeSaM step 3 
P4 gcggacagtgcgggctttgttagcagccggatctcag Template generation_SeSaM step 3 
P5 ctaacaaagcccgaaaggaagctgagttg Cloning of SeSaM 
library_Fwd_gene amplification 
P6 cgggctttgttagcagccggatctcag Cloning of SeSaM library_Rev_gene 
amplification 
P7 gactcactataggggaattgtgagcgg Cloning of SeSaM 
library_Fwd_vector amplification 
P8 ctatagtgagtcgtattaatttcgaacatgtgagc Cloning of SeSaM 
library_Rev_vector amplification 
 
* Bold and underlined letters indicate phosphorothioate bases. 
 
Chapter 4 
Section 4.2 
Table 2A. List of nucleotides used for construction of CinA-CinC fusion protein. 
 
Primer  
Name 
Sequence Purpose 
FA1 
RA1 
gactcactataggggaattgtgagcgg 
ttcgctcagacgtttgcctttcgg 
cinA amplification 
cinA amplification 
FC1 cgtctgagcgaaatgggtaatgccctgattttatatggc cinC amplification 
RC1 cgggctttgttagcagccggatctcag cinC amplification 
FP1 ctaacaaagcccgaaaggaagctgagttg Vector amplification 
RP1 ctatagtgagtcgtattaatttcgaacatgtgagc Vector amplification 
 
* Bold and underlined letters indicate phosphorothioate bases. 
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Table 2B. List of nucleotides used for insertion of linkers (length 1-16) in the CinA-CinC 
fusion protein. 
 
Primer  
Name 
Purpose Sequence 
RL1 R.P. for linkers 1-5 ttcgctcagacgTTTGCCTTTCGGAAAAATAATC 
FL1 F.P. for Linker 1 cgtctgagcgaaCCTATGGGTAATGCCCTGATTTTATATGGCAC 
FL2 F.P. for Linker 2 cgtctgagcgaaCCTTCTATGGGTAATGCCCTGATTTTATATGGCAC 
FL3 F.P. for Linker 3 cgtctgagcgaaCCTTCTCCAATGGGTAATGCCCTGATTTTATATGGCAC 
FL4 F.P. for Linker 4 cgtctgagcgaaCCTTCTCCATCTATGGGTAATGCCCTGATTTTATATGGC 
FL5 F.P. for Linker 5 cgtctgagcgaaCCTTCTCCATCTACTATGGGTAATGCCCTGATTTTATATGGC 
   
RL2 R.P. for linkers 6-11 agtagatggagaAGGTTCGCTCAGACGTTTGCCTTTC 
FL6 F.P. for Linker 6 tctccatctactGACATGGGTAATGCCCTGATTTTATATGGCAC 
FL7 F.P. for Linker 7 tctccatctactGACCAAATGGGTAATGCCCTGATTTTATATGGCAC 
FL8 F.P. for Linker 8 tctccatctactGACCAATCCATGGGTAATGCCCTGATTTTATATGGCAC 
FL9 F.P. for Linker 9 tctccatctactGACCAATCCCCTATGGGTAATGCCCTGATTTTATATGGCAC 
FL10 F.P. for Linker 10 tctccatctactGACCAATCCCCTTCTATGGGTAATGCCCTGATTTTATATG 
FL11 F.P. for Linker 11 tctccatctactGACCAATCCCCTTCTACTATGGGTAATGCCCTGATTTTATATG 
   
RL3 R.P. for linkers 12-16 agtagaaggggaTTGGTCAGTAGATGGAGAAGGTTCGCTCAGACGTTTGCC 
FL12 F.P. for Linker 12 tccccttctactGGAATGGGTAATGCCCTGATTTTATATGGCAC 
FL13 F.P. for Linker 13 tccccttctactGGAGACATGGGTAATGCCCTGATTTTATATGGCAC 
FL14 F.P. for Linker 14 tccccttctactGGAGACGCTATGGGTAATGCCCTGATTTTATATGGCAC 
FL15 F.P. for Linker 15 tccccttctactGGAGACGCTGTTATGGGTAATGCCCTGATTTTATATG 
FL16 F.P. for Linker 16 tccccttctactGGAGACGCTGTTGCTATGGGTAATGCCCTGATTTTATATG 
 
* Bold and underlined letters indicate phosphorothioate bases. 
 
Section 4.3 
Table 3. List of nucleotides used for construction of SDM mutants A91F (Heme (-)) and 
G594D (FMN (-)) 
Primer  
Name 
Primer sequence Purpose 
SDM_A91F_FP gaactgatgatgtttggccaggatgatccg Forward primer for SDM at position 
A91 
SDM_A91F_RP cggatcatcctggccaaacatcatcagttc Reverse primer for SDM at position 
A91 
SDM_G594D_FP gtgtttggtctggatgatagctattacactacg Forward primer for SDM at position 
G594 
SDM_G594D_RP cgtagtgtaatagctatcatccagaccaaacac Reverse primer for SDM at position 
G594 
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Section 4.4 
Table 4. List of nucleotides used for construction of SSM libraries at position Q385, V386, 
T77 and L88 
 
Primer 
Name 
Sequence Purpose 
SSM_Q385V386_FP gctgatgggcnnknnkgcgggcatgctgc Forward primer for SSM at position 
385 and 386 
SSM_Q385V386_RP gcagcatgcccgcmnnmnngcccatcagc Forward primer for SSM at position 
385 and 386 
SSM_77_FP gcaacaaaggcgtgnnktttccgcgttatgaaaccg Forward primer for SSM at position 
77 
SSM_77_RP cggtttcataacgcggaaamnncacgcctttgttgc Reverse primer for SSM at position 
77 
SSM_88_FP ccggcgaatttgaannkatgatggcgggccag Forward primer for SSM at position 
88 
SSM_88_RP ctggcccgccatcatmnnttcaaattcgccgg Reverse primer for SSM at position 
88 
 
 
Section 4.5 
Table 5. List of nucleotides used for construction of simultaneous SSM library at position 
P79, R80 and Y81. 
 
Primer Name Primer sequence Purpose 
SSM_798081_FP ggcgtgacctttnnknnknnkgaaaccggcgaatttg Forward primer for SSM at 
position 79,80,81 
SSM_798081_RP caaattcgccggtttcmnnmnnmnnaaaggtcacgcc 
 
Reverse primer for SSM at position 
79,80,81 
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Protein and Nucleotide sequences 
CinA WT 
Start codon 
atg ggc acc gcg acc gtg gcg agc acc agc ctg ttt acc acc gcg gat cat tat 
 M   G   T   A   T   V   A   S   T   S   L   F   T   T   A   D   H   Y 
 
cat acc ccg ctg ggc ccg gat ggc acc ccg cat gcg ttt ttt gaa gcg ctg cgt 
 H   T   P   L   G   P   D   G   T   P   H   A   F   F   E   A   L   R  
  
gat gaa gcg gaa acc acc ccg att ggt tgg agc gaa gcg tat ggc ggc cat tgg 
 D   E   A   E   T   T   P   I   G   W   S   E   A   Y   G   G   H   W 
 
gtg gtg gcg ggc tat aaa gaa att cag gcg gtg att cag aac acc aaa gcg ttt 
 V   V   A   G   Y   K   E   I   Q   A   V   I   Q   N   T   K   A   F 
 
agc aac aaa ggc gtg acc ttt ccg cgt tat gaa acc ggc gaa ttt gaa ctg atg 
 S   N   K   G   V   T   F   P   R   Y   E   T   G   E   F   E   L   M  
  
atg gcg ggc cag gat gat ccg gtg cat aaa aaa tat cgt cag ctg gtt gcg aaa 
 M   A   G   Q   D   D   P   V   H   K   K   Y   R   Q   L   V   A   K 
 
ccg ttt agc ccg gaa gcg acc gac ctg ttt acc gaa cag ctg cgt cag agc acc 
 P   F   S   P   E   A   T   D   L   F   T   E   Q   L   R   Q   S   T 
 
aac gat ctg att gat gcg cgt att gaa ctg ggc gaa ggt gat gcg gcg acc tgg 
 N   D   L   I   D   A   R   I   E   L   G   E   G   D   A   A   T   W 
 
ctg gcc aac gaa att ccg gcg cgt ctg acc gcg att ctg ctg ggt ctg ccg ccg 
 L   A   N   E   I   P   A   R   L   T   A   I   L   L   G   L   P   P 
 
gaa gat ggc gat acc tat cgt cgt tgg gtg tgg gcg att acc cat gtg gaa aat 
 E   D   G   D   T   Y   R   R   W   V   W   A   I   T   H   V   E   N 
 
ccg gaa gaa ggc gcg gaa att ttt gcg gaa ctg gtg gcg cac gcg cgt acc ctg 
 P   E   E   G   A   E   I   F   A   E   L   V   A   H   A   R   T   L 
 
att gcg gaa cgt cgt acc aat ccg ggc aac gat att atg agc cgt gtg atc atg 
 I   A   E   R   R   T   N   P   G   N   D   I   M   S   R   V   I   M 
 
agc aaa att gat ggc gaa agc ctg agc gaa gat gat ctg att ggc ttt ttt acc 
 S   K   I   D   G   E   S   L   S   E   D   D   L   I   G   F   F   T 
 
att ctg ctg ctg ggc ggc att gat aac acc gcg cgt ttt ctg agc agc gtg ttt 
 I   L   L   L   G   G   I   D   N   T   A   R   F   L   S   S   V   F 
 
tgg cgt ctg gcc tgg gat att gaa ctg cgt cgt cgt ctg att gcg cat ccg gaa 
 W   R   L   A   W   D   I   E   L   R   R   R   L   I   A   H   P   E 
 
ctg att ccg aac gcg gtg gat gaa ctg ctg cgt ttt tat ggt ccg gca atg gtg 
 L   I   P   N   A   V   D   E   L   L   R   F   Y   G   P   A   M   V 
 
ggt cgt ctg gtg acc cag gaa gtg acc gtt ggc gat att acc atg aaa ccg ggc 
 G   R   L   V   T   Q   E   V   T   V   G   D   I   T   M   K   P   G 
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cag acc gcc atg ctg tgg ttt ccg att gcg agc cgt gat cgt agc gcg ttt gat 
 Q   T   A   M   L   W   F   P   I   A   S   R   D   R   S   A   F   D 
agc ccg gat aac att gtg att gaa cgt acc ccg aac cgt cat ctg agc ctg ggt 
 S   P   D   N   I   V   I   E   R   T   P   N   R   H   L   S   L   G 
 
cat ggc att cat cgt tgc ctg ggc gcg cat ctg att cgt gtg gaa gcg cgt gtg 
 H   G   I   H   R   C   L   G   A   H   L   I   R   V   E   A   R   V 
 
gcg att acc gaa ttt ctg aaa cgc att ccg gaa ttt agc ctg gac ccg aat aaa 
 A   I   T   E   F   L   K   R   I   P   E   F   S   L   D   P   N   K 
 
gaa tgc gaa tgg ctg atg ggc cag gtg gcg ggc atg ctg cat gtg ccg att att 
 E   C   E   W   L   M   G   Q   V   A   G   M   L   H   V   P   I   I 
 
ttt ccg aaa ggc aaa cgt ctg agc gaa taa taa 
 F   P   K   G   K   R   L   S   E   -   - 
       Stop codon 
 
CinC WT 
Start codon 
atg ggt aat gcc ctg att tta tat ggc acg gag act ggt aat gcg gag gcg tgt 
 M   G   N   A   L   I   L   Y   G   T   E   T   G   N   A   E   A   C 
 
gcg acc aca att tcg cag gtt ctg gcg gat acc gtt gat acg aag gtg cat gat 
 A   T   T   I   S   Q   V   L   A   D   T   V   D   T   K   V   H   D 
 
ctg gcc gat atg acc ccc cgc gca atg ctg gat agt ggt gcg gat ctg atc gtg 
 L   A   D   M   T   P   R   A   M   L   D   S   G   A   D   L   I   V 
 
ttt gcc acg gca acc tat ggc gaa ggc gaa ttt gcg ggt ggt ggc gca gcg ttc 
 F   A   T   A   T   Y   G   E   G   E   F   A   G   G   G   A   A   F 
 
ttt gag act ctg cgt gaa acc aaa ccc gat ctg agc ggt ctg cgt ttc gct gtg 
 F   E   T   L   R   E   T   K   P   D   L   S   G   L   R   F   A   V 
 
ttt ggt ctg ggc gat agc tat tac act acg ttt aac cag gcc ggt gca act gcc 
 F   G   L   G   D   S   Y   Y   T   T   F   N   Q   A   G   A   T   A 
 
gca acc att tta gcc agc ctg ggt ggt acc cag gtg ggt gat acg gcg cgc cac 
 A   T   I   L   A   S   L   G   G   T   Q   V   G   D   T   A   R   H 
 
gat act tcg tcg ggc gac gat cca gaa gaa acc gcc gaa gaa tgg gcc cgc gag 
 D   T   S   S   G   D   D   P   E   E   T   A   E   E   W   A   R   E 
 
atc ttg act gca ttg gca act ccg gca gtt agt taa taa 
 I   L   T   A   L   A   T   P   A   V   S   -   - 
          Stop codon 
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CinA-CinC fusion (linker length 0) 
 
Start codon 
atg ggc acc gcg acc gtg gcg agc acc agc ctg ttt acc acc gcg gat cat tat 
 M   G   T   A   T   V   A   S   T   S   L   F   T   T   A   D   H   Y 
 
cat acc ccg ctg ggc ccg gat ggc acc ccg cat gcg ttt ttt gaa gcg ctg cgt 
 H   T   P   L   G   P   D   G   T   P   H   A   F   F   E   A   L   R  
  
gat gaa gcg gaa acc acc ccg att ggt tgg agc gaa gcg tat ggc ggc cat tgg 
 D   E   A   E   T   T   P   I   G   W   S   E   A   Y   G   G   H   W 
 
gtg gtg gcg ggc tat aaa gaa att cag gcg gtg att cag aac acc aaa gcg ttt 
 V   V   A   G   Y   K   E   I   Q   A   V   I   Q   N   T   K   A   F 
 
agc aac aaa ggc gtg acc ttt ccg cgt tat gaa acc ggc gaa ttt gaa ctg atg 
 S   N   K   G   V   T   F   P   R   Y   E   T   G   E   F   E   L   M  
  
atg gcg ggc cag gat gat ccg gtg cat aaa aaa tat cgt cag ctg gtt gcg aaa 
 M   A   G   Q   D   D   P   V   H   K   K   Y   R   Q   L   V   A   K 
 
ccg ttt agc ccg gaa gcg acc gac ctg ttt acc gaa cag ctg cgt cag agc acc 
 P   F   S   P   E   A   T   D   L   F   T   E   Q   L   R   Q   S   T 
 
aac gat ctg att gat gcg cgt att gaa ctg ggc gaa ggt gat gcg gcg acc tgg 
 N   D   L   I   D   A   R   I   E   L   G   E   G   D   A   A   T   W 
 
ctg gcc aac gaa att ccg gcg cgt ctg acc gcg att ctg ctg ggt ctg ccg ccg 
 L   A   N   E   I   P   A   R   L   T   A   I   L   L   G   L   P   P 
 
gaa gat ggc gat acc tat cgt cgt tgg gtg tgg gcg att acc cat gtg gaa aat 
 E   D   G   D   T   Y   R   R   W   V   W   A   I   T   H   V   E   N 
 
ccg gaa gaa ggc gcg gaa att ttt gcg gaa ctg gtg gcg cac gcg cgt acc ctg 
 P   E   E   G   A   E   I   F   A   E   L   V   A   H   A   R   T   L 
 
att gcg gaa cgt cgt acc aat ccg ggc aac gat att atg agc cgt gtg atc atg 
 I   A   E   R   R   T   N   P   G   N   D   I   M   S   R   V   I   M 
 
agc aaa att gat ggc gaa agc ctg agc gaa gat gat ctg att ggc ttt ttt acc 
 S   K   I   D   G   E   S   L   S   E   D   D   L   I   G   F   F   T 
 
att ctg ctg ctg ggc ggc att gat aac acc gcg cgt ttt ctg agc agc gtg ttt 
 I   L   L   L   G   G   I   D   N   T   A   R   F   L   S   S   V   F 
 
tgg cgt ctg gcc tgg gat att gaa ctg cgt cgt cgt ctg att gcg cat ccg gaa 
 W   R   L   A   W   D   I   E   L   R   R   R   L   I   A   H   P   E 
 
ctg att ccg aac gcg gtg gat gaa ctg ctg cgt ttt tat ggt ccg gca atg gtg 
 L   I   P   N   A   V   D   E   L   L   R   F   Y   G   P   A   M   V 
 
ggt cgt ctg gtg acc cag gaa gtg acc gtt ggc gat att acc atg aaa ccg ggc 
 G   R   L   V   T   Q   E   V   T   V   G   D   I   T   M   K   P   G 
 
cag acc gcc atg ctg tgg ttt ccg att gcg agc cgt gat cgt agc gcg ttt gat 
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 Q   T   A   M   L   W   F   P   I   A   S   R   D   R   S   A   F   D 
agc ccg gat aac att gtg att gaa cgt acc ccg aac cgt cat ctg agc ctg ggt 
 S   P   D   N   I   V   I   E   R   T   P   N   R   H   L   S   L   G 
 
cat ggc att cat cgt tgc ctg ggc gcg cat ctg att cgt gtg gaa gcg cgt gtg 
 H   G   I   H   R   C   L   G   A   H   L   I   R   V   E   A   R   V 
 
gcg att acc gaa ttt ctg aaa cgc att ccg gaa ttt agc ctg gac ccg aat aaa 
 A   I   T   E   F   L   K   R   I   P   E   F   S   L   D   P   N   K 
 
gaa tgc gaa tgg ctg atg ggc cag gtg gcg ggc atg ctg cat gtg ccg att att 
 E   C   E   W   L   M   G   Q   V   A   G   M   L   H   V   P   I   I 
 
ttt ccg aaa ggc aaa cgt ctg agc gaa atg ggt aat gcc ctg att tta tat ggc 
 F   P   K   G   K   R   L   S   E   M   G   N   A   L   I   L   Y   G 
      CinC gene starts 
acg gag act ggt aat gcg gag gcg tgt gcg acc aca att tcg cag gtt ctg gcg 
 T   E   T   G   N   A   E   A   C   A   T   T   I   S   Q   V   L   A 
 
gat acc gtt gat acg aag gtg cat gat ctg gcc gat atg acc ccc cgc gca atg 
 D   T   V   D   T   K   V   H   D   L   A   D   M   T   P   R   A   M    
 
ctg gat agt ggt gcg gat ctg atc gtg ttt gcc acg gca acc tat ggc gaa ggc 
 L   D   S   G   A   D   L   I   V   F   A   T   A   T   Y   G   E   G    
 
gaa ttt gcg ggt ggt ggc gca gcg ttc ttt gag act ctg cgt gaa acc aaa ccc 
 E   F   A   G   G   G   A   A   F   F   E   T   L   R   E   T   K   P 
 
gat ctg agc ggt ctg cgt ttc gct gtg ttt ggt ctg ggc gat agc tat tac act 
 D   L   S   G   L   R   F   A   V   F   G   L   G   D   S   Y   Y   T 
 
acg ttt aac cag gcc ggt gca act gcc gca acc att tta gcc agc ctg ggt ggt 
 T   F   N   Q   A   G   A   T   A   A   T   I   L   A   S   L   G   G    
 
acc cag gtg ggt gat acg gcg cgc cac gat act tcg tcg ggc gac gat cca gaa 
T   Q   V   G   D   T   A   R   H    D   T   S   S   G   D   D   P   E    
 
gaa acc gcc gaa gaa tgg gcc cgc gag atc ttg act gca ttg gca act ccg gca 
 E   T   A   E   E   W   A   R   E   I   L   T   A   L   A   T   P   A    
 
gtt agt taa taa 
 V   S   -   - 
  Stop codon 
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CinA-CinC fusion (linker length 10 amino acids) 
 
Start codon 
atg ggc acc gcg acc gtg gcg agc acc agc ctg ttt acc acc gcg gat cat tat 
 M   G   T   A   T   V   A   S   T   S   L   F   T   T   A   D   H   Y 
 
cat acc ccg ctg ggc ccg gat ggc acc ccg cat gcg ttt ttt gaa gcg ctg cgt 
 H   T   P   L   G   P   D   G   T   P   H   A   F   F   E   A   L   R  
  
gat gaa gcg gaa acc acc ccg att ggt tgg agc gaa gcg tat ggc ggc cat tgg 
 D   E   A   E   T   T   P   I   G   W   S   E   A   Y   G   G   H   W 
 
gtg gtg gcg ggc tat aaa gaa att cag gcg gtg att cag aac acc aaa gcg ttt 
 V   V   A   G   Y   K   E   I   Q   A   V   I   Q   N   T   K   A   F 
 
agc aac aaa ggc gtg acc ttt ccg cgt tat gaa acc ggc gaa ttt gaa ctg atg 
 S   N   K   G   V   T   F   P   R   Y   E   T   G   E   F   E   L   M  
  
atg gcg ggc cag gat gat ccg gtg cat aaa aaa tat cgt cag ctg gtt gcg aaa 
 M   A   G   Q   D   D   P   V   H   K   K   Y   R   Q   L   V   A   K 
 
ccg ttt agc ccg gaa gcg acc gac ctg ttt acc gaa cag ctg cgt cag agc acc 
 P   F   S   P   E   A   T   D   L   F   T   E   Q   L   R   Q   S   T 
 
aac gat ctg att gat gcg cgt att gaa ctg ggc gaa ggt gat gcg gcg acc tgg 
 N   D   L   I   D   A   R   I   E   L   G   E   G   D   A   A   T   W 
 
ctg gcc aac gaa att ccg gcg cgt ctg acc gcg att ctg ctg ggt ctg ccg ccg 
 L   A   N   E   I   P   A   R   L   T   A   I   L   L   G   L   P   P 
 
gaa gat ggc gat acc tat cgt cgt tgg gtg tgg gcg att acc cat gtg gaa aat 
 E   D   G   D   T   Y   R   R   W   V   W   A   I   T   H   V   E   N 
 
ccg gaa gaa ggc gcg gaa att ttt gcg gaa ctg gtg gcg cac gcg cgt acc ctg 
 P   E   E   G   A   E   I   F   A   E   L   V   A   H   A   R   T   L 
 
att gcg gaa cgt cgt acc aat ccg ggc aac gat att atg agc cgt gtg atc atg 
 I   A   E   R   R   T   N   P   G   N   D   I   M   S   R   V   I   M 
 
agc aaa att gat ggc gaa agc ctg agc gaa gat gat ctg att ggc ttt ttt acc 
 S   K   I   D   G   E   S   L   S   E   D   D   L   I   G   F   F   T 
 
att ctg ctg ctg ggc ggc att gat aac acc gcg cgt ttt ctg agc agc gtg ttt 
 I   L   L   L   G   G   I   D   N   T   A   R   F   L   S   S   V   F 
 
tgg cgt ctg gcc tgg gat att gaa ctg cgt cgt cgt ctg att gcg cat ccg gaa 
 W   R   L   A   W   D   I   E   L   R   R   R   L   I   A   H   P   E 
 
ctg att ccg aac gcg gtg gat gaa ctg ctg cgt ttt tat ggt ccg gca atg gtg 
 L   I   P   N   A   V   D   E   L   L   R   F   Y   G   P   A   M   V 
 
ggt cgt ctg gtg acc cag gaa gtg acc gtt ggc gat att acc atg aaa ccg ggc 
 G   R   L   V   T   Q   E   V   T   V   G   D   I   T   M   K   P   G 
 
cag acc gcc atg ctg tgg ttt ccg att gcg agc cgt gat cgt agc gcg ttt gat 
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 Q   T   A   M   L   W   F   P   I   A   S   R   D   R   S   A   F   D 
agc ccg gat aac att gtg att gaa cgt acc ccg aac cgt cat ctg agc ctg ggt 
 S   P   D   N   I   V   I   E   R   T   P   N   R   H   L   S   L   G 
 
cat ggc att cat cgt tgc ctg ggc gcg cat ctg att cgt gtg gaa gcg cgt gtg 
 H   G   I   H   R   C   L   G   A   H   L   I   R   V   E   A   R   V 
 
gcg att acc gaa ttt ctg aaa cgc att ccg gaa ttt agc ctg gac ccg aat aaa 
 A   I   T   E   F   L   K   R   I   P   E   F   S   L   D   P   N   K 
 
gaa tgc gaa tgg ctg atg ggc cag gtg gcg ggc atg ctg cat gtg ccg att att 
 E   C   E   W   L   M   G   Q   V   A   G   M   L   H   V   P   I   I 
 
ttt ccg aaa ggc aaa cgt ctg agc gaa cct tct cca tct act gac caa tcc cct 
 F   P   K   G   K   R   L   S   E   P   S   P   S   T   D   Q   S   P 
             Linker sequence 
tct atg ggt aat gcc ctg att tta tat ggc acg gag act ggt aat gcg gag gcg 
 S   M   G   N   A   L   I   L   Y   G   T   E   T   G   N   A   E   A    
    CinC gene starts 
tgt gcg acc aca att tcg cag gtt ctg gcg gat acc gtt gat acg aag gtg cat 
 C   A   T   T   I   S   Q   V   L   A   D   T   V   D   T   K   V   H    
 
gat ctg gcc gat atg acc ccc cgc gca atg ctg gat agt ggt gcg gat ctg atc 
 D   L   A   D   M   T   P   R   A   M   L   D   S   G   A   D   L   I    
 
gtg ttt gcc acg gca acc tat ggc gaa ggc gaa ttt gcg ggt ggt ggc gca gcg 
 V   F   A   T   A   T   Y   G   E   G   E   F   A   G   G   G   A   A    
 
ttc ttt gag act ctg cgt gaa acc aaa ccc gat ctg agc ggt ctg cgt ttc gct 
 F   F   E   T   L   R   E   T   K   P   D   L   S   G   L   R   F   A    
 
gtg ttt ggt ctg ggc gat agc tat tac act acg ttt aac cag gcc ggt gca act 
 V   F   G   L   G   D   S   Y   Y   T  T   F   N   Q   A   G   A   T    
     
gcc gca acc att tta gcc agc ctg ggt ggt acc cag gtg ggt gat acg gcg cgc 
 A   A   T   I   L   A   S   L   G   G   T   Q   V   G   D   T   A   R    
  
cac gat act tcg tcg ggc gac gat cca gaa gaa acc gcc gaa gaa tgg gcc cgc 
 H    D   T   S   S   G   D   D   P   E  E   T   A   E   E   W   A   R    
 
gag atc ttg act gca ttg gca act ccg gca gtt agt taa taa 
E   I   L   T   A   L   A   T   P   A    V   S   -   - 
  Stop codon 
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